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ABSTRACT 
Resistant starch (RS) increases beneficial gastro-intestinal bacterial populations simultaneously 
increasing short-chain fatty acids (SCFA) such as butyrate. Butyrate acts as energy source for 
epithelial cells of colonic mucosa which stimulates intestinal cell proliferation and has been 
implicated as important in reducing obesity, diabetes and cancer. The Lactobacillus spp, 
Bifidobacterium spp, Bacteroides thetaiotaomicron, Clostridium cluster IV and Clostridium 
cluster XIV are mainly involved in the production of butyrate by fermenting RS in the large 
intestine. With age there is a decline in these gut bacteria, but in the present study RS and diet 
restriction both enhanced the bacteria involved in butyrate production.  In addition, RS reduces 
body fat in some types of obesity but not all.  For example, RS reduced body fat in an endocrine 
model of obesity caused by ovariectomy (OV).  In this study RS significantly increase bacterial 
populations involve in butyrate production.  However, in high fat diet induced obesity the results 
were different.  The high fat diet (41% dietary energy) prevented fermentation of RS and reduced 
bacterial populations in the ceca compared to a low fat diet (18% dietary energy). The RS failed 
to reduce obesity in these rodents fed a high fat diet while increasing Bacteroides group 
population. To follow up these studies and determine if type of fat was important in directly 
altering gut fermentation, an in-vitro fermentation model of rat large intestine was used.  Both 
Corn oil and Lard reduced bacterial populations which are involved in fermentation of RS.  
However, if the fat used was fish oil there were no negative effects on the fermentation of RS or 
the bacterial population. These studies illustrate the need to control the type of fat when studying 
the effects of prebiotics or other sources of resistant starch.  With the age Bifidobacterium spp, 
Bacteroides spp, Clostridium cluster IV and Clostridium cluster XIV decreased both calorie 
restricted diet and RS diets were able to improve these bacterial populations. 
1 
 
CHAPTER 1: INTRODUCTION 
  
2 
 
1.1 General Introduction 
Our gastro-intestinal system is sterilised when we are in the mother‟s womb, then rapid 
bacterial proliferation begins soon after birth.  Although within 24 hours after birth a newborn 
baby‟s  gut is proliferated with Coliform bacteria, Enterococcus, Lactobacilli, Staphylococci and 
some Clostridia spp, during the  next 3-4 days after birth, Bifidobacterium spp become dominant  
and remain throughout the infancy (Mitsuoka, 1978; Tannock et al., 1990). After the weaning 
stage, the infant‟s intestinal micro-flora changes rapidly and becomes similar to that of adults. A 
normal intestinal tract has around 10
14 
bacteria with more than 1000 different species (Rajilic-
Stojanovic et al., 2007). This wonderful ecosystem plays a vital role in safeguarding the health of 
the gut (Tlaskalova-Hogenova et al., 2004; Matsuki et al., 2004; Tomotari, 1978).  As a 
consequence of the digestive microbial ecosystem being very complex, it is not very well 
characterized.   Dietary changes regulate both quantitative and qualitative changes in microbial 
communities (Louis et al., 2007; Rudi et al., 2009). This modulation of host gut microbiota may 
help to regulate host health.  
 Prebiotics such as resistant starch stimulate the growth of beneficial bacteria in the 
colon, with the potential to increase fat oxidation and  reduce body fat while maintaining bowel 
health (Ferguson et al., 2000; Higgins, 2004; Higgins et al., 2004; Higgins et al., 2006; Keenan 
et al., 2006; Shen et al., 2009; Zhou et al., 2009).  Overweight and obesity are a major health 
concerns among developed countries; this has caused rapid growth of the weight reducing 
industry. Research into the beneficial effects of RS in controlling overweight and obesity has 
recently become a high priority of NIH (http://www.nih.gov/). To understand the real picture of 
lowering body fat microbial analyses are needed. 
3 
 
Short chain fatty acids (SCFA) such as acetate, propionate, and butyrate have been found 
in greater concentration in the feces of those consuming a diet containing RS (Hold et al., 2003). 
Benefits of and physiology of butyrate metabolism in the large intestine have been intensively 
studied by several investigators (Mortensen & Clausen, 1996; Hijova & Chmelarova, 2007). It is 
the major SCFA in providing protection against cancer and ulcerative colitis by reducing cell 
proliferation, by blocking the absorption of cancer-causing substances and by making the colon 
less vulnerable to DNA damage. It also helps to boost the absorption of calcium to maintain a 
healthy epithelium (Hagopien et al., 1977 ,Cummings & Macfarlane, 1991, Gibson et al., 1998). 
Fermentation of prebiotics such as RS in the large intestine, and production of butyrate is a 
complex process. Production of butyrate from RS requires the involvement of several groups of 
bacteria. The study of the fermentation of RS has demonstrated initial bacterial adherence to 
starch molecules especially by Bacteroides thetaiotaomicron, Bifidobacterium longum and some 
Lactobacillus spp (Bird et al., 2000; Xu et al., 2003; Louis, 2007). The main acidic fermentation 
products from Bacteroides thetaiotaomicron are acetate, propionate and succinate.  Lactate and 
acetate are produced by Bifidobacterium spp and Lactobacillus spp. Thus, these bacterial species 
adhere to the surface of starch molecules and ferment RS into intermediate products that are 
converted by other species to butyrate (Duncan et al., 2002; Duncan et al., 2004a; Duncan et al., 
2004b; Louis et al., 2007; Louis, 2007).  Those species fall under the Clostridium clusters I, III, 
IV, XI, XIVa, XV and XVI. The majority of the bacterial species that are butyrate producers are 
included in two Clostridium clusters - Clostridium cluster IV and Clostridium cluster XIV.   
Thus, resistant starch is a prebiotic and its fermentation results ultimately in production of 
butyrate through actions of several bacteria.  Production of butyrate from fermentation of dietary 
resistant starch is associated with reduced body fat in rats on a low fat diet (Keenan et al., 2006, 
4 
 
Shen et al., 2009).  However, it is known that adding higher than usual fat to the diet of the 
ruminant (Ferguson et al., 1990; Harvatine & Allen, 2006) or adding high fat to an in vitro model 
of the rumen (Ferguson et al., 1990) reduces fermentation.  The objectives of these studies were 
to investigate the effect of different diets, levels and types of fat on gut microflora involved with 
fermentation of RS.  To attain these goal three C57bl/6J mice studies, one rat study and one in-
vitro study were conducted. 
 
  
5 
 
CHAPTER 2: REVIEW OF LITERATURE 
  
  
6 
 
2.1 Gastro-Intestinal Tract Microbiota 
2.1.1 Development of Gastro-Intestinal Tract Microbiota 
The digestive system microbiota is a complex ecosystem system with the combination of 
bacteria, archaea, yeasts and filamentous fungi (Rajilic-Stojanovic et al., 2007).  Before birth the 
gastro-intestinal system is bacteria free. During the birth in short period of time infant has 
contact with the mother‟s vagina, feces, skin and the environment, resulting in a rapid bacterial 
proliferation in the infant‟s gastrointestinal system soon after the birth (Edwards & Parrett, 
2002).  In the caesarean babies gastrointestinal can inoculate during nursing and the handling. 
However cesarean infants seem to have a reduced
 
number of bacteria compared with those 
naturally delivered infants (Morelli, 2008). Kurokawa and his co-workers have found 136- 
unique infant intestinal microbiota, and out of those 78 were characteristic to infants (Kurokawa 
et al., 2007).  Within 24 hours of birth newborn baby‟s faeces contain variety of bacteria such as 
Coliform bacteria, Enterococcus, Lactobacilli, Staphylococci and some Clostridia spp. During 
the next 3-4 days after birth Bifidobacterium spp start to colonize and become dominant. Breast-
fed infant digestive tracts are dominated with both Bifidobacterium spp and Lactobacilli spp, 
whereas those who formula-fed infant digestive tracts prominent with more Bacteroides spp, 
Clostridia spp and Enterobacteriaceae family (Tannock et al., 1990; Edwards & Parrett, 2002). 
After the weaning stage the intestinal microflora changes rapidly similar to adults. During 
weaning introduction of solid food to the breast-fed infant causes a significant increase in the 
number of Enterobacteria and Enterococci, Bacteroides spp., Clostridium spp. and anaerobic 
Streptococci but addition of solid food to the diet of the formula-fed infant does not have such an 
impact on the gastro-intestinal flora (Stark & Lee, 1982).  
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2.1.2 Gastro-Intestinal Tract Microbiota in Adult 
  In adults, the combined microbial populations in the human body exceed 100 trillion 
cells, and are about 10 times more than total number of the human cells (Kurokawa et al., 2007). 
Our body can be known as „superorganisms‟ which is made up of „host‟ human cells and a 
complex ecosystem of indigenous microbes. Hence the human genes are naturally mixed with 
trillions of microbes which colonized in our bodies. The isolation of human genes from the 
microbe genes is impossible. Metagenome is the term applied to the complex interactions of the 
human genome with the microbial genome (Turnbaugh et al., 2006; Hattori & Taylor, 2009). 
The gastro-intestinal tract harbors a vast majority of microbiota more than anywhere else in the 
human body. A normal intestinal tract has around 10
14 
bacteria with close to 1000 different 
species (Cani & Delzenne, 2007). Even though the bacterial community in the gastro-intestinal 
tract is extremely diverse; the majority of species (98%) living in gastro-intestinal tract belongs 
to the few bacterial divisions or pyla. Those bacterial pyla are namely Firmicutes, Bacteroidetes 
Actinobacteria and Proteobacteria (Backhed et al., 2005).  The rests of species belong to minor 
taxonomic divisions that are secondary to the majority. The phylogenetic distributions of the 
human gastrointestinal prokaryotic phylotypes are clearly organized in Table 2.1.  
As explained in Rajilic-Stojanovic and coworkers 2007, other than bacteria Archaea, 
Eukarya and Viruses are also identified in the adult gastrointestinal tract. The major Archaeal 
communities that have been found in the human gut are Methanosphaera stadtmanae, 
Methanobrevibacter ruminantium and Methanobrevibacter smithii. The major eukaryote fungi in 
the human intestine are Candida, Aspergillus and Penicillium, and more than 1200 viral 
genotypes have also been identified in human feces (Rajilic-Stojanovic et al., 2007; Hattori & 
Taylor, 2009).  
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Table 2.1 The Phylogenetic Distribution of the Human Gastrointestinal Prokaryotic 
Phylotypes Based on SSU rRNA Gene Sequence (Rajilic-Stojanovic et al., 2007) 
Phylum Abundance Class Order Family/Cluster 
Firmicutes 10 
11
 
 
Asteroleplasma Anaeroplasmatales Anaeroplasmataceae 
Bacilli 
 
Bacillales 
 
Bacillaceae  
Staphylococcaceae 
Lactobacillales Aerococcaceae  
Carnobacteriaceae  
Lactobacillaceae  
Leuconostocaceae  
Lactococcaceae  
Streptococcaceae 
Clostridia Clostridiales Cl. cluster I  
Cl. cluster III  
Cl. cluster IV  
Cl. cluster IX  
Cl. cluster XI  
Cl. cluster XIII  
Cl. cluster XIVa  
Cl. cluster XV  
Unclassified  
Mollicutes Unclassified Cl. cluster XVI  
Cl. cluster XVII  
Cl. cluster XVIII  
Bacteroidetes 10 
11
 Bacteroidetes Bacteroidales Rikenellaceae  
Bacteroidaceae  
Prevotellaceae 
Porphyromonadaceae 
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(Table 2.1 Con’d) 
Phylum Abundance Class Order Family/Cluster 
Actinobacteria 10 
10
 Actinobacteria Actinomycetales Actinomycetaceae 6 
Corynebacteriaceae 6 
Micrococcaceae 4 
Propionibacteriaceae 
Bifidobacteriales Bifidobacterium 
Coriobacteriales Coriobacteriaceae 
Proteobacteria 10 
8
 Alphaproteobacteria 
 
Rhizobiales  
Sphingomonadales  
Unclassified 
Betaproteobacteria Burkholderiales 
 
 
 
Alcaligenaceae  
Oxalobacteriaceae  
Burkholderiaceae  
Incertae sedis  
Unclassified 
Neisseriales Neisseriaceae 
Gammaproteobacteria Aeromonadales Aeromonadaceae  
Succinivibrionaceae 
Enterobacterales Enterobacteraceae 
Pasteurellales Pasteurellaceae 
Pseudomonadales Moraxellaceae  
Pseudomonadaceae 
Vibrionales Vibrionaceae 
Xanthomonadales Xanthomonadaceae 
Deltaproteobacteria Desulfovibrionales Desulfovibrionaceae 
Epsilonproteobacteria Campylobacterales Campylobacteraceae 
Helicobacteraceae 
10 
 
It has been found people with the gastrointestinal conditions such as inflammatory bowel 
disease (IBD), allergy and cancer have reduced microbial diversity using 16S analysis  compared 
to those of healthy controls ( Penders et al., 2007a; Penders et al., 2007b; Xavier & Podolsky, 
2007; Hattori & Taylor, 2009). 
2.1.3 Composition of Intestinal Bacteria in Each Part of Digestive Tract 
The various different parts of the gastro-intestinal tract have different type of bacterial 
populations according to environmental condition. The mouth has the second largest population 
of bacteria that is influenced by large intestine having the largest population. The human oral 
cavity harbors around 10
10 
bacterial population with more than 500 bacterial species. The major 
inhabitant microbial divisions that inhibit the mouth are Firmicutes, Bacteroidetes, 
Proteobacteria, Fusobacteria and Actinobacteria (Tlaskalova-Hogenova et al., 2004). Due to the 
high acidity and digestive enzymes, the stomach contains the least amount of bacteria. Bacteria 
present in the stomach are attached to the gastric-epithelia or mucus (Tlaskalova-Hogenova et 
al., 2004). The stomach is mostly dominated by Gram positive and Gram negative aerobic 
bacteria and the overall bacterial population in the stomach is about 10
3
-10
4
. The most common 
micro-organism in the stomach is Gram negative Helicobacter pylori.   This organism is present 
in 30- 80% of healthy humans. This organism is an opportunistic pathogen and can cause 
gastritis, gastric ulsers and gastric cancers.   The small intestine harbors a relatively higher 
concentration of bacteria than the stomach, that are mainly Firmicutes such as Lactobacilli, 
Bacilli and Gram positive Coci but some Bacteroidetes, Proteobacteria, Fusobacteria and 
Actinobacteria. The bacterial population of the small intestine varies from 10
6
-10
8
. The large 
intestine contains an average of 10
11
-10
12
, and most of them are anaerobic or facultative 
anaerobic. The major divisions are Firmicutes, Bacteroidetes, Actinobacteria and Proteobacteria 
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(Table 2.1). The colonic microbiota changes due to a response in the nutritional shifts such as 
weaning, progressive changes such as aging or variation of food intake (Topping & Clifton, 
2001). 
                                 
Figure 2.1 Human Gastro-Intestinal Tract Microbiota (Rajilic-Stojanovic et al., 2007) 
2.1.4 Digestion in Simple Stomach Animals and Involvement of Microbiota  
The digestive system is one of the most complex and complicated biological system. The 
four major regions of the digestive system are the oral cavity, stomach, small intestine and large 
intestine.  Digestion of food starts in the mouth. During the oral phase of digestion food starts 
with mechanical breakdown, then salivary impregnation, α amylase hydrolysis and finally bolus 
formation occurs prior to swallowing (Woolnough et al., 2008). In the stomach hydrolysis of 
protein, carbohydrate and fat occurs. Protein digestion is initiated by pepsin and hydrochloric 
acid resulting in peptide formation; Carbohydrate digestion is initiated by salivary amylase and 
lipid digestion occurs with gastric lipase.  
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The food passing from the stomach is further hydrolyzed in the small intestine. Proteins 
and peptides passing from stomach expose to pancreatic enzymes such as trypsin, chymotrypsin, 
elastate, peptidase, carboxypeptidase and finally convert into free amino acids and smaller 
peptides. Carbohydrates are also further hydrolyzing by pancreatic amylase to maltose and to 
dextrin. Those are again exposing to maltase, lactase, sucrose, and isomaltase convert to 
monosaccharide. Lipid is also exposed to three different enzymes such as pancreatic lipase, 
carboxylic ester hydrolase, phospholipase and one coenzyme named colipase. The pancreatic 
lipase breakdown triacylglycerols into monoacylglycerols and fatty acids, the carboxylic ester 
hydrolase hydrolyses carboxylic esters, and phospholipase hydrolyses fatty acids in the 2-
position of glycerophospholipid. The presence of bile salts enhanced activity of lipase and 
absorption of long-chain fatty acids and monoacylglycerols. The amino acids, peptides simple 
sugar molecules and digested fatty acid are absorbed in small intestine (Boisen & Eggum, 1991).  
In the small intestine 98% of the fat is digested and absorbed. The reminders of digested fat (2%) 
carry over into the large intestine (Saunders & Sillery, 1988). 
In the large intestine endogenous microflora are directly involved with the digestion of 
dietary proteins and carbohydrates. From 10-20 % of endogenous nitrogen from protein intake in 
the small intestine is recovered by microflora in the large intestine. Dietary protein (ex. mucin) 
and dietary carbohydrates (ex. Resistant starch (RS), Fructo oligo sacharides (FOS), Inulin) are 
further hydrolyzed by bacterial enzymes. But fatty acids cannot be fermented by bacterial 
enzymes, so lipid is only marginally influenced during passage through the large intestine.  The 
major outcome of the dietary fibers and protein are Short chain fatty acids (SCFA), which can be 
absorbed and act as an energy source for humans (Boisen & Eggum, 1991). 
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2.2 Benefits of Microbiota in the Gut 
The first bacterial species recovered from a human gastrointestinal sample and identified 
was Escherichia coli, which was isolated in 1885 from children‟s diarrhoeal faeces (Rajilic-
Stojanovic et al., 2007). Microbes in the digestive system have a homeostatic symbiosis 
relationship in which the host provides a stable environment with nutrients and the microbes 
provide benefits to the host (Leser & Molbak, 2009). This wonderful ecosystem is playing a vital 
role by safeguarding the health of the gut (Tomotari, 1978 ;Tlaskalova-Hogenova et al., 2004).  
Gut microbiota are directly involved with several mechanisms including defense against 
pathogens, synthesis of vitamins, fermentation of dietary fibers and dietary proteins; priming the 
immune system early in life; Stimulating the gut motility (Topping & Clifton, 2001; Cani et al., 
2007a; Cani et al., 2007b ;Leser & Molbak, 2009). The gut microbiota helps to increase 
thickness of the villi in the intestinal wall. Germ free mice that are absences of gut 
microorganism resulted in a thinner villi and shorter crypt as well as low motility in the 
gastrointestinal tract (McCullogh et al., 1998; Langlands et al., 2004). The animals with gut 
microbiota conditions also exhibit fast epithelial cell turnover and it is twice faster compared 
with Germ free mice (Leser & Molbak, 2009). The microbiota in the gut contributes to the 
development of healthy conditions within the intestinal tract by fighting against colonization of 
pathogenic organisms suppressing. For example gut microbes such as Lactic acid bacteria 
produce antimicrobial peptides called bacteriocins which suppress the growth of potentially 
enteric pathogenic organisms (Itoh et al., 1995; Spinler et al., 2008).  Faecalibacterium 
prausnitzii provides protection against a major gastrointestinal condition named inflammatory 
bowel disease (IBD), Crohn‟s disease and ulcerative colitis (Sokol et al., 2008). Probiotics, live 
microorganisms that improve health on the host, are also using as antibiotic therapies (Mellon et 
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al., 2000; Kajander et al. 2008; Surawicz, 2003). For example Lactobacillus species, 
Enterococcus species, and S. boulardii have used as probiotics  to treat infective diarrhea in both 
adults and children and  that have shown   to be effective in the treatment of (Boyle et al., 2006). 
Dietary changes also regulate both quantitative and qualitative changes in microbial 
communities. The main factors affecting the GI microbial communities are: bacterial 
metabolism, competition and gut environment such as pH,  gases (oxygen and hydrogen), 
metabolite concentrations, the duration that food stays in the gastrointestinal tract, and host 
secretions such as acids, enzymes and hormones (Louis, & Others, 2007). Production of Short 
chain fatty acids (SCFA) is one of the most useful benefits of gut microbes.  
2.2.1 Benefits of SCFA Produced by Microbiota in the Gut 
Even though human beings are omnivorous the basic fermentative reaction in the human 
colon is similar to that in obligate herbivores (Topping & Clifton, 2001). Various bacterial 
populations involved with the process of SCFA production and those populations involves with 
conversion of polysaccharides, oligosaccharides, and disaccharides to their constituent sugars. 
This fermentation also yields metabolizable energy for microbial growth and maintenance and 
some metabolic end products. The fermentation of dietary carbohydrates and dietary protein in 
the mammalian gut is the results in production of high concentrations of SCFA. Intestinal 
microbial communities hydrolyze non-digestible plant polysaccharides such as lignin, 
hemicelluloses, pectin, cellulose and RS into SCFA. Other organism metabolise are carbon 
dioxide, hydrogen and methane.  The acetate, propionate, and butyrate have been found in 
greater concentration in the feces of those who consume a diet containing dietary fibers including 
RS (Morita et al., 1999). The typical ratios of SCFA in feces are proportion of 3:1:1 in acetate: 
propionate: butyrate (Duncan et al., 2002). These SCFA help regulate the colonic physiological 
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processes and maintain normal bowel function. Reduction of pH values from SCFA help to 
reduce the growth of pH sensitive pathogenic organisms, reduce absorption of toxic alkaline 
compounds with carcinogenic potential in the gut (Bird et al., 2000). In Inflammatory Bowel 
Disease (IBD) patients have reported lower levels of SCFA when compared to healthy 
individuals (Galvez et al., 2005).  
(a) Butyrate 
Benefits of butyrate and physiology of butyrate metabolism in the large intestine have 
been intensively studied by several investigators. Butyrate is a major energy source for epithelial 
cells of colonic mucosa which stimulates cell proliferation (Scheppach et al., 2001; Sato et al., 
2008). Butyrate is the major SCFA that in providing protection against cancer and ulcerative 
colitis by reducing cell proliferation, blocking the absorption of cancer-causing substances and 
making the colon less vulnerable to DNA damage (Pitcher & Cummings, 1996). It also helps to 
boost the absorption of calcium to maintain a healthy epithelium (Hagopien et al., 1977 
,Cummings & Macfarlane, 1991, Gibson et al., 1998). Keenan and his group  have shown that 
dietary resistant starch  was associated with increased gene and hormone expression for peptide 
YY (PYY) and glucagon-like peptide-1(GLP-1), which are also associated with increased 
butyrate in the cecum in rats (Keenan et al., 2006; Zhou et al., 2006).  
(b) Propionate 
Propionate is the primary precursor for gluconeogenesis and may inhibit liponeogenesis 
and protein synthesis (Louis et al., 2007; Schwiertz et al.2009). Propionate is believed to inhibit 
the synthesis of fatty acids in the liver and also
 
involved in the control of hepatic cholesterol 
synthesis.
 
It helps to lowers plasma cholesterol
 
concentrations by inhibiting hepatic 
cholesterogenesis through colonic fermentation (Cheng & Lai, 2000). The propionate 
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concentration and proportion of total SCFA increases significantly in lean to obese subjects 
(Schwiertz et al.2010). Production of propionate could be important factor that contributes to 
weight gain in obesity subjects. 
 (c) Acetate 
Acetate is the major SCFA produced by the colonic microflora. It is around 60–75% of 
the total SFCA detected in feces and it is formed by many of the colonic microflora and about 
one-third coming from reductive acetogenesis which is produced by anaerobic bacteria (Miller & 
Wolin, 1996; Louis et al., 2007). It is quickly absorbed soon after production and transport to the 
liver.  Because of that it is not metabolized in the colon. Remaining acetate is further utilized by 
colonic microbiota and covert in to butyrate. Acetate is essential for cholesterol synthesis in the 
body (Hijova & Chmelarova, 2007). The major benefit of acetate is it acts as an energy substrate 
for muscles and systemic circulation (the portion of the cardiovascular system which carries 
oxygenated blood away from the heart, to the body, and returns deoxygenated blood back to the 
heart). Acetate has been shown to suppress harmful bacteria (Araya-Kojima et al., 1995). 
2.3 Gut Hormones and Benefits  
Peptide YY (PYY) and glucagon-like peptide 1 (GLP-1), are two main hindgut hormones 
that are produced in greater amounts when increased food material passes through the small 
intestine in to the large intestine (Cani et al., 2005; Keenan et al., 2006; Zhou et al., 2006; Shen 
et al., 2009).  The gut hormone PYY is produced by L endocrine cells mainly located in the 
rectum, ileum, and large intestine (McGowan & Bloom, 2004).  GLP-1 is also produced by L 
endocrine cells that are located in the ileum and large intestine (Kreymann et al., 1987; 
Kreymann et al., 1988).  GLP-1 acts through binding to the GLP-1 receptors that are found on 
many cell types including, beta cells of the pancreas, neuronal cells in the brain, adrenal, 
17 
 
pituitary, kidney, and throughout the gastrointestinal tract (Gotthardt et al., 2006). GLP-1 
enhances both early and late phase of insulin secretion stimulated by glucose because of this 
GLP-1 is important in the treatment of diabetes mellitus (Wicki et al., 2007). GLP-1 controls 
feeding behavior in the brain that GLP-1 is more important on energy intake and energy 
expenditure make it a logical candidate for weight control (Perez-Tilve et al., 2006). 
Peptide YY (PYY) is also play a role in modulating energy balance and adiposity through 
control of food intake and nutrient partitioning.  It helps to inhibit both food intake and gut 
motility and fat oxidation (Adams et al., 2004; Adams et al., 2006). PYY is also important in the 
control of insulin sensitivity and controlling obesity (Boey et al., 2006a; Boey et al., 2006b; 
Boey et al., 2007).  
Increase of butyrate in the intestinal tract by fermentation of prebiotics may help to 
increase PYY and GLP-1 (Keenan et al., 2006; Zhou et al., 2006). PYY and GLP-1 are 
associated with reduced body fat and decreasing the blood glucose level, reducing body weight 
and improving insulin sensitivity in mammalians (Young et al., 1999). Lower respiratory 
exchange ratio is prominent in mice fed RS, indicating a partitioning of fat to oxidation rather 
than storage (Zhou et al., 2009).  
2.4 Probiotic, Prebiotic, Synbiotic and Gut Microbiota 
The term probiotic firstly defined by Parker then it modified by Fuller in 1989 as "A live 
microbial feed supplement which beneficially
 
affects the host by improving its intestinal 
microbial
 
balance" (Parker, 1974; Fuller, 1986, 1989).  The live microbial cultures that are 
present in dairy products sauerkraut, fermented cereals and other
 
plant-based foods, and salami 
are
 
known to be probiotic (Schrezenmeir & de Vrese, 2001). The main probiotic
 
microorganisms 
are in the genera of Lactobacillus, Bifidobacterium, and certain strains of Enterococcus and 
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Saccharomyces spp. Some of the species that are include Lactobacillus plantarum, Lactobacillus 
delbrüecki,
 
Lactobacillus bulgaricus , Bifidobacterium breve , B. longum, B. bifidum and 
Streptococcus
 
thermophilus.  
Probiotics should maintain following features:  
1. There should be the food products in addition to microorganisms. 
2. Microbial numbers should be at a sufficient number to exert health effects.  
3. Probiotics consumed in foods and dietary supplements are generally recognized as safe 
status (GRAS).   
Probiotics have shown vast range of health benefits including inhibiting the attachment and 
growth of pathogenic microbes in the epithelium of the intestinal tract.  For example 
Bifidobacteria are known to be involved in resisting the colonization of pathogens in the gut by 
producing bacteriocins, hydrogen peroxide, and biosurfactants (Macfarlane & Cummings, 1999).   
In-vitro and in-vivo studies showed that when pH-controlled co-culture of Bifidobacterium 
infantis was inoculated together with Escherichia coli, and Clostridium perfringens, with the 
presence of oligo-fructose the Bifidobacteria has expressed an inhibitory effect on the growth of 
the other two species (Cummings et al., 2001).The B. bifidum and Streptococcus thermophilus 
have also been used in studies of the prevention and treatment of rotavirus and diarrhea in 
children in the hospital (Saavedra et al., 1994). 
Lactobacillus probiotics can decrease intestinal mucosal permeability and prevent pathogenic 
activity (Reid, 1999). Lactobacillus GG (Lactobacillus casei sps. rhamnosus) exerted a 
beneficial effect on allergic reaction such as development of eczema by improving mucosal 
barrier function in pregnant women (Boyle et al., 2006). Probiotics are known to be enhanced the 
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immune response, increased ability to digest food, and alleviate many common digestive 
disorders such as constipation, diarrhea and Irritable bowel syndrome IBS. 
The term prebiotic was firstly defined by Gibson and Roberfroid as "a non-digestible 
food ingredient
 
that are beneficial to the host by selectively stimulating
 
the growth and/or activity 
of one or a limited number of bacteria
 
in the colon." this is overlaps with the
 
definition of dietary 
fiber (Gibson & Roberfroid, 1995; Schrezenmeir & de Vrese, 2001).  
Fiber can be divided in to three main categories which are dietary, functional and total 
fiber.  Dietary fiber includes non-digestible carbohydrates and lignin that are intrinsic and intact 
in plants, but functional fiber includes isolated, non digestible carbohydrates that have beneficial 
physiological effects in humans.  Total fiber is the combination of both dietary and functional 
fiber.  Some of the well recognized fermentable fibers that increase the beneficial bacterial loads 
in the large intestine are or Resistant starches (RS), and inulin, trans-galactosylated
 
oligosaccharides, soybean-oligosaccharides and oligo-fructoses or Fructo-oligosaccharides 
(FOS)  (Cani et al., 2004; Wang et al., 2004; Falony et al., 2006; Topping & Clifton, 2001). 
Dietary fiber which increase the beneficial bacterial loads in the large intestine are known as 
prebiotic.  
Resistant starch is considered as a prebiotic. The definition for the RS is starch which is 
resistant to digestive tract amylase. The RS can be divided in to four categories: 
1. Type1 or RS1 - found in whole grains with intact plant cell walls 
2. Type2 or RS2- consists of ungelatinized starch in high amylose cornstarches 
3. Type3 or RS3- retrograded starch formed from cooking and cooling or extrusion (Ex:  
Cooked potatoes).  
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4. Type 4or RS4 - chemically modified starch due to addition of esters, ethers and cross 
bonding.   
RS1 and RS2 can be digested by α-amylase the longer they remain in the small intestine, but 
RS3 and RS4 are not being digested in small intestine (Englyst et al., 1992; Cummings et al., 
1996). 
Resistant starch (RS) has been observed to benefit human health in numerous ways, 
including the potential decrease in metabolizable energy to reduce body weight while 
maintaining the bowel health (Ferguson et al., 2000; Keenan et al., 2006). Overweight and 
obesity are major health concerns among developed counties; overweight related maternal 
diabetes and hypertension in women can cause serious pregnancy-related complications, this has 
caused rapid growth of the weight reducing industry and in pregnant women. Research into the 
beneficial effects of RS in controlling weight has been a high priority. 
Synbiotics are defined as probiotic bacteria plus complex carbohydrates as prebiotics. When 
use combination of live probiotics with specific prebiotics
 
as a symbiotic, that combination will 
help for the survivability of probiotics. Prebiotics provides specific substrate which required for 
probiotic bacterial growth (de Vrese et al., 2001; Schrezenmeir & de Vrese, 2001). From this 
combination host is getting benefits from both probiotics and prebiotics. For example FOS and 
probiotic
 
Bifidobacterium or RS and Bifidobacterium or Lactobacillus would fulfill the 
definition.  
Synbiotic therapy is widely using to cure active inflammatory bowel disease (IBD), 
ulcerative colitis (UC) and Crohn disease (CD). The major advantage of using a synbiotic is that 
the prebiotic component would promote the growth of indigenous beneficial organisms in the gut 
with the help of probiotic properties. Furrie and colleagues conducted human clinical trials with 
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consumption of synbiotic (Bifidobacterium longum/Synergy 1) twice daily over four weeks. 
They have found significant reduced effect in mucosal inflammatory markers in active ulcerative 
colitis (Furrie et al., 2005). 
2.4.1 Fermentation of RS in the Large Intestine 
Fermentation of RS in the large intestine, and production of butyrate is a complex process. 
Production of butyrate requires several groups of bacteria.  The bacteria involved include 
Lactobacillus spp, Bifidobacterium spp, and Bacteroides spp. The majority of the bacterial 
species that are butyrate producers are included in two Clostridium clusters - Clostridium cluster 
IV and Clostridium cluster XIV (Louis et al., 2007a; Sato et al., 2008).  However, some butyrate 
producers are included in other Clostridium clusters I, III, XI, XV and XVIa. 
During the fermentation of RS, bacteria will attach to starch molecules (Figure 2.2) 
especially Bacteroides thetaiotaomicron, Bifidobacterium longum and some Lactobacillus spp 
(Bird et al., 2000; Xu et al., 2003; Louis et al., 2007b). However, Bacteroides spp, Lactobacillus 
spp and Bifidobacterium spp do not produce butyrate as a final product from RS. The end 
fermentation products for Bacteroides spp are acetate, propionate and succinate.  Lactate and 
acetate are produced by Bifidobacterium spp and Lactobacillus spp when fermenting RS. Thus, 
these bacterial species adhere to the surface of starch molecules and ferment RS into 
intermediate products that are converted by other species to butyrate (Duncan et al., 2002; 
Duncan et al., 2004a; Duncan et al., 2004b; Louis et al., 2007a).  
The butyrate producing bacteria are mainly species in Clostridium cluster IV and Clostridium 
cluster XIV.  Duncan and his collaborators initially discovered Coprococcus spp. and Roseburia 
spp. classified in Clostridium cluster XIV and the species Faecalibacterium prausnitzii that is 
classified in Clostridium cluster IV, that produce butyric acid from acetate. However, these 
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bacteria do not utilize lactate for production of butyrate (Duncan et al., 2002; Cani & Delzenne, 
2007). Later this same research group discovered lactate utilizing bacteria from human feces that 
produce butyrate as their main fermentation end product. Eubacterium hallii and Anaerostipes 
caccae from Clostridium cluster XIV were able to utilize both the D and L isomers of lactic acid 
while C. indolis from Clostridium cluster XIVa was only able to use D lactic acid (Duncan et al., 
2004b). Eubacterium limosum from Clostridium cluster XIVb also was able to convert lactate 
into acetate and butyrate in the presence of Bifidobacterium longum (Sato et al., 2008). 
                              
 
   
  
 
 
 
 
 
Figure 2.2  Bacteria Associated with Resistant Starch for the Production of Butyric Acid. 
(1a) High amylose starch granule (1b) after passage though small intestine and (1c) 
showing adherent bacteria (Bird et al., 2000; Topping & Clifton, 2001) 
(1c) (1b) 
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2.4.2 Bacteria involved with Fermentation of RS to Butyric Acid 
2.4.2.1 Bifidobacterium spp. 
Bifidobacterium spp is classified under phylum Actinobacteria; it is a Gram-positive 
strictly anaerobic branched rod that produces lactic and acetic acid without generation of CO2. 
The genus Bifidobacterium is the third most numerous bacterial populations in the human 
intestine after the genera Bacteroides and Eubacterium. Bifidobacterium is about 6% of total 
fecal bacteria (Matsuki et al., 2004). Bifidobacterium spp start to colonize the infants gut and 
becomes the predominant bacterial population during infancy then it gradually decreases during 
weaning stage becoming stable until adult hood but further decrease during old age (Edwards & 
Parrett, 2002; Mitsuoka, 1978; Mitsuoka, 1992). Bifidobacterium spp can be used as a probiotic 
because it improves the digestion absorption and immune system. Because of that it helps to 
decrease the side-effects of antibiotic therapy. It also provides protection against enteric 
pathogens, putrefactive substances, and believed to be involved with mechanisms of reduction of 
cholesterol levels and anti-tumoral activity (Leahy et al., 2005). Bifidobacterium spp. is involved 
in vitamin production and antagonic products production, like organic acids and bacteriocins. 
This organism shows synbiotic relationship with complex carbohydrates.  
It is well-known that Bifidobacterium spp promoted by the fermentation of dilatory fibers such as 
Resistant Starches, Fructo-oligosaccharides and inulin, transgalactosylated
 
oligosaccharides and 
soybean oligosaccharides
 
(Ito et al., 1993; Gibson et al., 1995; Gibson & Roberfroid, 1995; Cani 
et al., 2004; Wang et al., 2004; Falony et al., 2006; Topping & Clifton, 2001). Bifidobacterium 
spp is adhere to prebiotic and translocate starch molecules (change the position of starch 
molecules) and produce acetate and lactate as an end product, which help to promote butyrate. 
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(a) (b) 
Figure 2. 3 (a) Bifidobacterium bifidum, (b) Bifidobacterium longum.  ; Photograph:   From 
Nutrinibbles and Mark Schell, University of Georgia 
  
2.4.2.2 Lactobacillus spp. 
The members of the genus Lactobacillus are Gram-positive non-spore-forming rods 
(ranging from coccobacilli to long, slender bacilli organisms) that belong to the general category 
of lactic acid bacteria under phylum Firmicutes. Lactobacillus strains could grow under aerobic 
conditions, or even intestinal under anaerobic conditions.  Lactobacillus spp. produces lactic acid 
as the major acid during fermentation of glucose with acetic, succinic and formic acids in minor 
quantities.  
Lactobacillus spp. helps to decrease intestinal mucosal permeability that prevents 
entering pathogenic organisms by reducing pathogen adhesion. Some strains of Lactobacillus 
spp. can prevent adhesion
 
of pathogens by steric hindrance and by producing biosurfactants 
(Velraeds et al., 1996). Lactobacillus fermentum has evidence of reduction adhesion and 
competitive exclusion of pathogenic Escherichia coli, Listeria
 
monocytogenes, Shigella sonnei, 
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and Salmonella typhimurium in both in-vitro and animal studies (Reid, 1999). Lactobacillus 
GG (combination of Lactobacillus casei and L. rhamnosus) L. acidophilus, L. casei, L. 
plantarum, L. delbrueckii, and L. rhamnosus have shown beneficial effect on allergic reaction by 
modulation of immune system by increasing phagocyte activity and secretory
 
immunoglobulin 
(Perdigon et al., 1988a; Perdigon et al., 1988b).  L. acidophilus and L. casei are known to be 
balancing of gut microbiota and have shown anti-tumor effect. L. acidophilus, L. casei, L. 
gasseri, L. delbrueckii and L. plantarum are well studied for Prevention of diarrhea caused by 
Clostridium
 
difficile, Shigellae, Salmonellae, Campylobacter and E. coli. L. acidophilus effects
 
have been studied in humans as reducing problems associated
 
with lactose intolerance (Reid, 
1999). 
 
  
(a) (b) 
Figure 2.4 (a) Lactobacillus Bulgaricus , (b) Lactobacillus rhamnosus :Photograph: Visuals 
Unlimited/Corbis; bioweb.uwlax.edu 
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2.4.2.3 Bacteroide spp 
Bacteroides spp. is strictly anaerobic Gram-negative, dominant bacillus bacterial group in 
human gastrointestinal tract.  Bacteroides spp. could break down a wide variety of otherwise 
indigestible dietary carbohydrate by producing acetate and succinate as the major metabolic end 
products. Bacteroides thetaiotaomicron have been extensively studied by several investigators 
(Cani & Delzenne, 2007; Ley et al., 2008; Turnbaugh et al., 2009).  This organism increased 
rapidly soon after the introduction of prebiotics such as Resistant Starch. This bacterium attaches 
to starch molecules and starts the fermentation process (Wang & Gibson, 1993; Brown et al., 
1997; Bird et al., 2000). During young age higher population of Bacteroides spp. are seen in the 
intestinal tract compared to the elderly age. But the diversity among the genus Bacteroides 
increases with age. The highest diversity of genus Bacteroides could be seen in elderly 
population with compared to younger populations. 
 
(a) 
 
(b) 
Figure 5 (a) Bacteroides thetaiotaomicron (b) Bacteroides fragilis; Photograph:   From 
MicrobeWiki  
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2.4.2.4 Clostridium
 
Clusters 
Clostridium clusters categorization has done based on16S rRNA sequence analysis, 
According to Phylogenetic analysis of 16S rRNA genes shows that the group is very diverse, it 
includes non-clostridial species in deeply branching clusters. The main two butyrate producing 
Clostridium clusters groups that present in healthy humans are C. leptum group or Clostridium 
clusters IV (Figure 2.6) and Clostridium coccoides–Eubacterium rectale group or Clostridium 
clusters XIVa –XIVb (Figure 2.7).
 
Figure 2.6 C. leptum group or Clostridium clusters IV (Hold et al. 2003) 
 
2.5 Gut Microbes and Human Health 
2.5.1 Age and Related Effects in Gut Microbiota   
Our digestive tract microbial ecosystem changes with our age and the life pattern. 
Mother‟s vaginal birth canal introduces the very first bacterial inocula in to the babies during 
natural birth. During a cesarean section birth bacteria introduce in to babies during feeding and 
cleaning etc. The first bacteria in the gastrointestinal-tract harbours are Coliform bacteria, 
Enterococcus, Lactobacilli, Staphylococci and some Clostridia spp. 
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Figure 2.7 Clostridium coccoides–Eubacterium rectale group or Clostridium clusters 
XIVa-b (Hold et al. 2003 ) 
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These organisms appeared in newborn baby‟s feces within 24 hours after birth.  Soon 
afterword Bifidobacterium spp starts to colonize the gut and become dominant during the next 3-
4 days (Mitsuoka, 1978; Tomotari, 1978; Rajilic-Stojanovic et al., 2007). During the age of 2, 
after the weaning stage of babies, gut microbial diversity become similar to adults. Hence health 
and age-dependent changes in gut microbiota could be of major significance. The gut microbiota 
continues to evolve throughout the lifespan of the host. Children‟s digestive tract organisms are 
less complex bacteriologically than those of the adult (Tuohy, 2007).  During aging elderly 
populations,
 
indicated a decrease in Bifidobacterium spp. and an increase in Fungi, members of 
family Enterobacteriaceae, Lactobacillus spp.
 
and Clostridia spp.(C. difficile group) compared to 
adults (Hopkins et al., 2001; Mueller et al., 2006; Tuohy, 2007).  
Most of the age related gut microbial studies have been conducting in South East Asia 
and Europe for several decades (Rhodes et al., 1993; Sharma et al., 1995; Fukushima et al., 
1999; Mueller et al., 2006; Commane et al., 2009).  A Japanese group of scientist has found 
Clostridium
 
coccoides subgroup or Clostridium cluster XIVa tended to be lower in elderly than 
in younger Japanese
 
subjects.   Eventhough the Clostridium cluster XIVa including Clostridium 
leptum /Faecalibacterium prausnitzii
 
and relatives shows controversial results according to 
geographical location of the host (Mueller et al., 2006), several investigators have noticed 
reduction of Clostridium cluster XIVa with age.  
In all age group fecal samples contain E. coli and its occurrence is independent of age, 
whereas Enterobacter and Klebsiella spp have high counts in children and the elderly than in 
adults (Tuohy, 2007). Bacteroides thetaiotaomicron, B. ovatus, and Prevotella tannerae are 
commonly isolated Bacteroides spp. from younger adults. Although age-related reduction in the 
Bacteroides
 
group appeared, Bacteroides species richness was increased with age. The 
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Firmicutes/Bacteroidetes ratio increases with age that is from birth to adulthood and is further 
altered with advanced age (Mariat et al., 2009). 
2.5.2 Obesity and the Dominant Groups of Digestive Tract Bacteria 
Obesity is a growing epidemic in many developed western countries. Only in the United 
States more than half of the population is overweight and one third of the population obese. 
Obesity is a major concern because it‟s directly related to serious health consequences such as 
type 2 diabetes mellitus, cardiovascular diseases, pulmonary hypertension, obstructive sleep 
apnea, gastro esophageal reflux disease, musculoskeletal disorders, a variety of cancers, and even 
an increase risk of mortality.  A major reason for obesity is high energy intake with less physical 
activity, but resent findings suggest that the gut microbiota have direct effect on obesity (Ley; 
Ley et al., 2005; Ley et al., 2006; Turnbaugh et al., 2006; DiBaise et al., 2008). According to 
these articles gut microbiota is influencing energy harvest from dietary substances (Fiaf) of host 
as well as affecting genes that regulate how energy is expended and stored.  
  Lay and coworkers found variation in the microbial populations in the gut of obese and 
lean people. They suggest that obese people and mice demonstrated a lower percentage of 
Bacteroidetes and proportionally more Firmicutes than in lean. When the obese people lost 
weight their microflora reverted back to that observed in a lean person, suggesting that obesity 
may have a microbial component (Ley et al., 2006; Turnbaugh et al., 2006). Resent findings 
from Touhy and others suggested that obese animals have significantly lower Bifidobacterium 
spp. levels than their lean animals. Cani and co-workers had a controversial idea regarding 
metabolic endotoxaemia (ME) theory and Firmicutes to Bacteroidetes ratio.  According to this 
theory obese people and mice should demonstrated a higer percentage of Bacteroidetes and 
proportionally less Firmicutes than in lean (Cani & Delzenne, 2007). Similar results were 
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presented by Schwiertz and co-workers with the body Mass index (BMI). This article shows 
increase ratio of Firmicutes to Bacteroidetes with the obesity as well (Schwiertz et al.). 
2.5.3 Diabetics and the Dominant Groups of Digestive Tract Bacteria 
Diabetes also another growing epidemic is in the United States. Around 8% of adults are 
affected by this problem. This has potential of likely increase with the increase of child hood 
obesity (Robertson et al., 2005). Modulating gut microbial population could be beneficial for 
controlling diabetic by improving glycemic control and insulin sensitivity. The effect of gut 
microbiota on glycemia and insulinemia are not yet fully understood.   Moderate increase of 
plasma concentration of the bacterial lipopolysaccharide (LPS) may be responsible for the onset 
of metabolic diseases (Cani et al., 2008; Knauf et al., 2008). Modulation of gut microbiota by 
antibiotics such as norfloxacin and ampicillin improves whole body glucose tolerance and 
reduces hepatic steatosis/ fatty liver diseases. This could be used as a therapeutic strategy on 
controlling gut microbiota for treating or managing type 2 diabetes by reducing plasma LPS 
levels (Membrez et al., 2008).   
2.6 Analyzing the GI Microbiota 
2.6.1 Culture Based Techniques 
Plate based culture phenotypic characterization method is the traditional method for the 
identification and quantification of bacteria.  Even though most of the data available on the gut 
bacteria have been generated by cultivation and enumeration, it has some drawbacks. Those are 
inability to detect non-cultivatable bacteria and unknown species. Only 10% to 40% of complex 
bacterial communities cultured through the selective growth media and special growth conditions 
(Ott et al., 2006).  
32 
 
2.6.2 Nucleic Acid Based Methods for Analysing the GI Microbiota 
  Molecular techniques based Methods for analyzing the GI Microbiota have become 
popular in recent studies, since they do not require cultivation of microbes. It is evident that 10% 
to 40% or less of complex gut bacterial communities cultured through the selective growth media 
with special growth conditions. So that majority of the GI tract bacterial species cannot be 
cultivated. Due to that molecular methods based on 16S rRNA or 16S rDNA are more popular 
for analysis of gut microbiota. Those are namely fluorescent in situ hybridization, rRNA-targeted 
dot-blot hybridization with probes, denaturing gradient gel electrophoresis, temperature gradient 
gel electrophoresis, and cloning and sequencing of rDNA (Rinttila et al., 2004; Rajilic-
Stojanovic et al., 2007; Zoetendal et al., 2008).  
Early 2006, almost 900 rRNA gene based phylotypes originating from the human GI tract 
were available in public sequence databases (Rajilic-Stojanovic et al. 2007). The main phyla 
recognized by 16S rRNA gene sequencing-based studies are Firmicutes, Bacteroidetes, 
Proteobacteria, Actinobacteria, Fusobacteria and Verrucomicrobia (Eckburg et al., 2005; Wang 
et al., 2005; Dethlefsen et al., 2006). 
2.6.2.1 Real-time Polymerase Chain Reaction (PCR) 
Real-time PCR have several names. Those are kinetic PCR, qPCR, qRT-PCR and RT-
qPCR, which is quantitative PCR method for the determination of cope number of PCR 
templates such as DNA or cDNA in a PCR reaction. Higuchi and colleagues invented 
Quantitative real-time PCR in 1993. The first application was done using fluorescence of double-
stranded DNA (dsDNA)-bound ethidium and detect the accumulation of amplified DNA in the 
reaction (Higuchi et al., 1993).  
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Real-time PCR is based on the ability of quantifying the PCR product. There are several 
ways to detect the fluorescent PCR product. Those are Taqman PCR method and SYBER green 
method. 
(a) TaqMan Real-time PCR Method 
The principle of TaqMan real-time PCR is based on Thermus aquatic DNA polimarase 
cleaved fluorescence probe (TaqMan probe), which is designed to be complementary to a 
specific sequence spanned by the PCR primers.  The TaqMan probe has a reporter dye at its 
5́ end and a quencher dye at its 3́ end. The Quencher dyes usually FAM (6-carboxyfluorecein ) 
and TAMARA ( 6- carboxyl- tetra methyl -rhodamin). Using DNA binding dye more DNA 
copied created and florescence increased.   
SYBR Green method is an alternate method for TaqMan, which is used to perform real-
time PCR analysis. SYBR green is the most frequently used DNA binding dye in RT-PCR. 
SYBR Green is a dye that binds the minor groove of double stranded DNA, then intensity of the 
fluorescent emissions increases with more double stranded amplicons.  Figure2. 9 shows the 
entire process of each type of realtime chemistry.  
Running dissasociation curve is important for SYBER green based real-time PCR 
Method.  In SYBR Green RT-PCR, the SYBR Green dye can bind and detect any double 
stranded DNA as well as primer dimers. It is also able to detect contaminating DNA, and PCR 
product from misannealed primer. To prevail over these errors after the 40 reaction cycles, 
perform a dissociation curve following the real time PCR is needed.  
At the melting temperature, melting of the double-stranded DNA is indicated by a 
significant reduction in fluorescence .The real-time instruments generally plot disassociation 
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curves as a first derivative of decreasing the fluoracenc over Time. The Single peaks indicate a 
specific targeted product, without primerdimer artifact or contaminants, as in Figure 2.10 
 
Figure 2. 8 The Principle of TaqMan Real-time PCR: (1)Reporter and the quencher dyes 
are in close proximity, no fluorescence signal is emitted due to the quenching effect (black 
arrow in 1, 2, and 3), (2)  Soon after the annealing of the TaqMan probe (3) and the 
primers (4), the primers are extended by the DNA polymerase.  As the polymerase reaches 
the TaqMan probe, it uses its exonuclease activity to remove the probe one nucleotide at 
the time (5).  This releases the reporter from the proximity of the quencher and allows for 
the release of a fluorescence signal from the reporter (http://www.dpd.cdc.gov). 
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(b) SYBR green Real-time PCR Method 
 
 
 
Figure 2. 9 The Principle of SYBR Green Real-time PCR:(1-2). The fluorescent dye SYBR 
Green is added to the PCR mixture (3).  SYBR Green fluoresces strongly when bound to 
double-stranded DNA.  (4-5).  As the reaction proceeds and PCR product accumulates, the 
amount of double-stranded DNA increases and with it the fluorescence signal.  (6).  The 
signal is only detectable during annealing and extension, since the denaturation step 
contains predominantly single-stranded DNA. (http://www.dpd.cdc.gov). 
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.  
Figure 2.10 Dissasociation Curve Profile: the inflection point occurs at 82.5 
o
C  
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CHAPTER 3: CHANGES IN GUT MICROBIOTA BY DIETARY RESISTANT STARCH 
VERSUS ENERGY CONTROL DIET WITH LOW OR HIGH FAT LEVELS 
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3.1 Introduction 
Overweight and obesity are major health concerns among developed countries; this has 
caused rapid growth of the weight reducing industry. Research into the beneficial effects of RS 
in controlling overweight and obesity has recently become a high priority of NIH 
(http://www.nih.gov/).  
Like other ecosystems, the digestive microbial ecosystem is a complex system. Even 
though our gastro-intestinal system is bacteria free when we are in the mother‟s womb, rapid 
bacterial proliferation begins soon after birth (Tannock et al., 1990). Within 24 hours after birth a 
newborn baby‟s feces contains a variety of bacteria such as Coliform bacteria, Enterococcus, 
Lactobacilli, Staphylococci and some Clostridia spp. Within the next 3-4 days after birth, 
Bifidobacterium spp starts to colonize the gut and become dominant (Mitsuoka, 1978). After the 
weaning stage, the intestinal micro-flora change rapidly due to addition of different prebiotics 
(especially if breast fed) such as different carbohydrates and other dietary components in 
weaning foods that promote a baby‟s growth and the continued development of intestinal 
function (Edwards & Parrett, 2002). Gradually the microbial ecosystem becomes similar to 
adults. A normal intestinal tract has around 10
14 
bacteria with more than 1000 different species 
(Rajilic-Stojanovic et al., 2007). This wonderful ecosystem plays a vital role in safeguarding the 
health of the gut (Tlaskalova-Hogenova et al., 2004; Mitsuoka, 1978). As a consequence of the 
digestive microbial ecosystem being very complex, it is not very well characterised. Dietary 
changes regulate both quantitative and qualitative changes in microbial communities. The main 
factors affecting the microbial communities are: bacterial metabolism, competition and gut 
environment such as pH, oxygen and hydrogen; metabolite concentrations; the host‟s physical 
and chemical environment in the gastro-intestinal tract such as the duration that food stays in the 
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gastrointestinal tract; and host secretions such as acids, enzymes and hormones (Louis et al., 
2007; Rudi et al., 2009). Intestinal anaerobic and facultative anaerobic microbial communities 
help us in numerous ways; mainly by hydrolyzing non-digestible plant polysaccharides such as 
hemicelluloses, pectin, cellulose, resistant starch, lignin and proteins, by chemically altering 
conjugated bile acids, and by the synthesis of vitamins B12 and K.  
 Prebiotics such as resistant starch stimulate the growth of beneficial bacteria in the 
colon, with the potential to increase fat oxidation and reduce body fat while maintaining bowel 
health (Ferguson et al., 2000; Higgins, 2004; Higgins et al., 2004; Higgins et al., 2006; Keenan 
et al., 2006; Shen et al., 2009; Zhou et al., 2009). Overweight and obesity are major health 
concerns among developed countries; this has caused rapid growth of the weight reducing 
industry. Research into the beneficial effects of RS in controlling overweight and obesity has 
recently become a high priority of NIH (http://www.nih.gov/). To understand the real picture of 
lowering body fat microbial analysis is needed. 
Short chain fatty acids (SCFA) such as acetate, propionate, and butyrate have been found 
in greater concentration in the feces of those consuming a diet containing RS (Hold et al., 2003). 
These three SCFA account for 90- 95% of the total fatty acids produced by gut microflora (Wang 
et al., 2004). Colonic physiological processes and maintenance of normal bowel function are 
affected in part by SCFA. Increases in SCFA reduce pH values in the colon. This acidic 
environment reduces the growth of pH sensitive pathogenic organisms, the absorption of toxic 
alkaline compounds and the carcinogenic potential in the gut (Bird, Brown, & Topping, 2000). 
For example, in Inflammatory Bowel Disease (IBD) patients have lower levels of SCFA when 
compared to healthy individuals (van Nuenen et al., 2004). 
50 
 
Benefits of butyrate and physiology of butyrate metabolism in the large intestine have 
been intensively studied by several investigators (Mortensen & Clausen, 1996; Hijova & 
Chmelarova, 2007). It is the major SCFA in providing protection against cancer and ulcerative 
colitis by reducing cell proliferation, by blocking the absorption of cancer-causing substances 
and by making the colon less vulnerable to DNA damage. It also helps to boost the absorption of 
calcium to maintain a healthy epithelium (Hagopien et al., 1977 ,Cummings & Macfarlane, 
1991, Gibson et al., 1998). 
The butyrate producing bacteria fall under the Clostridium clusters I, III, IV, XI, XIVa, 
XV and XVI. The majority of the bacterial species that are butyrate producers are included in 
two Clostridium clusters - Clostridium cluster IV and Clostridium cluster XIV. Duncan and his 
collaborators initially discovered Coprococcus spp. and Roseburia spp. classified in Clostridium 
cluster XIV and the species Faecalibacterium prausnitzii which is classified in Clostridium 
cluster IV. These species are associated with production of butyric acid from acetate. However, 
these bacteria do not utilize lactate for production of butyrate (Duncan et al., 2002; Cani & 
Delzenne, 2007). Later this same research group discovered lactate utilizing bacteria from human 
feces that produce butyrate as their main fermentation end product. Eubacterium hallii and 
Anaerostipes caccae from Clostridium cluster XIV were able to utilize both the D and L isomers 
of lactic acid while C. indolis from Clostridium cluster XIVa was only able to use D lactic acid 
(Duncan et al., 2004b). Eubacterium limosum from Clostridium cluster XIVb also was able to 
convert lactate into acetate and butyrate in the presence of Bifidobacterium longum (Sato et al., 
2008). 
Thus, resistant starch is a prebiotic and its fermentation results ultimately in production of 
butyrate through actions of several bacteria. Production of butyrate from fermentation of dietary 
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resistant starch is associated with reduced body fat in rats on a low fat diet (Keenan et al., 2006, 
Shen et al., 2009). However, it is known that adding higher than usual fat to the diet of the 
ruminant (Ferguson et al., 1990; Harvatine & Allen, 2006) or adding high fat to an in vitro model 
of the rumen (Ferguson et al., 1990) reduces fermentation. Therefore, the aim of this experiment 
was to investigate the effect of a high fat diet on gut microflora involved with fermentation of 
RS. Female C57bl/6J mice were fed either a low (18% of dietary energy) or high fat (41% of 
dietary energy) diet with RS either presents (27% w/w) or absent in the diet. 
3.2 Material and Methods 
3.2.1 Animals and Diets 
Thirty-six C57bl/6J female mice ranging in age from 10 to 15 weeks were stratified by 
age and body fat and fed one of four diets, Low fat (Lo fat) Energy Density Control, High fat (Hi 
fat) Energy Density Control, Lo fat RS, or Hi fat RS, for two weeks with two levels of energy as 
fat (18% and 41%) and two levels of RS (0 and 27% w/w). Control diet contained cellulose to 
equalize the energy density to the RS diet. The diet table is shown in Table 3.1. Mice ceca were 
tied with threads, separated from the rest of the GI tract, and aseptically transferred to separate 
Whirl-pak bags. Whirl-pak bags were placed in a double Zip lock bag with an anaerobic 
GasPak™ EZ Gas generating Pouch System (BBL GAS PAK, Voiglobal Distribution INC. P.O. 
Box 1130, Lawrence, Kansas 66044-8130 USA) and immersed in ice. 
3.2.2 Microbial Analysis of the Cecal Contents 
3.2.2.1 Direct Plating 
Anaerobic and aerobic bacterial counts were enumerated using plate count methods. Ceca 
and contents were diluted 1:4 with peptone buffer solutions (PBS) and serial dilutions were 
made.  
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Table 3.1 Diet Compositions 
   
Ingredients 
Energy Density Control  RS diet 
High Fat   Low  Fat  High Fat   Low  Fat  
grams  kcal  grams  kcal  grams  kcal  grams  kcal  
Amioca® Cornstarch
1
   
100% amylopectin 
384.7 1346.5 450.7 1577.5 0 0 70 245 
Hi-Maize® Cornstarch
1
  
60% Amylose/ 40%  Amylopectin  
0 0 0 0 480.7 1346 480.7 1346 
Sucrose  100 400 100 400 100 400 100 400 
Casein  170 608.6 170 608.6 170 608.6 170 608.6 
Soybean Oil
2
 100 845 70 591.5 100 845 70 591.5 
Lard
2 
100 880  0 0 100 880  0 0 
Cellulose  96 0 160 0 0 0 60 0 
Mineral Mix  35 30.8 35 30.8 35 30.8 35 30.8 
Vitamin Mix  10 38.7 10 38.7 10 38.7 10 38.7 
Choline Chloride  1.3 0 1.3 0 1.3 0 1.3 0 
L-Cystine  3 12 3 12 3 12 3 12 
 Total  
1000 
g/kg  
3.3 
Kcal/g  
1000 
g/kg  
4.2 
Kcal/g   
1000 
g/kg  
4.2 
Kcal/g  
1000 
g/kg  
3.3 
Kcal/g  
1. Amioca®and Hi-Maize® cornstarches were gifts from National Starch and 
Chemical Company (Bridgewater, NJ).  Hi-Maize® cornstarch consists of 56% 
resistant starch determined by the Englyst method (Englyst et al., 1992) as provided 
by National Starch and Chemical Company. 
2. The fat levels in the low and high fat diets were 18% and 41% of energy, 
respectively. 
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3M Petrifilms were used to detect total E. coli-coliform and the Total Enterobacteriaceae 
family (3M Microbiology.St. Paul, MN).One milliliter of each dilution was plated onto E. coli-
Coliform Count Plates, and Enterobacteriaceae Count Plates, and plates were aerobically 
incubated at 37°C for 48 hrs. Lactic acid bacteria (LAB) were enumerated by using de Man-
Rogosa-Sharpe Agar (MRS agar) (Difco, Laboratories, Detroit, Michigan, USA). Reinforced 
Clostridial agar (Oxoid, Basingstoke, UK) plates were used to quantitate total anaerobic and 
Clostridial counts. The MRS agar plates were anaerobically incubated at 30°C for 48 hrs and 
reinforced Clostridial agar plates were anaerobically incubated at 37°C for 3-4 days in a 
chemically generated anaerobic system using anaerobic GasPak™ EZ in an anaerobic box 
(Mitsubishi Gas Chemical America, Inc., New York, N.Y.). Then the totals Colony Forming 
Units (CFU) were determined. 
3.2.2.2 DNA Extraction 
The above mentioned 1:4 diluted ceca samples which were used for direct plating were also 
used for DNA extraction.  DNA was extracted using
 
a QIAamp DNA Stool Mini kit (QIAGEN, 
Valencia, CA) using the
 
manufacturer's instructions with slight modifications. After adding stool 
lysis (ASL) buffer to samples of the diluted cecal contents (200 µl), the samples were subjected 
to three cycles of freeze-thaw in liquid
 
nitrogen and 5 min at 95°C in water bath  to break the 
thick gram positive bacterial cell walls. Purified DNA was quantified using a NanoDrop 
Spectrophotometer and all DNA sample extracts were diluted to 1ng/µl. Purified DNA was 
stored in a -80 
o
C freezer. 
3.2.2.3 Quantitative Real-time PCR 
The SYBR® Green method of quantitative real–time PCR (qRT-PCR) assay was 
performed using an ABI Prism 7900HT Sequence Detection System (serial 100151) (Applied 
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Biosystems, Foster City, CA). The information of the targeted bacterial groups, primer 
sequences, annealing temperatures and literature references are given in Table 3. 2. All reactions 
were performed in sterile MicroAmp® optical 384-well reaction plates with barcode sealed with 
MicroAmp® optical adhesive film (Applied Biosystems, Foster City, CA). All reactions 
consisted of 5µl of 2X SYBR Green Master Mix (Applied Bio systems, Foster City, CA,USA), 
0.5 µl of each primer at 10 µM, 0.5 µl of bovine serum albumin (BSA )  (final concentration 250 
mg /ml), 0.5 µl of  nuclease free water and  3 µl of  DNA template in a 10 µl total volume. The 
cycling conditions were 50°C for 2 min, 95°C for 10 min, then 40 cycles of 95°C for 15 s, 
primer-specific annealing temperature (Table 3. 2) for 1 min, then 78°C for 30 s. Following 
amplification, a dissociation step was included to analyze the melting curve of the amplified 
product to determine the specificity of the amplification. 
3.2.2.4 Preparation of PCR Standards for DNA Quantification 
To construct a standard curve for qRT PCR bacterial dilutions were prepared, Ct values 
(fractional cycle number) and CFU/ml for each dilution were determined for the following 
bacterial species Lactobacillus acidophilus ATCC 4646, Clostridium leptum ATCC 29065, 
Clostridium coccoides ATCC 29236, Bacteroides fragilis ATCC 25285, and Bifidobacterium 
longum ATCC 15708. Escherichia coli ATCC 25947 was used to construct the total bacterial 
(16S universal) domain standard curve (Table 3. 2).  
 Bacterial cultures were grown overnight and serial dilutions were made. Then for each 
dilution the Ct value was measured by qRT- PCR and plated onto appropriate media to 
determine the actual bacterial cells present in the overnight culture (CFU/ml). For real-time PCR, 
200 µl of each dilution tube was used to isolate DNA templates from the bacterial standard 
species listed above. DNA was isolated by the commercial QIAamp method as explained above. 
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qRT- PCR primers were used to amplify the16S rDNA (Table 3. 2). To determine CFU/ml 
unknown Ct values were compared to the Ct of the standard curves.  
 Table 3.2 16S rDNA qRT-PCR Primers Used to Profile Intestinal Samples 
Targeted bacteria 
 
Annealing 
Temp ( 
0
C) 
 
Sequence of oligonucleotide 
 
  
Reference 
 
standard 
curves 
Slope R
2
 
Firmicutes 
 
Lactobacillus spp 
 
60 
F -TGG ATG CCT TGG CAC TAG GA 
R- AAA TCT CCG GAT CAA AGC 
TTA CTT AT 
 
Haarman & 
Knol, 2006 
-3.5 0.98 
Clostridial cluster IV 
 (Clostridium leptum 
subgroup, includes 
Faecalibacterium 
prausnutzii) 
 
60 
 
F- TTA CTG GGT GTA AAG GG  
R- TAG AGT GCT CTT GCG TA 
Wise & 
Siragusa, 
2007 
-3.5 0.99 
Clostridium cluster 
XIVa and XIVb 
(Clostridium 
coccoides – 
Eubacterium rectale 
subgroup) 
 
50 
F- AAA TGA CGG TAC CTG ACT 
AA  
R- CTT TGA GTT TCA TTC TTG 
CGA A 
Matsuki et 
al. (2002) 
 
-3.6 0.99 
Bacteroidetes 
Bacteroides group 
including Prevotella 
and Porphyromonas 
 
60 
F -GAA GGT CCC CCA CAT TG 
R- CAA TCG GAG TTC TTC  GTG 
Wise & 
Siragusa, 
2007 
-3.5 0.99 
Actinobacteria 
Bifidobacterium spp 
 
60 
F –GGG TGG TAA TGC CGG ATG 
R- TAA GCC ATG GAC TTT CAC 
ACC 
Bartosch et 
al. (2004) 
-3.6 0.99 
 
Bacterial Domain 
16S universal primers  
60 F - TGSTGCAYGGYYGTCGTCA 
R -ACGTCRTCCMCNCCTTCCTC 
Belenguer, et 
al., 2006 
-3.2 0.99 
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To assess the correct annealing of primers during PCR melting curves profile of each 
bacterium was obtained and analyzed.  
3.2.3 Statistical Analysis 
 This study was analyzed as a completely randomized factorial with two independent 
variables, diet (two levels, RS or Energy control) and fat (low and high) using Two-way 
ANOVA to determine the main and interactive effects. Results were considered significant at 
p<0.05. Statistical analyses were done using SAS version 9.13 (SAS Institute Inc., Cary, NC). 
All data are presented as least square means (Ls means) with pooled SE. 
3.3 Results  
Using only culture based methods to examine samples from either cecal or fecal material 
gives a limited representation of the microbiota. Culture based methods will represent about 10 - 
40% of the microbiota in the gut (Sharp & Macfarlane, 2000). Most of the anaerobic colonic 
bacteria need special requirements such as substrates, the colonic environment, including co-
culture with other bacterial species, for proper growth in culture. Several of the culturable 
bacterial populations that we investigated in the current study are given in Table 3.3 Total 
culturable anaerobic bacteria and the total culturable LAB were incubated anaerobically; total 
coliform bacteria and total Enterobacteriaceae family bacteria were incubated aerobically. 
Total culturable anaerobic bacteria and total culturable Lactic Acid Bacteria (LAB) were 
significantly affected by the dietary fat level because animals fed low fat diets had greater 
numbers of bacterial populations in the cecal contents than those fed high fat diets. For these two 
types of bacteria there was also a significant diet effect as well because animals fed RS diets had 
greater numbers of bacteria in cecal contents than those fed the EC diet. These results emphasize 
anaerobe populations and facultative anaerobes such as LAB populations increased with the RS 
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diets. These diet effects confirmed previous findings (Kleessen et al.1997; Louis, Scott, Duncan, 
& Flint, 2007). Total Coliform and Enterobacteriaceae family bacteria were significantly greater 
in the two low fat diet groups in cecal contents than for the two high fat diet groups. However, 
there was a significant interaction as EC diet fed animals had higher Total Coliform and 
Enterobacteriaceae family bacteria than the RS fed with low fat diet, but the reverse was true 
with animals fed the high fat diets.  
Table 3.3 Total Culturable Anaerobic/Aerobic Bacterial Population  
Bacterial Population  
(Log CFU) 
Diets 
EC  RS  
High Fat   Low  Fat  High Fat   Low  Fat  
          
Total culturable anaerobic 
bacteria 
6.4 + 0.07 6.98 + 0.07 8.5 + 0.07 9.2 + 0.07 
Total Culturable LAB 7.18 + 0.10 7.65+ 0. 10 7.88 + 0. 10 8.42+ 0.10 
Total Coliform bacteria 3.99 + 0.11 6.36 + 0.11 5.12 + 0.11 4.49 + 0.07 
Total Enterobacteriaceae 
family bacteria 
3.99 + 0.11 6.77+ 0.11 5.04  + 0.11 5.32 + 0.11 
 
RS, resistant starch; EC, energy density control; Factorial statistical analysis demonstrated the following 
results: Total culturable anaerobic bacteria (Diet, p < 0.001; Fat, p < 0.053; Interaction, NS), Total 
Culturable LAB (Diet, p < 0.001; Fat, p < 0.014; Interaction, NS), Total Coliform (Diet, NS; Fat, p < 0.002; 
Interaction, p<0.0001); Total Enterobacteriaceae family (Diet, NS; Fat, p < 0.0002; Interaction, p<0.0007). 
One of our major interests for this study was the determining the changes in bacterial 
populations involved in the process of fermenting resistant starch (RS) to butyric acid in the 
ceca. 
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Table 3.4 Quantitative RT- PCR Results 
 Bacterial Populations  
 (Log CFU) 
Diets 
EC  RS  
High Fat   Low  Fat  High Fat   Low  Fat  
Firmicutes 
Lactobacillus spp 
7.99 + 0.15 8.31 + 0. 15 8.67 + 0. 15 9.4 + 0. 15  
Clostridial cluster IV 
 (Clostridium leptum subgroup, 
includes Faecalibacterium 
prausnutzii) 
9.12 + 0.22 9.49 + 0.22 9.69 + 0.22 10.26 + 0.22 
Clostridium cluster XIVa and XIVb 
(Clostridium coccoides – 
Eubacterium rectale subgroup) 
8.95 + 0.32 9.00 + 0.32 9.74 + 0.32 10.31+ 0.32 
Bacteroidetes 
Bacteroides group including 
Prevotella and Porphyromonas 
10.06 + 0.07 9.55 + 0.07 9.81 + 0.07 9.38 + 0.07 
Actinobacteria 
Bifidobacterium spp 
 
7.56 + 0.32 
 
7.35 + 0.32 
 
8.34+ 0.32 
 
9.33 + 0.32 
Bacterial Domain 
16S universal primers 
10.15 + 0. 15 10.68 + 0. 15 10.55 + 0. 15 11.11 + 0. 15 
Ratio of 
 Fermicute/ Bacteroidetes 
0.217 1.58 3.04 11.12 
RS, resistant starch; EC, energy density control; Factorial statistical analysis demonstrated the following 
results: Lactobacillus spp (Diet, p < 0.0004; Fat, p < 0.008; Interaction, NS), Clostridial cluster IV (Diet, p < 
0.01; Fat, p < 0.06, Interaction, NS), Clostridium cluster XIVa and XIVb (Diet, p < 0.01; Fat, NS, Interaction, 
NS); Bacteroides group (Diet, NS; Fat, p < 0.02, Interaction, NS),  Bifidobacterium spp (Diet, p < 0.002; Fat, 
NS, Interaction, NS), Bacterial Domain (Diet, p < 0.01; Fat, p < 0.003; Interaction, NS); Ratio of Fermicutes/ 
Bacteroidetes (Diet, p < 0.01; Fat, p < 0.03; Interaction, NS). All primers were sensitive and specific for the 
group that they were targeted as demonstrated by amplification. 
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The total culturable anaerobic bacteria population counts are reported in Table 3.3, we 
used Reinforced Clostridial agar plates. In these plates different anaerobic cultures have different 
growth rates and appearance.  For example most anaerobic cultures such as Bacteriodes spp. and 
Clostridium spp on this medium take relatively long periods (4-5 days) to appear on the plates 
while others appear within 2-3 days. Even though they eventually appear, several of these 
species could be hard to recognize in mixed cultures because some colonies are often tiny and 
colorless. These colorless tiny colonies would not be visible during counting with other colonies. 
However, our results were similar to previous studies with these culture techniques.  For better 
confirmation of results, molecular methods may be more appropriate.   
Bacterial populations involved in the process of fermenting resistant starch to butyric acid 
were further analyzed using qRT- PCR (Table 3.2) and the rsults were given in Table 3.4. 
Results for the Bacterial Domain and Lactobacillus spp showed significant effects for fat and 
diet because animals fed low fat diets versus high fat diets or RS diets versus EC diets had 
greater numbers of bacteria in the cecal contents. 
Bacteria from Clostridial clusters IV and Clostridial clusters XIVa - b were significantly 
greater in cecal contents of mice fed RS versus EC diets. However, the effect of fat only 
approached significance for Clostridial cluster IV as bacteria from cecal contents from mice fed 
the low fat diets were greater than for those fed the high fat diet. There were also a greater 
number of Bifidobacterium spp in cecal contents of mice fed the RS versus the EC diet. There 
was no effect of diet on bacteria from the Bacteroides genus in cecal contents of mice. However, 
mice fed the high fat diet had greater levels of Bacteroides genus in their cecal contents 
compared to mice fed the low fat diets. The ratio of Fermicutes measured to Bacteriodetes 
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measured was significantly greater in cecal contents of mice fed the RS versus EC diet and lower 
for mice fed the high fat versus low fat diet. 
3.4 Discussion 
The major reason for conducting this current study was to compare effects of high and low 
fat diets on fermentation. In a preliminary study (unpublished data) effects of fermentation of RS 
were not observed in rats fed a high fat diet. The results showed the pH was not reduced, the size 
of the cecum was not increased, SCFA including butyrate were not increased in cecal contents, 
and blood levels of PYY were not increased in rats fed RS in a high fat diet (41% of energy) 
compared to rats fed RS in a low fat diet (18% of energy). These results were in agreement with 
research with high fat diets in ruminant animals, as it is known that adding higher than usual fat 
to the diet of the ruminant (Ferguson et al., 1990, Harvatine and Allen, 2006) or adding high fat 
to an in vitro model reduces rumen fermentation. 
Resistant starch is defined as starch that is resistant to amylotic reaction in the small intestine. 
Once this resistant starch reaches the cecum of the large intestine it is fermented by the bacterial 
populations. Thus, resistant starch is considered a fermentable dietary fiber (DRI for 
Macronutrients, 2002/2005). The complex microbial community in the cecum consists of a 
diverse range of bacteria that are predominantly obligate anaerobes. These bacteria act together 
to ferment dietary substrates such as RS, producing a range of beneficial products that are 
favorable to maintain good health. In this study the main observation was that favorable bacterial 
populations which are involved in production of butyrate, such as Lactobacillus spp, 
Bifidobacterium spp, Clostridial cluster XIV a - b and Clostridial cluster IV populations were 
significantly higher in cecal contents of RS fed verses EC animals. Our research has 
demonstrated that RS increase SCFA in the cecum (Keenan et al., 2006), gene expression of 
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peptide YY (PYY ) and proglucagon (GLP-1) in the cecum (Keenan et al., 2006; Zhou et al., 
2006) and peptide levels of PYY and GLP-1 in the blood (Keenan et al., 2006; Zhou et al., 2008; 
Shen et al., 2009).  
Production of SCFA reduces gut pH which helps to maintain a healthy colon. For example, a 
pH of 6.8 is considered the pH of a healthy mammalian gut, and a pH of 7.5 and greater, can be 
indicative of many diseases, including bowel cancer (Pitcher & Cummings, 1996; Vulevic et al., 
2004; Van Nuenen et al, 2004). Butyrate is a well known SCFA, which helps to regulate colonic 
health (Sakata, 1987; Mortensen & Clausen, 1996; Weaver et al., 1997; Sharp & Macfarlane, 
2000; Topping & Clifton, 2001; Hijova & Chmelarova, 2007). Because of these benefits we 
were interested in studying population changes of bacteria involved in fermentation of RS 
ultimately to butyrate.   
The main observation in this study was favorable bacterial populations which involved the 
production of butyrate such as Lactobacillus spp Bifidobacterium spp, Clostridial clusters IV and 
Clostridial clusters XIVa - b and Bacteroides group population using qRT-PCR. All these 
populations were significantly high with the RS fed animal‟s ceca than EC fed animals except 
Bacteroides spp.  
In the present study, we have tested total culturable anaerobic bacteria; total culturable LAB; 
total Coliform and Enterobacteriaceae family using plate count methods. Both total culturable 
anaerobic bacteria (p < 0.001) and total culturable LAB (p < 0.001) were significantly increased 
with the RS fed animals than EC fed group. Both total Coliform and Enterobacteriaceae family 
bacterial populations were not significantly different from each other with the diet type. 
Lactobacillus spp and Bifidobacterium spp are two major probiotic groups that are used 
in the food industry. Some strains from these two genera start the fermentation of prebiotic by 
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attaching and changing the position (translocating) starch molecules (Duncan et al., 2002; Louis 
et al., 2007). Total culturable LAB populations (p < 0.001) in plate count method and 
Lactobacillus spp (p < 0.0004) and Bifidobacterium spp (p < 0.002) in Rt-PCR were 
significantly in mice on the RS diets. Both of these strains have beneficial health effect. Several 
investigators have shown that Lactobacillus Spp, such as L. acidophilus, L. reuteri, L. casei and 
L. gasseri, are able to remove cholesterol via various mechanisms and reduce serum total 
cholesterol concentration triglycerides in mice (Akalin et al., 1997; Xiao et al., 2003; Liong & 
Shah, 2005). Bifidobacterium spp such as Bifidobacterium longum, Bifidus Regularis™ / 
Bifidobacterium animalis also help to reduce serum total cholesterol concentrations in the blood 
aswell (Beena & Prasad, 1997; Xiao et al., 2003). In addition Bifidobacterium spp have 
beneficial effects on gut health and liver health (O'Sullivan, 2008). 
In this research the Bacteroides thetaiotaomicron species was not specifically measured, 
instead the Bacteroides group populations including Prevotella and Porphyromonas spp targeted 
primers were used enumerate the Bacteroides group. That may be the reason for not to get 
significant effect. In other words in this experiment, we expected significantly higher amounts of 
bacteria from the Bacteroides group in animals fed the RS diet. Because the Bacteroides 
thetaiotaomicron species is one of the bacterial populations reported to be attach to RS 
molecules to begin the fermentation process (Louis et al., 2007). However, our results 
demonstrated no effect of diet on the Bacteroides group; this could be because of the reduction in 
other species within the Bacteroidetes genus. Even though Bacteria from the Bacteroides group 
were not significantly increased with feeding of RS, increased amounts of these bacteria were 
associated with feeding a high fat diet. 
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With the high fat diet there were significant increases of Bacteroides group (p < 0.02) while 
significant reduction of Lactobacillus spp (p < 0.008), Bifidobacterium spp (p < 0.07) Clostridial 
cluster IV (p < 0.06) and Bacterial Domain (p < 0.003). Similar results for high fat diet were 
reported by Cani and his group with non-digestible but fermentable fiber. In that research they 
found feeding high-fat diet reduced number of Bifidobacterium spp, Clostridial cluster XIV a 
while increasing group and Bacteroides-related mouse intestinal bacteria (Cani & Delzenne, 
2007; Cani et al., 2007). Furthermore Their results suggest that gram negative bacteria, which 
include the Bacteroides group, increase plasma lipo- polysaccharide levels which activate the 
inflammatory response and the onset of obesity as well as type 2 diabetes (Cani & Delzenne, 20 
07). Another group of scientist  has been reported Lactobacillus Spp have ability to remove 
cholesterol via various mechanisms and reduce serum total cholesterol concentration 
triglycerides  in mice (Akalin et al., 1997; Xiao et al., 2003; Liong & Shah, 2005). Our current 
study animal fed hi fat EC diets have increased Bacteroides group while decreasing total 
Lactobacillus spp. According above two facts by increasing Bacteroides group while reducing 
Lactobacillus spp in the ceca badly affect for serum total cholesterol concentration triglycerides 
(Cani & Delzenne, 20 07; Lee et al., 2006). 
In this study we have used energy as fat 18% for LF diets and energy as fat 41% for HF diets. 
The energy values were, for LF 3.5 kcal/g and HF 4.2 kcal/g. Our results have shown reduction 
of total bacteria domain. Usually 98% of fat as a fatty acid is absorbed by the ileum part of small 
intestine and only 2% of fat enters in to the Large intestine or to the cecum (Saunders & Sillery, 
1988). This 2% of fatty acid which enter in to the cecum or large intestine with the RS might 
affect two ways. One of them is The free fatty acid entering in to the cecum can kill some of the 
native commensal bacterial populations by acting as antibacterial compounds. For example it has 
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been studied beneficial effect of antibiotic-like action of essential fatty acids against pathogenic 
bacteria (Das, 1985). The other one is some starch granule may cover with fatty acid layer and it 
might prevent the bacterial attachments. 
The Firmicutes to Bacteroidetes ratio may be important as an indicator for obesity (Ley et al., 
2006; Mariat et al., 2009; Schwiertz et al., 2009). However, the value of this ratio in favor of 
Fermicutes or Bacteriodites for obesity is uncertain at this time.  Ley et al. (2006) and Mariat et 
al. (2009) report greater ratios of Fermicutes to Bacteriodetes in obese subjects. The argument 
for the increased ratio of Fermicutes to Bacteriodetes in overweight and obese subjects is their 
increased ability to ferment fermentable fibers (Fermicutes include the bacterial populations that 
ferment the fermentable fibers such as RS and fructans) that allows for greater harvest of energy 
from the large bowel. But Schwiertz et al. (2009) had conflicting results. According to their 
study overweight (1.1) and obese subjects (1.2) have a significantly lower Firmicutes to 
Bacteroidetes ratio in fecal material than for non-overwieght subjects (3.3). They concluded that 
SCFA produced by the bacteria is more important to the obesity compired to number of bacteria 
in the gut (Schwiertz et al.2009). 
Our study had a greater ratio of Fermicutes to Bacteriodetes in mice fed RS, a fermentable 
fiber, this suggest that Fermicute bacteria can increase in numbers because they ferement RS and 
fructans (Sharp & Macfarlane, 2000; Louis et al., 2007). Our results of a greater Fermicute to 
Bacteriodetes ratio with feeding of a fermentable fiber are similar to those of Schwiertz et al. 
(2010) for lean subjects. However, our value is much higher because we used a fermentable fiber 
in our study, which is a prebiotic that is fermented by Fermicute bacteria. Our results agree with 
Cani and his group‟s theory that Gram negative gut microbiota such as Bacteriodetes increases 
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with the high fat diets and that increase the plasma lipopolysaccharide levels which trigger the 
inflammatory tone and the onset of obesity and type 2 diabetes. 
In previous studies, we showed lower abdominal fat with the consumption of low fat RS diets 
compared to diets with equal energy density (Keenan, et al., 2006, Shen et al. 2009, Zhou et al., 
2009). These results indicated that fermentable RS has possible physiological benefits, including 
lowering abdominal fat, beyond energy dilution alone. The ability to ferment RS appears to be 
necessary for the effect of lower abdominal fat as lean mice that fermented RS had lower 
abdominal fat, but polygenic obese mouse models that did not ferment RS did not have reduced 
abdominal fat (Zhou et al., 2009). Since rodents that are fed and ferment RS are leaner than 
controls, it would seem reasonable that the leaner rodents would share characteristics, such as 
Firmicute to Bacteriodetes ratio in the large gut, with lean people. As a result of reports of 
different values for the ratio of Firmicutes to Bacterioidetes, more research is needed to resolve 
the bacterial ecology issue. However, our results of the ratio of Firmicutes to Bacterioidetes are 
in agreement with those of Schwiertz et al. (2010). 
In this study, we hypothesized that bacterial fermentation of RS would be reduced and 
reflected by high fat diet. This result was observed for Lactobacillus spp., Clostridial cluster IV 
(p<0.06), the bacterial domain, and the Firmicute to Bacteriodetes ratio (qPCR results).  
Therefore, high fat diets may reduce beneficial results from incorporation of fermentable fibers 
in the diet. Our results support nutrition and health recommendations to avoid high fat diets 
(http://www.cnpp.usda.gov/dietaryguidelines.htm). 
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4.1 Introduction 
A high fat western diet with high energy density is a concern in developed western 
countries because of health problems associated with it such as obesity, diabetes miletus, 
coronary heart disease and colon cancer (Assmann et al., 1999; Cani & Delzenne, 2007; Cani et 
al., 2008; Shikany et al., 2009). Obesity is one of the major concerns in western countries 
including in the USA. According to resent survey childhood obesity was the number 1 health 
concern for kids in 2008 (Epstein et al., 2008; Wickham et al., 2009). These health issues are 
associated with enormous economic costs in leading public health issues in the western
 
countries. 
As a result interest of dietary fiber diet has increased, because it can help to maintain a healthy 
body weight and reduce obesity related health issues (Burton-Freeman, 2000; Slavin, 2005). 
Establishment of diverse gut bacterial microbiota is unique for each individual. Consumption of 
high fiber diet helps to improve gut microbial ecology. For example dietary fiber such as 
Resistant Starch, Fructo-oligosaccharides and inulin stimulate the growth of beneficial bacteria 
in the colon, with the potential to increase fat oxidation and reduce body fat while maintaining 
bowel health (Ferguson et al., 2000; Higgins, 2004; Higgins et al., 2006; Keenan et al., 2006; 
Zhou et al., 2008; Shen et al., 2009). Hence, the beneficial effects of RS in controlling 
overweight and obesity has increased interest in the scientific community. 
Butyrate, one of the principal colonic SCFA, is produced by fermentation of fiber 
including RS diet. Studies have shown that RS protects against colorectal cancer by maintaining 
healthy epithelium cells in the intestinal tract (McIntyre et al., 1993; Gibson et al., 1998). High 
fat levels can interfere with the fermentation of RS into butyrate by lowering the bacterial 
populations in the intestinal tract. Hence high fat diets can lower the expected benefits of RS 
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(chapter 3). Bearing this in mind, this experiment was designed to study the involvement of 
moderate levels of fat with RS fermentation using C57bl/6J female mice. 
4.2 Material and Methods 
4.2.1 Animals and Diets 
Thirty-six C57bl/6J female mice ranging in age from 10 to 15 weeks were stratified by age 
and body fat divided into 2 x 2 factorial four groups (n=9). All four mice groups were fed the 
control diet for the first six weeks prior to dietary treatment to observe energy intake and body 
weight gain. Then they were fed one of four diets, Low fat (Lo fat) Control, Moderate fat (M fat) 
Control, Lo fat RS, or M fat RS. Both M fat diets had equal energy density: 26% fat and Lo fat 
diets had 18% fat to equalize the energy density of the two diets; increased cellulose was added 
to the EC diet (Table 4.1).Mice were fed the diets for 10 weeks and at the end of the study, mice 
were sacrificed 
  Mice ceca were tied with threads, separated from the rest of the GI tract, and aseptically 
transferred to separate Whirl-pak bags. Whirl-pak bags were placed into a double Zip lock bag 
with an anaerobic GasPak™ EZ Gas generating Pouch System (BBL GAS PAK, Voiglobal 
Distribution INC. P.O. Box 1130, Lawrence, Kansas 66044-8130 USA) and immersed in ice. 
4.2.2 Microbial Analysis of the Cecal Contents 
4.2.2.1 Direct Plating 
Total Anaerobic and Lactic acid (LAB) bacterial counts were enumerated using plate 
count methods. Ceca contents were diluted 1:4 with peptone buffer solutions (PBS) and serial 
dilutions were made. LAB counts were enumerated by using de Man-Rogosa-Sharpe Agar (MRS 
agar) (Difco, Laboratories, Detroit, Michigan, USA). Reinforced Clostridial agar (Oxoid, 
Basingstoke, UK) plates were used to quantify total anaerobic and Clostridial counts.  
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Table 4.1 Diet Compositions 
Ingredient (g/kg) Energy Control   RS diet  
Moderate fat Low Fat   Moderate fat Low Fat   
Corn starch 432.5 424.5 0 0 
sistant starch 0 0 540.7 530.7 
Sucrose 100 100 100 100 
Casein 200 200 200 200 
Soybean oil 70 70 70 70 
lard 40 0 40 0 
Cellulose 108.2 156.2 0 50 
Mineral mix  
(AIN-93G) 
35 35 35 35 
Vitamin mix 
 (AIN-93G) 
10 10 10 10 
Choline chloride 1.3 1.3 1.3 1.3 
L-cystine 3 3 3 3 
Metabolizable 
Energy 
1000g/kg 1000g/kg 1000g/kg 1000g/kg 
(3.7kcal/g) (3.3kcal/g) (3.7kcal/g) (3.3kcal/g) 
Fat content 11%(wt/wt) 
26% (cal/cal) 
7%(wt/wt) or 
18% (cal/cal) 
11%(wt/wt)  
26%( cal/cal) 
7%(wt/wt) or 
18% (cal/cal) 
3. Amioca®and Hi-Maize® cornstarches were gifts from National Starch and 
Chemical Company (Bridgewater, NJ).  Hi-Maize® cornstarch consists of 56% 
resistant starch determined by the Englyst method (Englyst et al., 1992) and 
provided by National Starch and Chemical Company. 
4. The fat levels in the low and moderate fat diets were 18% and 26% of energy, 
respectively. 
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The MRS agar plates were anaerobically incubated at 30°C for 48 hrs and reinforced Clostridial 
agar plates were anaerobically incubated at 37°C for 3-4 days in a chemically generated 
anaerobic system using anaerobic GasPak™ EZ in an anaerobic box (Mitsubishi Gas Chemical 
America, Inc., New York, N.Y.). Then the total Colony Forming Units (CFU) were determined. 
4.2.2.2 DNA Extraction 
Bacterial DNA was extracted using the same method explained in Chapter 3. The above 
mentioned 1:4 diluted ceca samples were used for direct plating for DNA extraction with 
QIAamp DNA Stool Mini kit (QIAGEN, Valencia, CA). All the manufacturer's instructions were 
followed with slight modifications. Briefly adding stool lysis (ASL) buffer to the diluted cecal 
contents (200 µl), the samples were subjected to three cycles of freeze-thaw in liquid
 
nitrogen to 
a 5 min at 95°C water bath to break the thick Gram-positive bacterial cell walls. After the 
extraction of DNA the purified DNA was quantified using a NanoDrop ectrophotometer and all 
DNA extract samples were diluted to 1ng/µl. Purified DNA was stored at -80 
o
C freezer until 
used. 
4.2.2.3 Quantitative Real-time PCR 
The SYBR® Green method of quantitative real–time PCR (qRT-PCR) assay was 
performed using an ABI Prism 7900HT Sequence Detection System (serial 100151) (Applied 
Biosystems, Foster City, CA). The information of the targeted bacterial groups, primer 
sequences, annealing temperatures and literature references are given in Chapter 3, Table 3.2. All 
reactions were performed in sterile MicroAmp® optical 384-well reaction plates with barcode 
sealed with MicroAmp® optical adhesive film (Applied Biosystems, Foster City, CA) with 
Chapter 3 bacterial samples. Hence construction of a standard curve for real-time PCR bacterial 
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dilutions, Targeted bacteria, Annealing Temperature (
o
C), Sequence of oligonucleotide and 
information of the standard curves were exactly same as done in Chapter 3. 
4.2.3 Statistical Analysis 
 This study was analyzed as a completely randomized factorial with two independent 
variables, diet (two levels, RS or Energy control) and fat (low and Medium ) using Two-way 
ANOVA followed by least significant difference if the ANOVA F value was significant, p<0.05. 
Statistical analyses were done using SAS version 9.13 (SAS Institute Inc., Cary, NC). 
Again this study was analyzed by statistical comparisons of all pairs using the Student‟s t 
test following 1-way analysis of variance (ANOVA) (JUMP In version 7.0, SAS Institute Inc., 
Cary, N.C., U.S.A.). Statistical significance occurs for P<0.05.  
4.3 Results  
The results of both Total culturable anaerobic bacteria and Total culturable Lactic Acid 
Bacteria (LAB) bacteria are given in Figurer 4. 1 and Figurer 4.2. The statistical significant 
levels t < 0.05 were indicated in either gray or red color. 
Total culturable anaerobic bacteria and Total culturable LAB were not affected by the dietary 
fat level in p<0.05 significant level. Both of these two types of bacteria were showing significant 
diet effect, for animals fed RS diets with significantly higher bacterial counts in cecal contents 
than those fed EC diets. Both of these populations have significantly higher population in RS fed 
animals (p<0.0001). These results emphasize anaerobe populations and facultative anaerobes 
such as LAB populations increased with the RS diets but these levels were not affected with a 
moderate amount of fat.  
As we discussed in the Chapter 3, the bacterial populations involved in the process of 
fermenting resistant starch to butyric acid were further analyzed using qRT-PCR (Figure 4.3- 
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Figure 4.8). Even though culture based bacterial analysis methods to examine cecal samples 
gives a limited representation, this culturable method gives opportunity to isolate colonies for 
future studies. It also gives a good overview on total culturable populations. 
 
Figure 4.1 Analysis of Total Anaerobic Bacteria Counts: Fat NS, Diet p< 0.001, Fat x Diet  
NS 
All three Total bacterial domain, Lactobacillus spp., and Bifidobacterium spp. which 
analized using qRT-PCR were comparable to the Plate count results. Low and Moderate fat 
levels were not significant and no Fat and Diet interactions were detected for p<0.05 significant 
levels. RS fed animals had higher levels of Total bacterial domain, Lactobacillus spp., and 
Bifidobacterium spp. compared to the EC diet (p< 0.0001). The total bacterial domain Lo EC diet 
represented significantly lower bacterial population than Lo RS (p< 0.0001) and M RS (p < 
0.003) diets. Similarly, bacterial populations in M EC diet fed mice ceca were significantly lower 
than Lo RS (p<0.0001) and M RS (p< 0.0005) diets. Similar results were found for Lactobacillus 
spp., and Bifidobacterium spp. 
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Figure 4.2 Analysis of Culturable Lactic acid bacteria Counts: Fat NS, Diet p< 0.0001, Fat x 
Diet NS RS, resistant starch; EC, energy control 
 
Figure 4.3 Analysis of Total Bacterial Domain Counts: Fat NS, Diet p< 0.0001, Fat x Diet  
NS 
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Figure 4. 4 Analysis of Lactobacillus spp.Counts: Fat NS, Diet p< 0.0001, Fat x Diet  NS 
 
Figure 4.5 Analysis of Culturable Bifidobacterium Spp. Counts: Fat NS, Diet p< 0.0001, Fat 
x Diet NS 
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Figure 4. 6 Analysis of Bacteroides group Counts: Fat p< 0.062, Diet NS, Fat x Diet  NS 
 
Figure 4.7 Clostridium cluster IV Counts : Fat p< 0.004, Diet p< 0.0175, Fat x Diet p< 0.049 
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Both Fat levels and Fat and Diet interactions were not significantly detected for 
Bacteroides group for p<0.05 significant level however these fat levels were significant for 
p<0.06. The type of diet the mice were fed had no effect on the bacterial numbers for the 
Bacteroids group in the cecal contents. However, mice fed the moderate fat diet had higher 
counts of Bacteroides group in their cecal contents compared to mice fed the low fat diets.   
The Clostridium cluster group IV the fat levels were significant p<0.004 hence low fat 
diet fed mice ceca had significantly higher Clostridium cluster group IV than the medium fat diet 
fed mice ceca. Diet levels were also significant (p<0.01), in other words RS diet fed animals ceca 
had significantly higher Clostridium cluster group IV populations. At the same time Fat and diet 
interactions also significant (p< 0.05).  
 
Figure 4.8 Clostridium cluster XIV a-b Counts: Fat NS, Diet NS, Fat x Diet NS 
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Fat levels, diet type or fat diet interactions were not significant for Clostridium cluster 
group XIVa counts (p<0.05) but for animals fed low fat levels ceca contents had higher 
population of Clostridium cluster group XIVa counts.  
4.4 Discussion 
Our previous chapter emphasized that a diet high in fat interfered with the fermentation 
of RS and reduced the beneficial bacterial population involved in fermenting RS to butyric acid.  
In this current study our main objective was to identify what effect a moderate level of dietary fat 
had on fermentation of RS. 
Most of the analyzed cecal bacterial population did not significantly changed with 
moderate fat with compared to low fat diets. Those unchanged bacterial populations were total 
culturable anaerobic, total culurable LAB, total bacterial domain Lactobacillus spp., and 
Bifidobacterium spp. Although fat effect was not significant on these populations the diet levels 
were significant. In other words these bacterial populations were increased with RS diet with 
compared to EC diets. This also confirmed that as a prebiotic RS help to increase benificial 
bacterial populations which involved in fermentation of RS in to butyrate.  
Bacteroides group observations in this study (Moderate fat versus Low fat) were similar 
to observations inchapter 3 (High fat RS diet versus Low fat die).  The diet effect was not 
significant for p<0.05.therefor there are no effect RS on Bacteroides group population. Modarate 
fat fed animals ceca were observed higher population of  Bacteroides group than the animal fed 
low fat in p<0.06 significance level. 
  The bacterial species under Clostridium cluster group IV were sensitive for the medium 
fat diet and the Clostridium cluster group IV group were reduced by moderate fat in mice ceca 
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with compared to low fat diets. At the same time the Clostridium cluster group IV group was 
increased with RS diet. There were fat and Diet interaction also appeared. 
 According this observation we could argue that it is not essential to have a low fat diet to 
alter the all the bacteria in gut microbial profile, by consuming a moderate amount of fat with the 
RS similar benefits could be obtained.  
High dietary fat levels (41% of energy) had an impact on Gram positive bacteria which 
are involved with fermentation of fermentable fiber such as resistant starch (previous chapter). 
The fatty acids which enter into the cecum or large intestine might act as antibacterial 
compounds and interfere with bacterial cells by enhancing formation of cytoplasmic lipid 
droplets and affecting bacterial metabolism. In ruminants, the effect of high fat on fermentation 
has been well studied and fatty acids have exibited a direct effect on ruminal in-vitro (with pure 
cultures) bacteria (Jenkins, 1993). Our observation in this study indicated that a medium level of 
dietary fat (28% of energy) did not have the negative impact that high dietary fat had on 
fermentation. According to the observations in this chapter and in the previous chapter, the 
consumption of probiotics or synbiotics can be taken with a low fat or medium fat diet, but not 
with a high fat diet.  Further studies need to be done to determine the timing of the probiotics or 
synbiotics and consumption of foods contining high fat. Almost all the probiotics ( Lactobacillus 
spp., and Bifidobacterium spp.) are Gram positive bacteria, and consumption of these organisms 
with high fat levels might not give the expected result for consumers. 
The 2% of presumably digested, but unabsorbed fat from the moderate fat diet that 
entered the large intestine had a similar effect as the low fat diet. Nevertheless, further 
investigations
 
are needed to delineate the effect of different types of fat such as saturated, 
unsaturated and polyunsaturated fat in the fermentation of RS. Furthermore, investigations of 
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population variation of bacteria involved in RS fermentation to butyric acid in endocrine obesity 
and aging are needed. 
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5.1 Introduction 
Dietary resistant starch (RS) is beneficial to health in numerous ways. These benefits include, 
a decrease in metabolizable energy, reduction in body fat and obesity and improved bowel 
health. Short-chain fatty acids (SCFA), such as acetate, propionate, succinate, malate and 
butyrate are increased in the intestinal tract of animals and humans on a RS diet (Bird et al., 
2000). Adding RS to the diet promotes a greater ratio of butyrate to other SCFA and is associated 
with increased gene and hormone expression for peptide YY (PYY) and glucagon-like peptide-
1(GLP-1) and reduced body fat(Keenan et al., 2006; Zhou et al., 2006; Shen et al., 2009). 
However energy intake is not reduced in RS fed rats. Later studies demonstrated a lower 
respiratory exchange ratio in RS fed mice, indicating a partitioning of fat to oxidation rather than 
storage (Zhou et al., 2008). An increase of butyrate in the intestine may be important for reduced 
body fat and an important component of the mechanism for the control of obesity and for 
improving the health of the colon. Thus, fermentation of RS in the large intestine, and production 
of butyrate, continues to attract attention from the scientific community because of its 
importance to the health. 
Our previous work shows that high fat diet reduces cecal and fecal beneficial bacterial 
populations and fermentation in rats fed RS diets. Hence, effects of fermentation of RS were not 
observed in rats fed a high fat diet (Chapter 3). The results included: cecal pH was not reduced, 
the size of the cecum was not increased as expected, SCFA including butyrate and blood levels 
of PYY were not increased in cecal contents. 
Diets high in saturated fat result in poor health including increases in the onset of 
atherosclerosis (fatty material collects along the walls of arteries), obesity, diabetes and cardio 
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vascular disease. On the otherhand, high consumption of long chain poly unsaturated fatty acid 
(PUFA) helps to alleviate these conditions and has positive effects on health (Ravnskov, 1998).  
Natural fats are complex blends of triglycerides (Carey et al., 1983). For this research we 
used three types of digested natural fats and oil with RS, to understand the effect of different 
types of fat and oil on RS fermentation in the large intestine. Three different types of fats used 
for this study were lard, corn oil, and fish oil from tuna. Average western diet contain high 
amount of fat. That is about 150 g of triglyceride and 4-8 g of phospholipids mainly from animal 
origin lecithin (Carey et al., 1983). Hence these foods increase the risk of diseases such as 
obesity, diabetes and cardiovascular disease 
The present study focuses on the inhibitory effects of different types of fat; lard (a major 
source of saturated fatty acids); corn oil (a major source of unsaturated omega 6 fatty acids) and 
fish oil (a major source of omega 3 fatty acids) on RS fermentation and butyric acid producing 
microbiota.  
5.2 Materials and Methods 
We used an in-vitro anaerobic fermentation system to investigate the effects of different 
fats on fermentation and growth of bacteria in the following combinations:1) hydrolyzed RS 
(RS), 2) hydrolyzed RS combined with corn-oil (C/RS), 3) fish-oil (F/RS) and 4) lard (L/RS).  
5.2.1 Preparation of Fermentation Substrate 
5.2.1.1 Fat Hydrolysis  
Corn oil, tuna fish oil and lard were used as the major fat sources. Corn oil is contains 
mainly triglycerides with proportions of approximately 59% polyunsaturated fatty acids (PUFA), 
24% monounsaturated fatty acids (MUFA), and 13% saturated fatty acids (Dupont et al., 1990). 
Tuna fish oil contains 37.4% saturated fatty acids, 20.2 % MUFA, 5.4% omega 6 (also called 
ω−6 or n-6) long chain PUFA and 31.9% omega 3 (also called ω−3 or n-3) long chain PUFA 
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(Jenvanitpanjakul & Laixuthai ,1992: Napier & Sayanova, 2005). The fatty acid composition of 
corn oil, tuna fish oil and lard pig fat are given in Table 5.1, Table 5.2 and Table 5.3 
respectively. 
Table 5.1 Fatty Acid Composition of Mazola Corn Oil  
Fatty acid Composition  % 
Myristic 0.2 
Palmitic 9.9 
Stearic 2.9 
Saturated above CL8 0.2 
Hexadecenoic 0.5 
Oleic 30.1 
Linoleic 56.2 
Linolenic 0 
                                                                           (Kuksis & Beveridge, 1960) 
 
Table 5.2 Fatty Acid Composition of Tuna Fish oil 
Fatty acid Composition  % 
Myristic 3.8 
Palmitic 23 
PalmitoleateC16:1 (n-7) 7 
Heptadecanoic Acid (C17:0) 1.9 
Stearic (C18:0) 8.1 
Oleic(C18:0) (n-9 and n-7) 11.9 
Linoleic (C18:1) 1.3 
Alpha linolenic acid (C18:3)(n-3)  0.6 
Therapic Acid(C18:4) (n-3) 0.6 
Arachidic acid (C 20:0) 0.4 
Gadoleic acid. (20:1) 0.3 
Arachidonic acid (20:4) 2 
EPA / Eicosapentaenoic acid (C20 :5) 4.8 
DTA / Docosatetraenoic acid (C22:4)( n-6) 0.2 
DPA/ Docosapentaenoic acid  (C22:5) (n-6) and (n-3) 3.5 
Tetracosanoic acid 0.2 
DHA/docosahexaenoic acid (C22:6) (n-3) 24.3 
                                                                            (Jenvanitpanjakul & Laixuthai, 1992) 
Lard is pig fat composed of approximately 40.8% saturated fatty acids, 43.8% MUFA, 
and 9.6% PUFA (Dupont et al., 1990). 
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Table 5.3 Fatty acid composition of Lard Fat 
Fatty acid Composition  % 
Myristic 2 
Palmitic 26 
Stearic 14 
Oleic 44 
Linoleic 10 
Linolenic 0 
 
All three types of fat (corn oil, fish oil and lard) were separately hydrolyzed using 
pancreatic lipase as explained in Ferna´ndez-Moya et al., 2000. One gram of fat was hydrolyzed 
with 100 ml of pancreatic lipase. That is mixture of 2 g of P3292 Pancreatin from porcine 
pancreas powder (Sigma-Aldrich Corp. St. Louis, MO, USA) in 965 mL of 1 M Tris-HCl buffer 
(pH 8), with 10 mL of CaCl2 (22%) and 25 mL bile sat (0.1%)(Sigma Aldrich) for 5min. After 
digestion the solution was microwaved 1-2 min to stop the enzyme reaction and cooled over ice. 
Solidified fat were filtered through No1 watman filter paper (Whatman Int'l. Ltd. Maidstone, 
England) and washed two times with cooled water. Each digested fat was collected and stored in 
refrigerator. 
5.2.1.2 Carbohydrate Hydrolysis  
One hundred gram of RS was hydrolyzed with 240 ml of pancreatic amylase as explained 
in Al-Rabadi at el., (2009). That is mixture of 2 g of P3292 Pancreatin from porcine pancreas 
powder (Sigma-Aldrich Corp. St. Louis, MO, USA) in 965 mL of 1 M sodium acetate buffer (pH 
5), with 10 mL of CaCl2 (22%) and 25 mL bile sat (0.1%)(Sigma Aldrich) for 30min. After 
digestion the solution was microwaved 1-2 min to stop the enzyme reaction and cooled at room 
temperature. Precipitate included the undigested RS was separated from the solution by 
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centrifugation and then washed with distilled water twice.  Undigested RS was air dried under a 
sterilized hood and stored in refrigerator. 
5.2.1.3 Preparation of Four Different Types of Fermentation Substrates 
Fermentation substrates mix were made by using each type of above hydrolyzed fat (2%) 
separately mixing with hydrolyzed RS (98%) and compared to control RS (100%) to mimic the 
fermentation substrate entering to the large intestine (Saunders & Sillery, 1988).  
5.2.2 In- vitro System for Culturing Gut Microbiota 
To create complex microbial ecosystem similar to large intestine, four anaerobic 
fermenters were used. Each of the four reactors contains the microbiota of the rat gastrointestinal 
tract. The all four vessels were inoculated with pooled rat fecal samples, and the microbial 
ecosystem was sustained by the addition of a culture medium. A detailed scheme of the reactor 
setup is provided in Figure 5.1. 
5.2.2.1 Experimental Setup 
(a) Instrumentation 
The Simulator of the rat large intestinal microbial ecosystem consists of one liter media 
storage bottle with the stainless three steel port assemblies for adding and with drawing media 
(340 Edrudo Road Vineland, NJ 08360). This setup was maintained at a temperature of 37°C 
using an incubator. Each vessel simulates a one separate large intestine. One port of each 
fermenter was used for anaerobic gas supply, next for feeding and the last one for drawing the 
samples.  
The two- way variable-speed compact pump with four-channel pump head was used to 
fill and draw the vessel (Cole-Parmer, 625 East Bunker Court, Vernon Hills, IL 60061). For the 
tubing and connections Cole-Parmer Silicone auto analysis tubing, master flex barbed fittings 
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and connectors were used. After the experiment tubes were cleaned with diluted 2.5% NaOCl 
(Clorox ® bleach). 
  
(A)                                                                                  (B) 
Figure 5.1 Large Intestinal Microbial Ecosystem Consists (A)Before adding diets. (B) After 
adding diets.  1. Anaerobic gas cylinder, 2. LI vessel fermenters  [2.1 hydrolyzed RS (RS), 
2.2 combination of hydrolyzed RS with hydrolyzed corn-oil (C/RS), 2.3 hydrolyzed fish-oil 
(F/RS) and 2.4 hydrolyzed lad (L/RS)], 3. Magnetic stirrer, 4. Pump, 5. Pump head 
 
Each vessel was filled with 350 mL of anaerobic solution (Fig 5.1). The anaerobic 
solution prepared according to Monsma & Marlett, 1995, that was combining nine parts of 
solution A to one part of solution B. Solution A contained the following (per L of distilled 
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water): 0.14 mol NaHCO3, 11.1 mL hemin solution (0.78 mmol/L water), 1.1mL menadione 
solution (0.36 mmol/L water), and 1.1 mL resazurinsolution (3.98mmol/L water) as a redox 
indicator and autoclaved (121°C, 15 min) after preparation.  Solution B was made using 
autoclaved 1L distilled water and contained the 0.48mol NaCl and 0.02 mmol K2HPO4. 
Cysteine-HCl (0.63 mmol) was added to the inoculum buffer just before use to reduce the redox 
potential (Monsma & Marlett, 1995, 1996). After mixing solution A and Solution B pH was 
adjusted to 7.5pH with 0.1 M NaOH. 
After adding the anaerobic solution to the LI vessel fermenters, both anaerobic strip and 
magnetic string rod were placed in each vessel. All four LI vessels s were set up on top of a 
magnetic stirrer and anaerobic gas was pumped for 10 min until the color of the strip change 
from blue to colorless and stable. The composition of anaerobic gas was 80% N2, 10% H2, 10% 
CO2, supplied by a gas cylinder (Shahin et al., 2003).  There was no gas exchange between the 
different vessels and the headspace of the culture system was flushed after feeding and drawing 
of samples for 5 min to ensure anaerobic conditions. 
(b) Preparation of Fecal Inoculum 
 Rat feces were used as the inoculums of the LI vessel fermenters. After 12 days of the 
Resistant starch (RS) diet, within about a 1h period, 50 g of fresh feces were collected 
immediately upon voiding to Whirl-pak bag (Nasco - Fort Atkinson, 901 Janesville Avenue, P.O. 
Box 901, Fort Atkinson, WI 53538-0901). Whirl-pak bags were placed in a double Zip lock bag 
with an anaerobic GasPak™ EZ Gas generating Pouch System (BBL GAS PAK, Voiglobal 
Distribution INC. P.O. Box 1130, Lawrence, Kansas 66044-8130 USA) and immersed in ice 
until transfer to the lab. At the beginning of the experiment, the vessels were inoculated with a 
pooled fecal sample of rats. Aliquots (50 g) of freshly voided fecal samples were diluted and 
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homogenized with 200 mL anaerobic solution in Whirl-pak filter bag. Filtrate was collected into 
another sterilized Whirl-pak bag and Incubated in 37°C for1 hr under anaerobic condition using 
anaerobic Gas Pak™ EZ Gas generating Pouch System.  
After one hour, 50 mL of homogenized anaerobic inoculums was added in to the each LI 
vessels. When the fermenters were stabilized, 10 g of fermentation substrate were introduced 
separately to each fermenter. Anaerobic contents were aseptically collected into separate 15ml 
centrifuge tubes at 0, 1/2, 1, 2, 4, 12, 24, 48, and 72h in triplicates. This whole experiment was 
repeated three times and microbial analysis was done for each time point using plate count 
methods. qRt-PCR analysis was done for 0-24h samples. 
5.2.3 Microbial Analysis of the Anaerobic Contents 
5.2.3.1 Direct Plating 
Anaerobic and aerobic bacterial counts for each time point were enumerated using plate 
count methods. Using peptone buffer solutions (PBS), serial dilutions were made in anaerobic 
contents. MacConkey sorbitol agar was used to detect total E. coli (Difco, Laboratories, Detroit, 
Michigan, USA), and plates were aerobically incubated at 37°C for 24 hrs/ 1day. Lactic acid 
bacteria (LAB) were enumerated by using de Man-Rogosa-Sharpe Agar (MRS agar) (Difco, 
Laboratories, Detroit, Michigan, USA). Bifidobacterium agar (Oxoid, Basingstoke, UK) plates 
were used to quantify total Bifidobacterium spp. Counts. Reinforced Clostridial agar (Oxoid, 
Basingstoke, UK) plates were used to quantitate total anaerobic and Clostridial counts. The MRS 
agar plates were anaerobically incubated at 30°C for 48 hrs, Bifidobacterium agar plates were 
anaerobically incubated at 37°C for 2 days and reinforced Clostridial agar plates were 
anaerobically incubated at 37°C for 3-4 days in a chemically generated anaerobic system using 
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anaerobic GasPak™ EZ in an anaerobic box (Mitsubishi Gas Chemical America, Inc., New 
York, N.Y.). Then the totals Colony Forming Units (CFU) were determined.  
5.2.3.2 DNA Extraction 
Collected anaerobic contents from each fermenter in each time points used for DNA 
extraction using
 
a QIAamp DNA Stool Mini kit (QIAGEN, Valencia, CA) using the
 
manufacturer's instructions with slight modifications. After adding stool lysis (ASL) buffer to 
samples of the anaerobic contents (200 µl), the samples were subjected to three cycles of freeze-
thaw in liquid
 
nitrogen and a 5 min at 95°C water bath to break the thick gram positive bacterial 
cell walls. Purified DNA was quantified using a NanoDrop ectrophotometer and all DNA sample 
extracts were diluted to 1ng/µl. Purified DNA was stored in a -80 
o
C freezer. 
5.2.3.3 Quantitative Real-time PCR 
The SYBR® Green method of quantitative real–time PCR (qRT-PCR) assay was 
performed using an ABI Prism 7900HT Sequence Detection System (serial 100151) (Applied 
Biosystems, Foster City, CA) as explained in chapter 3.2.3 The information of the targeted 
bacterial groups, primer sequences, annealing temperatures and literature references were similar 
to chapter 3 Table 3. 2. Standards curves of DNA quantification disassociation curves are 
displaying in Appendix A. To determine CFU/ml unknown Ct values were compared to the Ct of 
the standard curves.  
5.2.4 Statistical Analysis 
The study was analyzed as a mixed model repeated time followed by Tukey to determine 
differences among levels of treatment (p<0.05). Statistical analyses were done using SAS version 
9.13 (SAS Institute Inc., Cary, NC). All data are presented as least square means (ls means) with 
pooled SE. 
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5.3 Results 
5.3.1 Direct Plate Count Results 
Culture-based methods were used to examine culturable bacterial counts in all four 
different anaerobic LI vessel fermenters and repeated three times. Each of these fermenters 
represented a single large intestine. Even though plating gives limited representation (10 - 40%) 
of the microbiota (Sharp & Macfarlane, 2000); plating helps to quantitate populations of 
culturable (live) bacterial populations. The variability of culturable bacterial population over 
time is given in the following Figures. Both substrate and time effects could be seen for all 
bacteria that were analyzed by plating (p< 0.05 significance level).  
  There were significant time and treatment effects (The effects of different fermentation 
substrate mixtures when means were collapsed over all times, up to and including 72 hrs) 
observed for all culturable bacterial groups which were analyzed in this study. Only the 
Bifidobacterium spp. (p< 0.002) demonstrated a significant interaction between time and the 
fermentation substrates. The total culturable bacterial counts were increased over the time up to 
24 hours and then decreased after that up to 72 hours, which was the total time of the incubation. 
The reason for the decline after 24 hours appears to be the reduction of substrate and the data 
after 24 hours are likely not meaningful. Hence the results were further analyzed up to and 
including 24hrs. 
Figure 5.2 indicates the population variation of total anaerobic bacteria including 
Clostridium spp up to 24 hrs. Treatment level means collapsed across all time points up to and 
including 24hrs for total anaerobic counts were RS=9.57, F/RS=9.01, L/RS=8.75 and C/RS=8.64 
Log CFU/ml. Total Anaerobic counts were significantly higher in RS substrate compared to the 
rest of the substrates. The second largest population was observed for F/RS substrate and that 
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also was significantly different from the growth of bacteria fed RS and L/RS. The populations 
that grew in L/RS and C/RS were not significantly different from each other. 
When we compared the growth over time for the population changes, all four 
fermentation substrates; RS, C/RS, L/RS and F/RS; when comparing the means across all time 
points through the 12 hr time point, RS fed anaerobic fermenters had higher populations of total 
anaerobic bacteria than F/ RS, C/RS and L/RS. F/RS and L/RS were not significantly different 
whereas C/RS had the lowest bacterial population. RS and F/RS were not significantly different 
and C/RS and L/RS were not significantly different.  
 
Figure 5.2 Effects of Different Fermentation Substrates on Total Culturable Anaerobic 
Bacteria Population Variation Analyzed by Direct Plate Count Method (Log CFU/mL): 
treatment p< 0.001, time p< 0.001, and treatment x time NS. Groups different from other 
groups are indicated with a, b and c for significant differences of substrate means across all 
time points for the 72hours: RS
a
, C/RS
b c
, L/RS
c
 and F/RS
b
.  
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Figure 5.3 indicates population variation of Total culturable Bifidobacterium spp. 
bacteria. Treatment level means collapsed across all time points up to and including 24hrs for 
Total Bifidobacterium spp. counts were RS=9.40, F/RS=9.17, L/RS=8.55 and C/RS=8.47 Log 
CFU/ml. Total Bifidobacterium spp. counts were significantly higher in the RS substrate than for 
the rest of the fermentation substrates, and the second largest population was observed for the 
F/RS substrate, which was also significantly different from the other two fermentation substrates. 
The L/RS and C/RS substrate samples were not significantly different from each other. 
  
Figure 5.3 Effects of Different Fermentation Substrates on Total Culturable 
Bifidobacterium spp. Population Variation Analyzed by Direct Plate Count Method (Log 
CFU/mL): treatment p< 0.001, time p< 0.001, and treatment x time p <0.002. Groups 
different from other groups are indicated with a, b and c for significant differences of 
substrate means across all time points for the 72hours: RS
a
, C/RS
 c
, L/RS
c
 and F/RS
b
. 
When we compared the trend of time with the growth of the population for all four 
substrates, RS, C/RS, L/RS and F/RS, the total culturable Bifidobacterium spp. were increased 
over the first 24 hrs. The highest bacterial populations were after 12hrs for F/RS and RS 
substrates, but for C/RS and L/RS media, the highest bacterial population was at 24hrs. There 
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also was a substrate by time interaction observed for culturable Bifidobacterium spp, likely the 
result of the F/RS substrate effect. The effect of hydrolised tuna fish oil on fermentation was 
very strong over the first 12 hours of incubation and then dropped off by 24 hours. This may be 
due to using up all the fish oil substrate. 
 
Figure 5.4. Effects of Different Fermentation Substrates on Total Culturable LAB 
Population Variation Analyzed by Direct Plate Count Method (Log CFU/mL): treatment 
p< 0.001, time p< 0.001, and treatment x time NS. Groups different from other groups are 
indicated with a, b and c for significant differences of substrate means across all time 
points for the 72hours: .RS
a
, C/RS
b
, L/RS
b
 and F/RS
a
. 
Treatment level means collapsed across all time points for Total Lactic Acid Bacteria 
(LAB) populations time points up to and including 24hrs were RS=8.28, F/RS=7.96, L/RS=7.28 
and C/RS=7.41 Log CFU/ml (Figure 5.4). LAB counts were significantly higher in both RS 
substrate and F/RS substrate and bacterial counts for these substrate samples were not 
significantly different from each other. These substrates were also significantly different from 
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the other two fermentation substrates. The L/RS and C/RS substrate samples were not 
significantly different from each other. 
The mean population of LAB at 12
 
hrs in RS fed fermenter was significantly higher than 
the means for F/ RS, C/RS and L/RS. Bacterial populations of F/RS and L/RS means were not 
significantly different whereas the C/RS substrate had the lowest mean bacterial population. The 
analysis of the means at the 24 hour time point indicated that both the RS and F/RS fed anaerobic 
fermenters had significantly higher populations of total LAB than both C/RS and L/RS. Means 
for RS and F/RS were not significantly different from one another, and similarly C/RS and L/RS 
were not significantly different.  
  
Figure 5.5 Effects of Different Fermentation Substrates on Total Culturable E.coli 
Population Variation Analyzed by Direct Plate Count Method (Log CFU/mL): 
treatment p< 0.04, time p< 0.001, and treatment x time NS. Groups different from 
other groups are indicated with a, b and c for significant differences of substrate 
means across all time points for the 72hours: RS
a
, C/RS
b
, L/RS
b
 and F/RS
b
. 
Culturable E. coli counts were plated on Sorbitol MacConkey Agar and all the colonies 
were dark pink in color. Hence we did not see any potentially pathogenic E. coli counts on these 
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plates, which would have appeared as a light pink. The only difference for E. coli counts 
populations time points up to and including 24hrs was significant for RS compared to the other 
fermenters. Treatment level means collapsed across all time points up to 24hours were RS=7.18, 
F/RS=6.64, L/RS=6.57 and C/RS=6.54 Log CFU/ml. The analysis of the means culturable E. 
coli counts at the 24 hour time point indicated that all four fermenters (RS, F/RS C/RS and L/RS) 
were not significantly different.Further detailed information about the analysis of culturable 
bacterial levels is in the Appendix. 
5.3.2 Quantitative RT-PCR Count Results 
The plate count results were further confirmed by qRT- PCR analysis. The bacterial 
populations for the qRT-PCR analyses were not identical to the cultured analyses as the goal was 
to more specifically target the bacteria known to ferment RS to butyric acid. QRT-PCR is more 
targeted and allows for better detection of specific bacterial populations than with culture. As 
with culture, LAB populations and bifidobacteria were included. However, Clostridial clusters 
IV and Clostridial clusters XIVa and b are major butyrate producers (Louis et al., 2004; Louis et 
al., 2007). Instead of total anaerobic culture, the total bacterial domain was also included in qRT-
PCR analyses. In order to calculate a Bacteriodetes to firmicutes ratio, the Bacteriodes group 
including Prevotella and Porphyromonas was also included. All the qRT-PCR sample analyses 
were performed on samples collected up to and including the 24 hour time point as the culture 
analyses indicated that substrates for total anaerobic bacteria and Bifidobacteriam spp. may have 
become limited after 24 hours.   
There was a significant time effect observed for all bacterial groups and strains which 
were analyzed using qRT-PCR. The effect of different fermentation substrate mixtures when 
means were collapsed over all times, up to and including 24 hrs was significant for three of the 
101 
 
six bacterial populations measured, Lactobacillus spp. (p< 0.005), and Bifidobacterium spp.  (p< 
0.001) and Clostridial cluster IV(p< 0.04) . For Clostridial cluster XIVa and b there was not a 
significant effect for fermentation substrate mixtures, but the fermentation substrates effect 
approached significance (p< 0.09). Similar to the results with culturable bacterial populations, 
only the Bifidobacterium spp. demonstrated an interaction between time and the fermentation 
substrates that only approached significance (p<0.06).  Again, the F/RS substrate mixture 
appears to have a different response in Bifidobacterium spp. growth over time compared to the 
other three media groups (Figure 5. 6). 
  
Figure 5.6 Effects of Different Fermentation Substrates on Bifidobacterium spp. Population 
Variation Analyzed by qRT PCR (Log CFU/mL): treatment p< 0.007, time p< 0.006, 
treatment x time p< 0.06.  Groups different from other groups are indicated with a, b and c 
for significant differences of substrate means across all time points for the 72hours:  RS
a
, 
C/RS
bc
, L/RS
c
 and F/RS
ab
.  
The Bifidobacterium spp. treatment level substrate means collapsed across all time points 
up to and including 24 hours were RS=7.72, F/RS=7.59, L/RS=7.38 and C/RS=7.49 Log 
CFU/ml. Bifidobacterium spp. populations were significantly higher for RS compared to C/RS 
and L/RS substrates. However, levels in RS fermenters only approached a significant difference 
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with F/RS (P< 0.103). The F/RS fermenter was significantly different from L/RS and F/RS 
fermenters. Bifidobacterium spp. with F/RS increased until 12 hours and then decreased by 24 
hours. This appears to be what produced the time by substrate effect for Bifidobacteria spp.that 
approached significance (p<0.06). At the 12 hr time point L/RS had the lowest count compared 
to the rest of substrate fermenters.  
 
 
Figure 5.7. Effects of Different Fermentation Substrates on Lactobacillus spp. Population 
Variation Analyzed by qRT PCR (Log CFU/mL): treatment p< 0.007, time p< 0.006, and 
treatment x time NS.   Groups different from other groups are indicated with a, b and c for 
significant differences of substrate means across all time points for the 72hours: RS
a
, 
C/RS
ab
, L/RS
b
 and F/RS
a
. 
The means for Lactobacillus spp. fermentation substrates collapsed across all time points 
up to and including 24 hours were RS=7.51, F/RS=7.59, L/RS=7.40 and C/RS=7.41 Log 
CFU/ml. The F/RS substrate had significantly higher levels of Lactobacillus spp. compared to 
both C/RS and L/RS substrate, but the difference between the RS fed fermenters and the L/RS 
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(p< 0.06) and the C/RS (p<0.10) only approached significance Both F/RS and RS were not 
significantly different from one another and, both C/RS and L/RS were not significantly different 
from one another.  
 
Figure 5. 8. Effects of Different Fermentation Substrates on Clostridial cluster IV 
Population Variation Analyzed by qRT PCR (Log CFU/mL): treatment p< 0.04, time p< 
0.002, and treatment x time NS. Groups different from other groups are indicated with a, b 
and c for significant differences of substrate means across all time points for the 72hours: 
RS
a
, C/RS
a
, L/RS
b
 and F/RS
a
. 
For the Clostridial cluster IV populations (Figure 5.8), the substrate means collapsed 
across all means up to and including 24 hours were RS=9.58, F/RS=9.58, L/RS=9.38 and 
C/RS=9.44 Log CFU/ml. Analyses of these means demonstrated that the RS and F/RS substrate 
means were higher than for the L/RS substrate mean. However, the difference between the RS 
and F/RS substrate means compared to the C/RS substrate mean only approached significance 
(p< 0.1) and RS and F/RS were not significantly different. The mean population of Clostridial 
cluster IV at the 12
 
hr time point was significantly higher in the F/ RS fermenter than the means 
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of RS, C/RS and L/RS, whereas this population was not significantly different when compared to 
the rest of the substrates at the
 
24 hr time point. 
 
Figure 5.9. Effects of Different Fermentation Substrates on Clostridial cluster XIVa - b 
Population Variation Analyzed by qRT PCR (Log CFU/mL): treatment p< 0.09, time p< 
0.006, and treatment x time NS.  Groups different from other groups are indicated with a, 
b and c for significant differences of substrate means across all time points for the 72hours: 
RS
a
, C/RS
a
, L/RS
b
 and F/RS
a
. 
The substrate means for the Clostridial cluster XIVa and b (Figure 5. 9) collapsed across 
all time points up to and including 24 hours were RS=7.89, F/RS=7.84, L/RS=7.64 and 
C/RS=7.67 Log CFU/ml. The Clostridial clusters XIVa-b bacterial means were similar to the 
Clostridial cluster IV at the 12
 
hr time point. The mean population of Clostridial cluster XIVa-b 
at the 12
 
hr time point was significantly higher for the F/ RS fermenter than the means of RS, 
C/RS and L/RS Clostridial cluster XIVa-b bacterial population.   
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The substrate means for both the Bacterial Domain and the Bacteroides group 
populations collapsed across all times up to and including 24 hours demonstrated no significant 
differences among substrate means for either bacterial population.  
A list of means for the Bacteroides (Figure 5. 10) and the Bacterial Domain (Figure 5. 11) 
group were: RS=8.99, F/RS=8.94, L/RS=8.91 and C/RS=8.84 and RS=10.69, F/RS=10.67, 
L/RS=10.55 and C/RS=10.54 Log CFU/ml; Log CFU/ml, respectively. 
Summary of Results 
All bacterial populations involved in this study regardless of measurement tool, culture or 
qRT-PCR, demonstrated significant time effects. Hence, the bacterial populations regardless of 
fermentable substrate were changed with time. Those populations only analyzed by culture all 
demonstrated treatment effects (effect associated with Fermentable substrate). Those effects 
were: Total Anaerobic bacteria (treatment p< 0.001, treatment x time NS), culturable 
Bifidobacterium spp. (treatment p< 0.001, treatment x time p <0.002), LAB population variation 
(treatment p< 0.001, treatment x time NS) E.coli (treatment p< 0.04, treatment x time NS). 
Populations measured by qRT-PCR demonstrated Bifidobacterium spp. population treatment p< 
0.007, treatment x time p< 0.06, Lactobacillus spp. population (treatment p< 0.007 treatment x 
time NS), Clostridial cluster IV population (treatment p< 0.04, treatment x time NS), Clostridial 
cluster XIV (treatment p< 0.09, treatment x time NS), Bacteroides group (treatment NS, 
treatment x time NS), Bacterial Domain (treatment NS, treatment x time NS). 
5.4 Discussion 
Our previous study concluded there were effects of high fat levels on fermentation of RS 
(Chapter 3 and 4). The main reason for conducting the current study was to compare the direct 
effects of three major types of hydrolised fat; lard, corn oil, and tuna fish oil on RS fermentation.  
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Figure 5.10. Effects of Different Fermentation Substrates on Bacteroides group Population 
Variation Analyzed by qRT PCR (Log CFU/mL): treatment NS, time p< 0.001, treatment x 
time NS. 
 
 
Figure 5.11. Effects of Different Fermentation Substrate on Bacterial Domain Population 
Variation Analyzed by qRT PCR (Log CFU/mL): treatment NS, time p< 0.001, treatment x 
time NS 
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For instance, L/RS added to an in vitro fermenter in the current study indicated reduction 
of populations of most of the bacteria which are involved with butyric acid production. Namely 
those populations were total culturable anaerobic bacteria, culturable LAB, and culturable total 
Biffidobacterium spp which were analyzed by direct plating as well as Lactobacillus spp. 
Bifidobacterium spp, Clostridial cluster IV and Clostridial cluster XIVa and b population which 
were analyzed by qRT-PCR. Similar results were observed with the C/RS diet, and during the 
study period analyzed, bacterial populations were generally not significantly different between 
L/RS fed fermenter and C/RS fed fermenter. These fermenters were fed with 2% of different 
sources of fat with 98% of digested RS to simulate composision of large intestine. Because in the 
small intestine 98% of the fat which digested is absorb and only (2%) carry over into the large 
intestine (Saunders & Sillery, 1988). Hence low level of 2% of the fatty acids coming from corn 
oil digestion and lard digestion interfered with RS fermentation. In other words, fat which enter 
to the large intestine by escaping the absorption from the small intestine also interferes with the 
fermentation process in the large intestine. 
Bacterial suppression by fatty acids was studied by several investigators for decades 
(Boughton & Pollock, 1953; Jenkins & Jenny, 1989, 1992; Jenkins, 1995; Onetti et al., 2001; 
Kim et al., 2008; Amorocho et al., 2009). Almost all these studies were on rumen microbes. In 
this study we targeted the effect of fat interference in the large intestine on a non-ruminant 
animal. The rat fecal inoculums were used as the inoculums for all fermenters to mimic large 
intestine bacterial populations because the main target was investigation of different types of fat 
involvement in large intestine of rodents. The basic fermentative reaction occurred in 
omnivorous are reported similar fermentative reaction to that in obligate herbivores (Topping & 
Clifton, 2001). The reason for that is because; the intestinal microbial community structure is 
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more similar in mammalian species than in between different species (Leser & Molbak, 2009).  
Different types of Clostridium clusters, some Bacteroides spp.Bifidobacterium spp and 
Lactobacillus spp were frequently isolated from rumen contents in early investigations 
(Trovatelli & Matteuzzi, 1976; Yanke & Cheng, 1998; Cook et al., 2007). Even though some of 
the bacterial populations which are involved in fermentation of prebiotics in the non-ruminant 
are similar in the ruminant, fat interference in fermentation of the mono-gastric digestive system 
is different from complex stomachs of the ruminant. In the ruminant, the whole amount of fat 
that is consumed interferes with the fermentation, but in the mono-gastric animals 98% of fat is 
absorbed in small intestine before it reaches the large intestine. Therefore only 2% of the fat can 
interfere with the fermentation of the large intestine (Saunders & Sillery, 1988). In a high fat diet 
this may be a substantial amount of fat in the large intestine that can interfere with bacterial 
fermentation. 
The main reason why rumen microbes were observed to have reduced function with 
increased fatty acids such as unsaturated fatty acids is antimicrobial effect of the unsaturated 
fatty acid (Ferguson et al., 1990; Jenkins, 1993), was that the fatty acids associate with the 
bacterial cell wall and disrupts the cell membrane. These disruptions primarily impact Gram-
positive bacteria as they are generally more susceptible to fatty acids and other anionic agents 
than the gram negative bacteria (Maczulak et al., 1981). The Gm - bacteria less susceptible to 
Fatty acid due bauble cell membrane in their cell wall. Gram-negative bacteria have a restricting 
sieving mechanism in their outer membranes, which reduces the penetration of fatty acids into 
bacterial cell. This is probably the main reason for reduction of Gram positive populations such 
as Lactobacillus spp. Bifidobacterium spp, Clostridial cluster IV and Clostridial cluster XIVa-b 
populations in the fermenters containing lard and corn oil. 
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 Soon after a fatty acid adsorbs to a bacterial cell membrane, it will penetrate into the 
protoplast membrane changing the cell layer orientation and destroying the bacterial activity 
(Galbraith & Miller, 1973; Jenkins, 1993). On the other hand high fat diets have been shown to 
increase gram negative bacteria. The Gram negatives such as the family Enterobacteriaceae and 
the Bacteroides group were reported to increase with high fat diets (Cani & Delzenne, 2007; 
Cani et al., 2009). The main reason of increasing population of Gram negative bacteria could be 
due to better opportunity by reducing the competition from native Gram positive bacteria.  
The data showed that the substrate F/RS had the opposite effect compared to C/RS and 
L/RS; F/RS had a significantly greater mean population for most of the favorable bacterial 
populations. Similar results were observed by our research group with in vivo study, in rat fed 
fish oil combined with RS in the diet (Unpublished data). In that study fish oil fed animals had 
significantly greater ceca weight and lower pH compared to rats fed the control diet and rats fed 
the RS diet without fish oil. Hence, fish oil appears to interact synergistically with RS to enhance 
its fermentation. 
 A similar phenomenon has been observed by several investigators with fish oil 
supplemented diets in rumen fermentation (Kim et al., 2008; Amorocho et al., 2009). A recent 
study by Kim et al (2008) showed that the addition of fish oil to the ruminant diet has an effect 
on bio-hydrogenation. Bio-hydrogenation could be known as biological
 
process which occurred 
in the rumen with the help of rumen microbes (Mosley et al., 2002). During bio-hydrogenation 
conjugated linoleic acid was produced by ruman microbes which have antioxidant and anti 
carcinogenic
 
properties. These effects of fish oil (LCPUFA) on bio-hydrogenation in the rumen 
have not been clearly explained yet (Kim et al., 2008). But for signal stomach animal does not 
occur bacteria which were able to break down dietary fat. 
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In this present study, we observed a significantly greater population of total culturable 
anaerobic bacteria, culturable LAB, and culturable total Biffidobacterium spp. with the F/RS 
substrate compared to both C/RS and L/RS. With qRT-PCR there was also a significantly higher 
population of Lactobacillus spp observed with the F/RS substrate.  
In our previous in vivo study in chapter 3, we observed a significant increase in the 
Bacteroides group populations with a high fat diet. However, in the present study, we haven‟t 
seen a significant increase of the Bacteroides group populations with the substrates containing 
fats (p > 0.05). For this study we used 100% digested RS as the control diet while rest of three 
diets contained 98% of the RS. Hence control diets had extra 2% of RS than the rest of the diets 
(rest of the diets had 2% of different digested fat).   
In this study total mean Bacteroidetes group was not significantly different within each 
diet. The one reason for this could be because of the high variations of Bacteroidetes group in 
each individual (Layton et al., 2006). The second reason could be increase of population of 
Bacteroides thetaiotaomicron during RS fermentation (Bird et al., 2000; Louis et al., 2007; 
Louis, 2007) might have diluted the increase of Gram negative Bacteroides group populations 
that have been observed with high fat diets not containing RS (Cani & Delzenne, 2007; Cani et 
al., 2009).   
The main conclusion of this study is that hydrolyzed fish-oil which presumably enters the 
large intestine promoted the growth of some beneficial bacteria during fermentation of RS 
whereas hydrolyzed unsaturated corn-oil and saturated lard fat reduced the counts of beneficial 
bacteria. Hence our findings agree with the recent nutritional advice of need to decrease the 
intake of saturated fatty acid and to increase the intake of omega 3 fatty acids in fish oil in the 
diet relative to unsaturated omega 6 fatty acids in vegetable oils. 
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CHAPTER 6: CHANGES IN POPULATIONS OF BUTYRIC ACID FORMING 
BACTERIA CAUSED BY RESISTANT STARCH FERMENTATION IN A RAT MODEL 
OF HUMAN ENDOCRINE OBESITY 
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6.1 Introduction 
Overweight and obesity are a growing epidemic in many developed western countries 
including the United States. In the United States more than half of the population is overweight 
and 30% of the population is obese. According to National Institute of Health (NIH) Clinical 
Guidelines classification, overweight and obesity in adults is defined according to BMI, the ratio 
of weight in kilograms to the square of height in meters (kg/m2). People with 25-29.9 BMI are 
classified as overweight and people with 30.0 or above BMI are considered obese.  Obesity has 
been divided into three levels; level1 is the BMI range of 30.0-34.9, level II is a BMI ranging 
from 35.0-39.9, and level III includes anyone with a BMI greater than or equal to 40. 
Obesity has a direct relationship to serious health consequences such as type 2 diabetes 
mellitus, cardiovascular diseases, pulmonary hypertension, obstructive sleep apnea, gastro- 
esophageal reflux disease, musculoskeletal disorders, a variety of cancers, and with the 
relationship with these diseases and disorders that there is an increased risk of mortality. The 
mortality associated with overweight and obesity is more frequently common among women 
(Guallar-Castillon et al., 2002).  This obesity epidemic could be known as a multi-factorial 
disorder deriving from genetic and metabolic factors as well as environmental, socioeconomic, 
and behavioral factors (Marin-Guerrero et al., 2008). Endocrine changes, such as reductions in 
the hormone estrogen in females at menopause, also increases fat accumulation and this is 
considered an endocrine cause of obesity. However, it is well known that not all individuals in a 
group of people subjected to similar conditions are susceptible to the same negative effects, such 
as diet-induced weight gain and hyperglycemia. Other factors may help trigger the weight gain 
and hyperglycemia. Gastrointestinal microbial ecology varies from to individual to individual 
and may also have a direct effect on obesity by influencing energy harvest from dietary 
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substances as well as affecting genes that regulate how energy is expended and stored  (Ley; Ley 
et al., 2005; Ley et al., 2006; Turnbaugh et al., 2006; DiBaise et al., 2008; Tsukumo et al., 
2009). 
The endocrine system is composed of tissues and glands. Hormones are the chemical 
messengers of the body, and are involved with transformation of information and instructions 
from one set of cells to another. Hormone levels also can be influenced by factors such as stress, 
infection, and changes in the balance of fluid and minerals in blood. Endocrine glands are 
responsible for releasing more than 20 major hormones directly into the bloodstream where they 
can be transported to cells in other parts of the body. The major glands that are involved with the 
endocrine system are the hypothalamus, pituitary, thyroid, parathyroids, adrenals, pineal body, 
and the reproductive glands, which include the ovaries and testes. Hormones from these 
reproductive glands influence energy metabolism related to body fat content and body weight. 
However, females primarily undergo menopause, either surgically or naturally, and this is often 
related to increased body fat and weight gain. Thus, the postmenopausal period is related is 
caused by a loss of functioning ovaries, including the production and release of estrogen (Wing 
et al., 1991a; Wing et al., 1991b; Arabi et al., 2003). Reduced estrogen production during 
menopause is believed to be a major cause for the increase in body fat and one of the triggers 
that induces obesity in the later period of female life (Burger et al., 1995; Shimizu et al., 1997; 
Danilovich et al., 2000; Gotoh et al., 2009). 
Possible modification of gastro-intestinal microbiota may be able to alleviate obesity by 
controlling energy expenditure and storage.  Antibiotics such as norfloxacin and ampicillin have 
been studied for their modification of gastro-intestinal microbiota and improvement of oral 
glucose tolerance and reduced hepatic steatosis in ob/ob mice. These antibiotic treatments 
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regulate the metabolic endotoxaemia (ME), and lower plasma lipopolysaccharide (LPS) levels. 
Other effects of antibiotic treatment include reduced gut permeability for bacteria, a lower 
occurrence of visceral adipose tissue inflammation and macrophage infiltration in high-fat-fed 
mice. Finally this tends to reduce glucose intolerance and weight gain (Cani & Delzenne, 2007; 
Membrez et al., 2008). 
Taking antibiotics for modification of gut microbiota is not a good solution for obesity. In 
fact, we now have antibiotic-resistant diseases that are much more difficult to treat. Those diseases 
are caused by certain strains of bacteria such as gonorrhea, tuberculosis, and Methicillin resistant 
Staphylococcus aureus (MRSA) (Levy & Marshall, 2004). Another way to control gut microbial 
ecology is adding prebiotics and probiotics to the diet (Kleessen et al., 1997; Weaver et al., 1997; 
Sharp & Macfarlane, 2000).  
This study was conducted to examine the effects of resistant starch (RS) as a prebiotic on 
cecal microbial community populations in an endocrine model of obesity, using ovariectomized 
(OV) or sham-operated (SH) virgin female Sprague-Dawley rats.  
6.2 Materials and Methods 
6.2.1 Animals and Diets 
Twenty OV and 20 sham (SH) 10 week old virgin rats were purchased from Harlan 
(Indianapolis, IN) and they were fed an energy control (EC) diet for six weeks prior to dietary 
treatment to observe energy intake and body weight gain during the hyperphagic period after 
surgery. After six weeks, rats were stratified by body weight within a 2 x 2 factorial (surgery and 
diet) and fed either the EC or the diet containing resistant starch (RS, Hi-Maize, National Starch, 
Bridgewater, NJ). Both diets had equal energy density: 3.3 kcal/g and to equalize the energy 
density of the two diets, increased cellulose was added to the EC diet (Table 6. 1). Each group of 
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rats was fed the diets for 13 weeks and food intake and body weights were monitored 3 times per 
week. At the end of the study, rats were killed and ceca were tied with threads, separated from 
the rest of the GI tract, and aseptically transferred to separate Whirl-pak bags ( Figure6.1). 
Whirl-pak bags were placed in a double Zip lock bag with an anaerobic GasPak™ EZ Gas 
generating Pouch System (BBL GAS PAK, Voiglobal Distribution INC. P.O. Box 1130, 
Lawrence, Kansas 66044-8130 USA) and immersed in ice. 
Table 6.1 Diet Compositions 
   Energy Control  Resistant Starch  
Ingredients grams Kcal grams Kcal 
Amioca  424.5 1527 0 0 
Hi-Maize  0 0 530.7 1486 
Sucrose  100 400 100 400 
Casein  200 716 200 716 
Soybean Oil  70 591.5 70 591.5 
Cellulose  156.2 0 50 0 
Mineral Mix  35 30.8 35 30.8 
Vitamin Mix  10 38.7 10 38.7 
Choline Chloride  1.3 0 1.3 0 
L-Cystine  3 12 3 12 
  
1000  
g/kg 
3.3 
Kcal/g 
1000 
g/kg 
3.3 
Kcal/g 
 
Amioca®and Hi-Maize® cornstarches were gifts from National Starch Food Innovation 
(Bridgewater, NJ).  Hi-Maize® cornstarch consists of 56% resistant starch determined by 
the Englyst method (Englyst et al., 1992) as measured by National Starch Food Innovation. 
 
 
6.2.2 Microbial Analysis of the Cecal Contents 
6.2.2.1 Direct Plating 
Anaerobic bacterial counts were enumerated using plate count methods. Ceca and 
contents were diluted 1:4 with peptone buffer solutions (PBS) and serial dilutions were made. 
Lactic acid bacteria (LAB) were enumerated by using de Man-Rogosa-Sharpe Agar (MRS agar) 
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(Difco, Laboratories, Detroit, Michigan, USA). Reinforced Clostridial agar (Oxoid, Basingstoke, 
UK) plates were used to quantitate total anaerobic and Clostridial counts. The MRS agar plates 
were anaerobically incubated at 30°C for 48 hrs and reinforced Clostridial agar plates were 
anaerobically incubated at 37°C for 3-4 days in a chemically generated anaerobic system using 
anaerobic GasPak™ EZ in an anaerobic box (Mitsubishi Gas Chemical America, Inc., New 
York, N.Y.). Then the total Colony Forming Units (CFU) were determined. Colonies were 
isolated and verified by gram staining. 
  
(a) (b) 
Figure 6.1  Rat Dissection (a) Rat Digestive System (b) Rat Cecum and Large Intestine 
 
6.2.2.2 DNA Extraction 
Previously mentioned 1:4 diluted ceca samples which were used for direct plating were 
also used for DNA extraction.  DNA was extracted using
 
a QIAamp DNA Stool Mini kit 
(QIAGEN, Valencia, CA) using the
 
manufacturer's instructions with slight modifications in the 
third step.   The samples were then subjected to three cycles of freeze-thaw in liquid
 
nitrogen and 
5 min at 95°C in a water bath to break the thick gram positive bacterial cell walls. Purified DNA 
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was quantified using a NanoDrop Spectrophotometer and all DNA sample extracts were diluted 
to 1ng/µl. Purified DNA was stored in a -80 
o
C freezer until the quantitative real–time PCR 
(qRT-PCR) analysis. 
6.2.2.3 Quantitative Real-time PCR 
The SYBR® Green method of quantitative real–time PCR (qRT-PCR) assay was used to  
quantify  bacteria as explained in chapter  3 using an ABI Prism 7900HT Sequence Detection 
System (serial 100151-Applied Biosystems, Foster City, CA). The information of the targeted 
bacterial groups, primer sequences, annealing temperatures and literature references are given in 
chapter 3, Table 3. 2. All reactions were performed in sterile MicroAmp® optical 384-well 
reaction plates with barcode sealed with MicroAmp® optical adhesive film (Applied 
Biosystems, Foster City, CA). All reactions consisted of 5µl of 2X SYBR Green Master Mix 
(Applied Bio systems, Foster City, CA,USA), 0.5 µl of each primer at 10 µM, 0.5 µl of bovine 
serum albumin (BSA )  (final concentration 250 mg /ml), 0.5 µl of  nuclease free water and  3 µl 
of  DNA template in a 10 µl total volume. The cycling conditions were 50°C for 2 min, 95°C for 
10 min, then 40 cycles of 95°C for 15 s, followed by the primer-specific annealing temperature  
(Chapter 3 :Table 3.2) for 1 min, then 78°C for 30 s. Following amplification, a dissociation step 
was included to analyze the melting curve of the amplified product to determine the specificity 
of the amplification. Further information of thermal profiles, standerd curves, diassociation 
curves are in Apendix A. 
6.2.2.4 Preparation of PCR Standards and Quantification of Target Bacterial DNA in Pure 
Cultured for Fecal Samples by Quantitative Real Time-PCR 
The standard curve was conducted by using serial dilutions of quantified pure cultures of 
Lactobacillus acidophilus ATCC 4646, Clostridium leptum ATCC 29065, Clostridium coccoides 
ATCC 29236, Bacteroides fragilis ATCC 25285, Bifidobacterium longum ATCC 15708 and 
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Escherichia coli ATCC 25947. Bacterial cultures were grown overnight and serial dilutions were 
made. Then for each dilution the Ct (cycles to threshold) value was measured by qRT- PCR and 
plated onto appropriate media to determine the actual bacterial cells present in the overnight 
culture (CFU/ml). For qRT- PCR, 200 µl of each dilution tube was used to isolate DNA 
templates from the bacterial standard species listed above. DNA was isolated by the commercial 
QIAamp method as explained above. qRT- PCR primers were used to amplify the DNA for the 
16S rRNA (Table 3. 2). To determine CFU/ml unknown Ct values were compared to the Ct of 
the standard curves.  
6.2.3 Statistical Analysis 
  This study was analyzed as a completely randomized factorial with two independent 
variables with two levels for each variable, diet (RS or Energy Control) and Surgery (OV and 
SH) using two-way ANOVA followed by least significant difference if the ANOVA F value was 
significant, p<0.05. Statistical analyses were done using SAS version 9.13 (SAS Institute Inc., 
Cary, NC). All data are presented as least square means (ls means) with pooled SE. 
6.3 Results  
Total culturable anaerobic bacteria including Clostridium spp. (Figure 6.2b ) and total 
culturable Lactic Acid Bacteria (LAB) (Figure 6.2a) were significantly affected by the diet type 
because animals fed RS diets had greater numbers of these bacterial populations in the cecal 
contents than those fed EC diets. 
These results emphasize anaerobe populations and facultative anaerobes such as LAB 
populations increased with the RS diets. These diet effects confirmed previous findings in non-
endocrine studies (Kleessen et al.1997; Louis et al 2007). 
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a b 
Figure 6.2 (a) Total Culturable Lactic Acid Bacteria Diet, p < 0.004; Surgery,NS; 
Interaction, NS (b) Total Culturable  Anaerobic/Aerobic Bacterial Populations in the 
Cecum: Diet, p < 0.004; Surgery, p < 0.04 ;Interaction, NS. 
In this experiment MRS plates were incubated anaerobically in 30
o
C for 48 hrs. Hence, 
MRS plates also indicated the growth of Bifidobacterium spp. which is found in another bacterial 
Order and also produces bacteria under anaerobic conditions.  
Lactic Acid Bacteria presence in cecal contents was not significantly affected by surgery. 
There was a significant increase of total culturable anaerobic bacteria including Clostridium spp 
for the SH groups compared to the OV groups. These results emphasize that total culturable 
anaerobic bacteria including Clostridium spp populations have endocrine effect on their growth. 
The size and the weight of the GI tract and ceca in RS fed animals were always greater 
than those in the EC fed animals. Contrasting results were observed regarding the total 
abdominal fat pads that included gonadal, perirenal and retroperitoneal fat in the abdominal 
cavity. There was a greater weight of the abdominal cavity fat pads observed in animals fed EC 
diet versus RS diets (data not shown; Robert et al.2008).   
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(a) (b) 
Figure 6. 3 (a) Lactobacillus spp Populations: Diet, p < 0.001; Surgery, p < NS ; Interaction, 
NS,  (b) Bifidobacterium spp. Diet, p < 0.001; Surgery, p < 0.04; Interaction, NS Analyzed 
by qRT-PCR. 
 
The effect of the two independent variables on bacteriaint the cecal contents was further 
analyzed using quantitative qRT-PCR. For this purpose we chose to analyze beneficial bacteria 
which help to produce butyric acid as an end product. Standard curves, bacterial DNA 
amplification plots and disassociation graphs were shown in the last chapter.   
 Results for the, Bifidobacterium spp (Figure 6. 3b) Clostridial clusters IV (Figure 6. 4a), 
Clostridial clusters XIVa, b (Figure 6. 4b),   Bacteroides spp and Bacterial Domain (Figure 6. 5b) 
were significantly affected by surgery without any significant interactions.  Animals fed the RS 
diet had greater populations of all bacteria analyzed. Except for Lactobacillus spp (Figure 6. 3a), 
and the entire bacterial domain (p<0.06), the rest of the bacterial populations were significantly 
greater in the SH groups versus the OV groups.  
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(a) (b) 
Figure 6. 4 (a) Clostridial clusters XIVa - b Population ;Diet, p < 0.0006; Surgery, p < 
0.008; Interaction, NS  (b) Clostridial clusters IV Population; Diet, p < 0.004; Surgery, p < 
0.02; Interaction, NS Analyzed by qRT-PCR 
 
(a)  (b) 
Figure 6. 5 (a) Bacteroides group Population ; Diet, p < 0.003; Surgery, p < 0.004; 
Interaction, NS (b) Clostridial clusters IV Population; Diet, p < 0.005; Surgery, p < 0.06; 
Interaction, NS, NS Analyzed by qRT-PCR 
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All three studies presented in chapters 3, 4 and 6 that involved isolation of bacterial DNA 
and performance of qRT-PCR analysis were conducted together. Hence Standard curves and 
melting curves were common to all three studies.  
Cycling conditions for bacterial types are given in Apendix Figure I and Figure II.  
Standard curves for each bacterial type and disassociation curves were given in Figure III-VIII 
and Figure IX-XIV, respectively. The square regression coefficients in the linear regressions of 
all bacterial types, determined for experiments in chapters 3, 4 and 5, indicated a good 
correlation between the amount of template (total bacterial copies) and the amount of product 
(represented by the Cts) in the standard curves (R
2
 = 0.99). The linearity of the standard curves 
and the fact that the PCR operates with consistent efficiency confirmed that the assay was well 
suited for quantitative measurements of each bacterial type. 
There were no contaminating DNA fragments, such as primers forming dimers and 
mispriming PCR products, present in the reactions for the Bacterial Domain, Lactobacillus spp, 
Clostridial clusters XIVa-b and Clostridial clusters IV. There were slight shoulders visible in 
Bifidobacterium spp. and the Bacteroides group due the effect of primers forming dimers. The 
reason for this effect is when primers anneal to themselves and create small templates for PCR 
amplification. This primer dimmer effect disassociation is show a small fall off in measured 
concentration at the highest level and peak is less in proportion, since the effect is very subtle 
primer dimmer effect can be neglected. These results are shown in disassociation curves in 
Figure IX- XIV.   
6.4 Discussion 
Dietary resistant starch is a fermentable fiber and a prebiotic, which resists the amylotic 
reaction in the digestive system because of its granular structure and it also, enhances the 
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butyrate production (Kleessen et al., 1997; Ferguson et al., 2000; Higgins, 2004; Higgins et al., 
2006). This study was conducted to observe the effects of resistant starch (RS) as a prebiotic on 
beneficial cecal bacteria in the microbial community populations and their relation in the 
endocrine model of obesity, using ovariectomized (OV) or sham-operated (SH) virgin female 
Sprague-Dawley rats. Sham-operated rats mimic the stress of surgry of OV rats without removal 
of ovaries. 
The targeted beneficial bacterial populations, which were analyzed in this study, were 
bacteria involved with the butyrate production in the large intestine. In this study, all analyzed 
bacterial populations, which support the production of butyric acid in the gut, were significantly 
increased in RS fed rats compared to rats fed EC diets regardless of type of surgery. 
Data on the rats separate from the microflora results were reported previously in the 
thesis of Julina Robert. In her study, she analyzed body fat, body weight in the beginning and the 
end of the study, gut weight (Full GI tract, Full small intestine, and Full large intestine and 
Energy intake).  The major result was reduced body fat and increased gut size for rats fed the RS 
diet versus the EC diet.  Similar results were previously demonstrated by several investigators 
with the RS consumption (de Deckere et al., 1993; Keenan et al., 2006; Shen et al., 2009; Zhou 
et al., 2009). Thus, increased gut size and decreased body fat in animals fed the RS versus the EC 
diet, was accompanied by changes in the cecal microflora. Total colony forming units 
determined by plate counts were assessed for total lactic acid producing bacteria and total  
culturable anaerobic. Using RT-PCR, bacterial analyses were broadened on the one hand to 
include the entire bacterial domain  and fine-tuned on the other hand to include Bifidobacteria, 
Clostridial clusters XIV a-b and Clostridial clusters IV, and Basteriodes. Bacterial results with 
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the use of both methods support the effects of reduced body fat with increased bacterial growth 
of bacteria known to be associated with fermentation of resistant starch. 
Lactobacillus spp have been studied regarding obesity and increased levels are associated 
with reduced body weight and reduced serum total cholesterol concentrations in the blood. 
Various proposed mechanisms for these effects have been reported. Specifically, increases in 
Lactobacillus Spp, such as L. acidophilus, L. reuteri , L. casei and L. gasseri, are reported to be 
associated with significantly reduced the serum total cholesterol concentrations and triglyceride 
concentrations in mice (Akalin et al., 1997; Xiao et al., 2003; Liong & Shah, 2005). Use of 
probiotics, such as Lactobacillus rhamnosus (L. rhamnosus) PL60, have been reported to result 
in a significant reduction of obesity in mice by producing weight loss without reducing energy 
intake (Lee et al., 2006).  
Bifidobacterium spp have been proven to have a beneficial effect on health by improving 
gut permeability and it also suppresses pathogenic species such as the Enterobacteriaceae family 
(O'Sullivan, 2008).  This same group of bacterial species has also been involved with reduction 
of serum total cholesterol concentrations in the blood (Beena & Prasad, 1997; Xiao et al., 2003) 
Although lactobacilli and bifidobacteria both feed on resistant starch, they do not produce 
butyrate. Both Clostridial clusters IV and Clostridial clusters XIVa-b are the major bacterial 
groups which produce butyrate. Butyrate has been identified as a beneficial SCFA which helps to 
maintain gut health (Cummings & Macfarlane, 1991; Gibson, 1998; Sato et al., 2008).  
The ovarian hormone estrogen is known to influence energy metabolism. The major 
factor which may contribute to the gradual fall in resting energy expenditure with age and 
menopause is the loss of the luteal phase. This specific effect of menopause may decrease the 
resting metabolic rate (Poehlman, 1993; Heymsfield et al., 1994; Panotopoulos et al., 1997). 
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Ovarian hormones are reported to delay the processes of aging (Morrison et al., 2006). 
Sham operation was done to imitate the ovariectomized operation but they have active ovaries. 
So that OV animals should age faster than SH animals. This aging process also may affect the 
ecology of gut microbial populations as well. The results of the current study may be a reflection 
of the aging process.  Lactobacillus spp populations are reported to increase with increasing age, 
while the populations of Bifidobacterium spp and Bacteriodes spp. are reduced with increasing 
age. Although, Bacteriodes spp population is reported to decrease with increasing age, their 
bacterial diversity has been reported to be increased (Mitsuoka, 1992). In agreement with the 
past studies, Bifidobacterium spp and Bacteriodes spp were significantly lower in OV compared 
to SH rats in the current study. However, Lactobacillus spp analyzed by either method were not 
change increased with OV surgery. The latter may be the result of measuring a broad range of 
bacteria with measurement of Lactobacillus spp, and specific lactobacilli that increased in 
previous studies were diluted with numerous other Lactobacilli that are not changed with OV. It 
is also possible that the aging process was not advanced enough by OV surgery during the study 
to observe the effect of an increase in Lactobacillus spp. It may take a longer study to observe 
the effects of aging on increased Lactobacillus spp in OV rats. 
All other bacterial populations analyzed in this study, the entire Bacterial Domain, 
Clostridial clusters IV, Clostridial clusters XIVa, b and Total anaerobic bacteria including 
Clostridium spp, were higher in cecal contents of SH versus OV rats.  However, the values for 
the bacterial domain only approached significance (p<0.06). The populations of Clostridial 
clusters IV, Clostridial clusters XIVa-b are also reported to be reduced with increasing age  
(Hayashi et al., 2003; Zwielehner et al., 2009). 
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6.5 Conclusion 
The present study demonstrated that, adding resistant starch to the diet may improve 
health by increasing beneficial bacteria and reducing body fat. This may mean that prebiotics 
like resistant starch could be used in the diet to overcome increased fat gaining during the 
postmenopausal period of women.  
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CHAPTER 7: COMPARISON OF DIET RESTRICTION VERSUS A LOW FAT 
RESISTANT STARCH DIET 
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7.1 Introduction 
One of the major problems each one of us has face in our life time is aging. Aging is 
often related with health related chronic problems and severe infectious disease. Most of these 
conditions are often associated with the gastrointestinal
 
tract (Garibaldi & Nurse, 1986). With 
aging the the gastro intestinal tract pH increases due to lack of acid production (Hurwitz et al., 
1997). This increase of pH has negative effects on the health numerous ways, such as increased 
ability to absorb toxic compounds, and promotion of pathogenic strains such as Helicobacter 
pylori in the gut consequently it also up regulates the ability gastritis, ulcers gastric cancers and 
colorectal cancers (Thornton, 1981; Sgouros & Bergele, 2006).    
Diet /Calorie restriction is a strategy of under-nutrition without malnutrition, which has 
been shown to improve longevity by improving health in rodents and primates including human 
(Hursting et al., 2003). Diet restriction has anti-cancer effects, and anti leukemia effect in rats 
(Hursting et al., 1993). Furthermore, HDL cholesterol increases were observed in monkeys and 
Muslims who fast during the daylight hours of the holy month of Ramadan cit original article 
here.  Similar results were indicated by inhabitants of Okinawa, Japan, with fewer calories and 
they indicated lower death rates from cancer and vascular diseases (Hursting et al., 2003). These 
evidences conclude that practice of calorie restriction will extend the healthy human life span. 
With the aging gut microbial diversity and population varies.  For example, in elderly 
populations,
 
the following occurs, a reduction of percentage of Bifidobacterium spp. Bacteroides 
spp. and Clostridium cluster IV (Clostridium leptum) and an increase in Fungi, members of 
family Enterobacteriaceae, Lactobacillus spp.
 
and some Clostridia spp. such as C. difficile group 
and C.perfringens (Hopkins et al., 2001; Mueller et al., 2006; Tuohy, 2007).  
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As discussed in early chapters RS is a prebiotic and it beneficially
 
affects the host by 
selectively stimulating the growth of beneficial bacteria while improving host health in numerous 
ways (Brown et al., 1997; Bird et al., 2000; Higgins, 2004; Keenan et al., 2006; Zhou et al., 
2008; Shen et al., 2009). 
Hence calorie restriction and RS diets both help to improve host health. The main focus 
of this study is compare on the gut microbiota
 
of the calorie restricted aged mice with the low fat 
RS fed mice main beneficial gut microbial populations. 
7.2 Material and Methods 
7.2.1Animals and Diets 
This study was conducted as two separate studies of restricted calorie diet study versus 
continuous diet and RS versus EC with low fat diet study.  
7.2.1.2 Study 1 
Two-year old twelve female C57BL/6 mice from the Mutant Mouse Aging Colony 
(National Institute of Aging colony ) were fed either restricted calorie diet or normal EC diet 
(n=6) to measure the effect of calorie restricted diet on the variation of beneficial gut microbial 
populations.  Both restricted calorie diet fed animals and normal EC diet fed animals were 
individually housed. CR was initiated at 14 weeks of age at 10% restriction, increased to 25% 
restriction at 15 weeks, and to 40% restriction at 16 weeks where it is maintained until 24 months 
of age.  
All 2 groups mice were Mice were fed the control diet for the first six weeks prior to 
dietary treatment to observe energy intake and body weight gain. Then these animals were fed 
with either restricted or continuous diet for 3 months. At the end of the study animals were 
sacrificed and mice ceca were tied with threads, separated from the rest of the GI tract, and 
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aseptically transferred to separate Whirl-pak bags. Whirl-pak bags were placed in a double Zip 
lock bag with an anaerobic GasPak™ EZ Gas generating Pouch System (BBL GAS PAK, 
Voiglobal Distribution INC. P.O. Box 1130, Lawrence, Kansas 66044-8130 USA) and immersed 
in ice. 
7.2.1.2 Study 2 
Eighteen C57bl/6J female mice were used to compare low fat Energy control (LO EC) diet 
versus Low fat RS (LO RS) diet (n=9). These 18 animals were similar to animals which we used 
for Chapter 3. All 2 groups mice were Mice were fed the control diet for the first six weeks prior 
to dietary treatment to observe energy intake and body weight gain. Then they were fed one of 
four diets, Low fat (Lo fat) Control, or Lo fat RS. Both Low fat diets had 18% fat to equalize the 
energy density of the two diets (Table 1 Chapter 3).Mice were fed each one of  the diets for 10 
weeks and at the end of the study, mice were sacrificed and ceca were collected as explained in 
study 1.  
7.2.2 Microbial Analysis of the Cecal Contents 
7.2.2.1 DNA Extraction 
Bacterial DNA were extracted using the same method explain in Chapter 3. DNA was 
extracted from ceca samples with the help of QIAamp DNA Stool Mini kit (QIAGEN, Valencia, 
CA). All the manufacturer's instructions were followed with slight modifications.  The  slight 
modification was after adding stool lysis (ASL) buffer to samples of the diluted cecal contents 
(200 µl), the samples were subjected to three cycles of freeze-thaw in liquid
 
nitrogen and a 5 min 
at 95°C water bath  to break the thick gram positive bacterial cell walls. After the extraction of 
DNA the purified DNA was quantified using a NanoDrop ectrophotometer and all DNA sample 
extracts were diluted to 1ng/µl. Purified DNA was stored in a -80 
o
C freezer. 
138 
 
7.2.2.3 Quantitative Real-time PCR 
The SYBR® Green method of quantitative real–time PCR (qRT-PCR) assay was 
performed using an ABI Prism 7900HT Sequence Detection System (serial 100151) (Applied 
Biosystems, Foster City, CA) as explained in previous chapters. The information of the targeted 
bacterial groups, primer sequences, annealing temperatures and literature references are given in 
Chapter 3, Table 2. All reactions were performed in sterile MicroAmp® optical 384-well 
reaction plates with barcode sealed with MicroAmp® optical adhesive film (Applied 
Biosystems, Foster City, CA). Hence construction of a standard curve for real-time PCR 
bacterial dilutions, Targeted bacteria, Annealing Temperature ( 
o
C) and Sequence of 
oligonucleotide were exactly same to the Chapter 3. 
7.2.3 Statistical Analysis 
Both the Study 1 (restricted calorie diet study and continuous diet) and Study 2 fat 
(Energy control diet and Low fat RS) were analyzed by statistical comparisons of all pairs using 
the Student‟s t test following 1-way analysis of variance (ANOVA) (JUMP In version 7.0, SAS 
Institute Inc., Cary, N.C., U.S.A.). Statistical significance occurs for P<0.05.  
7.3 Results  
The bacterial populations involved in the process of fermenting resistant starch to butyric 
acid were further analyzed using qRT-PCR (Figure 7.1-Figure7. 6).The statistical significant 
levels t < 0.05 were indicated in either gray or red color. 
The Total bacterial domain (Figure 7.1) and Lactobacillus spp (Figure 7.2) were 
comparable for each other. Both total bacterial domain and Lactobacillus spp were not 
significantly different for caloric restriction diet fed animal and control diet fed animals. 
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Whereas, low fat RS fed animals had significantly high Total bacterial domain (P < 0.0014) and 
Lactobacillus spp (P < 0.0001).   
 
(a) 
 
(b) 
Figure 7.1 Analysis of Bacterial Domain (a) Restricted Calorie Diet Study Versus 
Continuous Diet (b) RS Versus EC with Low Fat Diet Study: Diet p<0.0014 
 
(a) 
 
(b) 
 
Figure 7.2 Analysis of Lactobacillus spp. (a) Restricted Calorie Diet Study Versus 
Continuous Diet (b) RS Versus EC with Low Fat Diet Study: Diet p<0.0001 
140 
 
 
(a) 
 
(b) 
 
Figure 7.3 Analysis of Total Bifidobacterium Spp. (a) Restricted Calorie Diet Study Versus 
Continuous Diet :Diet p<0.0003.  (b) RS versus EC with Low Fat Diet Study: Diet p<0.005 
 
 
(a) 
 
(b) 
Figure 7.4 Analysis of Total Clostridium Cluster IV (a) Restricted Calorie Diet Study 
Versus Continuous Diet :Diet p<0.0006.  (b) RS versus EC with Low Fat Diet Study: Diet 
p<0.0001 
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The Total Bifidobacterium spp. (Figure 7.3) Clostridium cluster group IV (Figure 7.4) 
and Clostridium cluster group XIVa-b (Figure 7.5) were comparable for Study 1 and study 2. 
Ceca from mice fed Restricted calorie diet had higher levels of Total Bifidobacterium spp. (P < 
0.0003), Clostridium cluster group IV (P <0.0006) and Clostridium cluster group XIVa-b (P < 
0.0125) populations than ceca from mice fed normally. Similarly, ceca from mice fed the low fat 
RS diet had significantly higher levels of total Bifidobacterium spp. (P < 0.005), Clostridium 
cluster group IV (P < 0.0001), and Clostridium cluster group XIVa-b (P < 0.0001) populations 
than in ceca from mice fed a low fat diet without RS. 
There was no effect of diet treatment on bacteria from the Bacteroides group in cecal 
contents of mice with both studies.   
 
(a) 
 
(b) 
 
Figure 7.5 Analysis of Clostridum Cluster XIVa-b( a) Restricted Calorie Diet Study Versus 
Continuous Diet: Diet p<0.01.  (b) RS Versus EC with Low Fat Diet Study: Diet p<0.0001 
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(a) 
 
(b) 
Figure 7.6 Analysis of Bacteroides group Counts (a) Restricted Calorie Diet Study Versus 
Continuous Diet (b) RS Versus EC with Low Fat Diet Study 
 
7.4 Discussion 
Several investigators support the possibility of restricted calorie diet that can exert life 
span by reducing aging related diseases such as cardiovascular disease, cancer, leukemia and 
digestive tract related problems (Ma et al., 1992; Hursting et al., 2003; Hursting et al., 2007; 
Heilbronn et al., 2006; Sun et al., 2009).  In present investigation we observed significant 
increase of beneficial bacterial populations such as populations of Bifidobacterium spp. 
Clostridium cluster group IV and Clostridium cluster group XIVa-b with restricted calorie diet in 
aged mice than the normal diet fed aged mice (Figure 7.3, 7.4 and 7.5).  
The relationship between aging and the Bifidobacterium spp. were studied by several 
investigators and according to all of their finding; the Bifidobacterium spp. populations were 
reducedwith the age (Gorbach et al., 1967; Benno et al., 1992; Mitsuoka, 1992). Similar results 
were observed for Clostridium cluster group IV group. Clostridium cluster group IV group were 
decreased in terms of percentage microbiota
 
composition in the elderly (Zwielehner et al., 2009).  
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Hayashi et al, 2003 have indicated cecal microbial variation in six elderly individuals using 16S 
rDNA. They found that the proportion of Clostridium cluster XIVa was lower than in healthy 
adults (Hayashi et al., 2003).  
In our present study animals fed restricted calorie diet were able to elevate 
Bifidobacterium spp., Clostridium cluster group IV group and Clostridium cluster group XIVa 
group in aged mice. Hence restricted diet fed animals experienced an increase in beneficial 
bacteria.  For example Bifidobacterium spp helps to improves the digestion absorption and 
immune system while decreasing the side-effects of antibiotic therapy . Mean while it also 
provides protection against enteric pathogens, putrefactive substances, and believed to be 
involved with mechanisms of reduction of cholesterol levels and anti-tumoral activity (Leahy et 
al., 2005).  The Clostridium cluster group IV and Clostridium cluster group XIVa-b are the 
major two phylogenic groups involve with production of butyric acid. Butyric acid is well 
established for improving health (Scheppach et al., 2001; Hijova & Chmelarova, 2007; Sato et 
al., 2008). Some of these benefits are butyric acid act as a major energy source for epithelial cells 
of colonic mucosa which stimulates colorectal cell proliferation, while maintaining healthy 
epithelium by blocking the absorption of cancer-causing substances (Scheppach et al., 2001; 
Sato et al., 2008 Hagopien et al., 1977 ,Cummings & Macfarlane, 1991, Gibson et al., 1998).    
It is well known that as a prebiotic RS diet stimulates beneficial bacterial populations 
which involve fermenting RS in to Butyric acid. In this study low fat RS diet fed animals ceca 
were shown to significantly increase populations of Lactobacillus spp, Bifidobacterium spp. 
Clostridium cluster group IV and Clostridium cluster group XIVa-b and the total bacterial 
domain than the low fat EC fed Animals.  In both studies (Restricted calorie diet versus nomal 
diet and RS diet versus EC diet) were not significant for Bacteroidetes group in p<0.05 level 
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because Bacteroidetes group have been reported in high variations between individuals (Layton 
et al., 2006). 
  Both Restricted calorie diet and RS diets comparable for four out of six investigated 
bacterial populations. It is well established that diet restriction leads to improved health and 
increased longevity in many species (Ma et al., 1992; Hursting et al., 2003; Heilbronn et al., 
2006; Sun et al., 2009).  Most of the prebiotics have identified as a healthy aging diets (Tuohy, 
2007; Guigoz et al., 2008; Vulevic et al., 2008). In addition, resistant starch diets improve gut 
function and metabolic status. Hence we could argue that low fat RS diet as healthy diet which 
helps to increase life span.   
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CHAPTER 8: CONCLUSION 
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This study demonstrated that, Resistant starch (RS) increases beneficial gastro-intestinal 
bacterial populations which involved in fermentation RS in to butyrate. Those beneficial 
bacterial populations which increased by RS diets were Total culturabale anerobic bacteria, 
Lactic Acid Bacteria, Culturable Bifidobacterium spp which analysed by plate count metod; 
Lactobacillus spp, Bifidobacterium spp, Clostridium cluster IV and Clostridium cluster XIVa- 
XIVb which analysed by qRT-PCR. 
The High fat levels (41% dietary energy) were interfered with this process and prevented 
fermentation of RS and reduced bacterial populations in the ceca compared to a low fat diet 
(18% dietary energy). But Modarate fat levels (22% dietary energy) had relatively less effect on 
fermentation of RS and reduced bacterial populations in the ceca compared to a low fat diet. 
The type of diet the mice were fed had no effect on the bacterial numbers for the Bacteroids 
group in the cecal contents. However, high fat diet fed micehad higher counts of Bacteroides 
group in their cecal contents compared to mice fed the low fat diets. As a diferant type of fat both 
Corn oil and Lard reduced bacterial populations which are involved in fermentation of RS.  
However, if the fat used was fish oil there were no negative effects on the fermentation of RS or 
the bacterial population. These studies were highlighted importance of controling the type and 
level of fat when consuming resistant starch as a prebiotics in diet.   
With the ovariectomy and aging process simulate and with the age Bifidobacterium spp, 
Bacteroides spp, Clostridium cluster IV and Clostridium cluster XIV decreased. RS diet was able 
to reduced body fat in an endocrine model of obesity caused by ovariectomy (OV) while 
increasing the beneficial bacterial populations.  In Aged mice both calorie restricted diet and RS 
diets were able to improve Bifidobacterium spp, Clostridium cluster IV and Clostridium cluster 
XIV populations. 
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APPENDIX A: RT-PCR PROTOCOL AND STANDERD CURVES 
 
(a)Thermal Cycler Protocol of Rt-PCR 
 
Figure I Thermal Cycler protocol for Bacterial Domain, Lactobacillus spp, Clostridial 
clusters IV, Bacteroides group and Bifidobacterium spp. 
 
Figure II Thrmal Cycler Protocol for Clostridial clusters XIVa-b 
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(b)Bacterial Standerd Curves Which Analysed by Rt-PCR 
 
 
Figure III Standard Curve for Bacterial Domain 
 
 
Figure IV Standard Curve for Lactobacillus spp 
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Figure V Standard Curve for Bifidobacterium spp. 
 
 
 
Figure VI Standard Curve for Bacteroides group 
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Figure VII Standard Curve for Clostridial clusters XIVa-b 
 
 
 
Figure VIII Standard Curve for Clostridial clusters IV 
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(c)Bacterial Dissociation Curves Which Analysed by Rt-PCR 
 
 
Figure IX Bacterial Domain (Melting T 82.5 oC) 
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Figure X Lactobacillus spp (Melting T 78 oC) 
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Figure XI Bifidobacterium spp. (Melting T 86 oC) 
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Figure XII Bacteroides group (Melting T 81 oC) 
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Figure XIIIClostridial clusters XIVa-b (Melting T 83 
o
C) 
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Figure XIVClostridial clusters IV (Melting T 82.5 oC) 
159 
 
APPENDIX B: CHAPTER 5 SAS PROGRAM 
 
(a) SAS Programme for Chapter 5 
(a.1)SAS Cocde for programme 
 
proc options option = macro; run; 
dm'log;clear;output;clear'; 
options nodate nocenter nonumber ps=512 ls=132 nolabel; 
ODS HTML style=minimal body='C:\Documents and Settings\rsenev1\Desktop\ClosXiv.html' ; 
Title1 'Invitro Study'; 
data invitro; 
input  Diet $ Time Bacte1 Bacte2 Closiv Bif Lac Dom ClosXiv ; 
datalines; 
 
C 0.5 6.181871 6.003654 9.506346 6.755419 7.25122 9.873611 7.415339 7.755419 
C 0.5 7.073775 6.853974 10.21879 7.098233 7.256507 10.88366 8.231394 8.098233 
C 0.5 5.564315 5.414847 9.178546 6.698154 7.142024 9.565257 6.71726 7.698154 
C 1 6.366887 6.180006 9.462617 7.432922 7.387964 10.17754 7.708172 8.432922 
- 
- 
- 
- 
- 
- 
 
/*Proc print data = invitro ; run;*/ 
 
PROC mixed DATA=invitro cl covtest; 
   class Diet Time;   
   MODEL ClosXiv= Diet|Time /DDFM = KR outp=resids; 
   repeated Time/ type=AR(1) ; 
lsmeans Diet|Time / adjust=tukey cl; 
run; 
 
(b)SAS Results 
 
 
Table (a1) Results of Type 3 Tests of Fixed Effects of Total Anaerobic Bacteria Counts 
Effect Num DF Den DF F Value Pr > F 
Diet 3 64 27.85 <.0001 
Time 7 64 15.86 <.0001 
Diet*Time 21 64 1.1 0.3678 
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Table (a2) Results of Least Squares Means of Total Anaerobic Bacteria Counts 
Effect Diet Time Estimate t Value Pr > |t| 
Diet C   8.6879 125.65 <.0001 
Diet F   9.0317 130.62 <.0001 
Diet L   8.7533 126.59 <.0001 
Diet R   9.4904 137.25 <.0001 
Time   0.5 8.6592 88.55 <.0001 
Time   1 8.6825 88.79 <.0001 
      
Time   2 8.8442 90.44 <.0001 
Time   4 8.7808 89.79 <.0001 
Time   12 9.3842 95.96 <.0001 
Time   24 9.63 98.48 <.0001 
Time   48 9.31 95.21 <.0001 
Time   72 8.6358 88.31 <.0001 
Diet*Time C 0.5 8.3467 42.68 <.0001 
Diet*Time C 1 8.2433 42.15 <.0001 
Diet*Time C 2 8.6067 44.01 <.0001 
Diet*Time C 4 8.4933 43.43 <.0001 
Diet*Time C 12 8.8033 45.01 <.0001 
Diet*Time C 24 9.3667 47.89 <.0001 
Diet*Time C 48 9.1167 46.61 <.0001 
Diet*Time C 72 8.5267 43.6 <.0001 
Diet*Time F 0.5 8.32 42.54 <.0001 
Diet*Time F 1 8.8633 45.32 <.0001 
Diet*Time F 2 8.8733 45.37 <.0001 
Diet*Time F 4 8.7233 44.6 <.0001 
Diet*Time F 12 9.43 48.22 <.0001 
Diet*Time F 24 9.9067 50.65 <.0001 
Diet*Time F 48 9.57 48.93 <.0001 
Diet*Time F 72 8.5667 43.8 <.0001 
Diet*Time L 0.5 8.7233 44.6 <.0001 
Diet*Time L 1 8.33 42.59 <.0001 
Diet*Time L 2 8.6267 44.11 <.0001 
Diet*Time L 4 8.4233 43.07 <.0001 
Diet*Time L 12 9.26 47.35 <.0001 
Diet*Time L 24 9.1633 46.85 <.0001 
Diet*Time L 48 8.91 45.56 <.0001 
Diet*Time L 72 8.59 43.92 <.0001 
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Table (a2) Cont’d 
Effect Diet Time Estimate t Value Pr > |t| 
Diet*Time R 0.5 9.2467 47.28 <.0001 
Diet*Time R 1 9.2933 47.52 <.0001 
Diet*Time R 2 9.27 47.4 <.0001 
Diet*Time R 4 9.4833 48.49 <.0001 
Diet*Time R 12 10.0433 51.35 <.0001 
Diet*Time R 24 10.0833 51.56 <.0001 
Diet*Time R 48 9.6433 49.31 <.0001 
Diet*Time R 72 8.86 45.3 <.0001 
 
 
 
Table (a3) Results of p Values of Total Anaerobic Bacteria Counts 
Effect Diet _Diet t Value Pr > |t| 
Diet C F -3.52 0.0008 
Diet C L -0.67 0.5059 
Diet C R -8.21 <.0001 
Diet F L 2.85 0.0059 
Diet F R -4.69 <.0001 
Diet L R -7.54 <.0001 
 
 
 
Table (b1) Results of Type 3 Tests of Fixed Effects of Lactic Acid Bacteria Counts 
Effect Num DF Den DF F Value Pr > F 
Diet 3 64 15.7 <.0001 
Time 7 64 18.74 <.0001 
Diet*Time 21 64 0.99 0.487 
 
Table (b2) Results of Least Squares Means of Lactic Acid Bacteria Counts 
Effect Diet Time Estimate t Value Pr > |t| 
Diet C   7.6596 74.35 <.0001 
Diet F   8.1167 78.79 <.0001 
Diet L   7.5704 73.49 <.0001 
Diet R   8.4438 81.96 <.0001 
Time   0.5 6.9517 47.72 <.0001 
Time   1 7.2283 49.61 <.0001 
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Table( b2) Cont’d 
Effect Diet Time Estimate t Value Pr > |t| 
Time   4 7.8258 53.72 <.0001 
Time   12 8.205 56.32 <.0001 
Time   24 8.5108 58.42 <.0001 
Time   48 8.575 58.86 <.0001 
Time   72 8.5933 58.98 <.0001 
Diet*Time C 0.5 6.8267 23.43 <.0001 
Diet*Time C 1 6.98 23.96 <.0001 
Diet*Time C 4 7.62 26.15 <.0001 
Diet*Time C 12 7.5867 26.04 <.0001 
Diet*Time C 24 7.83 26.87 <.0001 
Diet*Time C 48 8.2867 28.44 <.0001 
Diet*Time C 72 8.5 29.17 <.0001 
Diet*Time F 0.5 7.16 24.57 <.0001 
Diet*Time F 1 7.38 25.33 <.0001 
Diet*Time F 2 8 27.46 <.0001 
Diet*Time F 4 8.09 27.76 <.0001 
Diet*Time F 12 7.96 27.32 <.0001 
Diet*Time F 24 9.1533 31.41 <.0001 
Diet*Time F 48 8.86 30.41 <.0001 
Diet*Time F 72 8.33 28.59 <.0001 
Diet*Time L 0.5 6.3867 21.92 <.0001 
Diet*Time L 1 6.9133 23.73 <.0001 
Diet*Time L 2 7.06 24.23 <.0001 
Diet*Time L 4 7.3367 25.18 <.0001 
Diet*Time L 12 8.1467 27.96 <.0001 
Diet*Time L 24 7.8567 26.96 <.0001 
Diet*Time L 48 8.2733 28.39 <.0001 
Diet*Time L 72 8.59 29.48 <.0001 
Diet*Time R 0.5 7.4333 25.51 <.0001 
Diet*Time R 1 7.64 26.22 <.0001 
Diet*Time R 2 8.0567 27.65 <.0001 
Diet*Time R 4 8.2567 28.34 <.0001 
Diet*Time R 12 9.1267 31.32 <.0001 
Diet*Time R 24 9.2033 31.59 <.0001 
Diet*Time R 48 8.88 30.48 <.0001 
Diet*Time R 72 8.9533 30.73 <.0001 
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Table (b3) Results of p Values of Lactic Acid Bacteria Counts 
Effect Diet _Diet t Value Pr > |t| 
Diet C F -3.14 0.0026 
Diet C L 0.61 0.5427 
Diet C R -5.38 <.0001 
Diet F L 3.75 0.0004 
Diet F R -2.25 0.0282 
Diet L R -5.99 <.0001 
 
 
 
Table (c1) Results of Type 3 Tests of Fixed Effects of Culturable Bifidobacterium spp. 
Counts 
Effect Num DF Den DF F Value Pr > F 
Diet 3 64 32.73 <.0001 
Time 7 64 7.75 <.0001 
Diet*Time 21 64 2.52 0.0024 
 
 
 
 
 
Table (c2) Results of Least Squares Means of Culturable Bifidobacterium spp. Counts 
Effect Diet Time Estimate t Value Pr > |t| 
Diet C   8.5127 129.74 <.0001 
Diet F   9.0081 137.29 <.0001 
Diet L   8.5458 130.25 <.0001 
Diet R   9.2881 141.56 <.0001 
Time   0.5 8.6742 93.48 <.0001 
Time   1 8.6821 93.57 <.0001 
Time   2 8.8292 95.15 <.0001 
Time   4 8.9142 96.07 <.0001 
Time   12 9.1633 98.75 <.0001 
Time   24 9.185 98.99 <.0001 
Time   48 8.8525 95.4 <.0001 
Time   72 8.4092 90.63 <.0001 
Diet*Time C 0.5 8.43 45.42 <.0001 
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Table (c2) Cont’d 
Effect Diet Time Estimate t Value Pr > |t| 
Diet*Time C 1 8.1183 43.75 <.0001 
Diet*Time C 2 8.53 45.96 <.0001 
Diet*Time C 4 8.2667 44.54 <.0001 
Diet*Time C 12 8.52 45.91 <.0001 
Diet*Time C 24 8.98 48.39 <.0001 
Diet*Time C 48 8.79 47.36 <.0001 
Diet*Time C 72 8.4667 45.62 <.0001 
Diet*Time F 0.5 8.3983 45.25 <.0001 
Diet*Time F 1 9.0033 48.51 <.0001 
Diet*Time F 2 9.04 48.71 <.0001 
Diet*Time F 4 9.6333 51.91 <.0001 
Diet*Time F 12 9.7667 52.63 <.0001 
Diet*Time F 24 9.21 49.63 <.0001 
Diet*Time F 48 8.7067 46.92 <.0001 
Diet*Time F 72 8.3067 44.76 <.0001 
Diet*Time L 0.5 8.6567 46.65 <.0001 
Diet*Time L 1 8.3633 45.07 <.0001 
Diet*Time L 2 8.5467 46.05 <.0001 
Diet*Time L 4 8.29 44.67 <.0001 
Diet*Time L 12 8.7267 47.02 <.0001 
Diet*Time L 24 8.87 47.8 <.0001 
Diet*Time L 48 8.57 46.18 <.0001 
Diet*Time L 72 8.3433 44.96 <.0001 
Diet*Time R 0.5 9.2117 49.64 <.0001 
Diet*Time R 1 9.2433 49.81 <.0001 
Diet*Time R 2 9.2 49.57 <.0001 
Diet*Time R 4 9.4667 51.01 <.0001 
Diet*Time R 12 9.64 51.94 <.0001 
Diet*Time R 24 9.68 52.16 <.0001 
Diet*Time R 48 9.3433 50.35 <.0001 
Diet*Time R 72 8.52 45.91 <.0001 
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Table (c3) Results of p Values of Culturable Bifidobacterium spp. Counts 
Effect Diet _Diet t Value Pr > |t| 
Diet C F -5.34 <.0001 
Diet C L -0.36 0.7223 
Diet C R -8.36 <.0001 
Diet F L 4.98 <.0001 
Diet F R -3.02 0.0037 
Diet L R -8 <.0001 
 
Table (d1) Results of Type 3 Tests of Fixed Effects of  Culturable E.coli. Counts 
Effect Num DF Den DF F Value Pr > F 
Diet 3 64 2.96 0.0388 
Time 7 64 33.99 <.0001 
Diet*Time 21 64 0.68 0.8381 
 
Table (d2) Results of Least Squares Means of Culturable E.coli Counts 
Effect Diet Time Estimate t Value Pr > |t| 
Diet C   6.9883 54.59 <.0001 
Diet F   6.9733 54.47 <.0001 
Diet L   6.8942 53.86 <.0001 
Diet R   7.3846 57.69 <.0001 
Time   0.5 5.6492 31.2 <.0001 
Time   1 5.7142 31.56 <.0001 
Time   2 6.1217 33.81 <.0001 
Time   4 7.3317 40.5 <.0001 
Time   12 7.6383 42.19 <.0001 
Time   24 7.9558 43.95 <.0001 
Time   48 7.9858 44.11 <.0001 
Time   72 8.0842 44.65 <.0001 
Diet*Time C 0.5 5.14 14.2 <.0001 
Diet*Time C 1 5.58 15.41 <.0001 
Diet*Time C 2 6.2433 17.24 <.0001 
Diet*Time C 4 7.0533 19.48 <.0001 
Diet*Time C 12 7.35 20.3 <.0001 
Diet*Time C 24 7.8933 21.8 <.0001 
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Table (d2) Cont’d 
Effect Diet Time Estimate t Value Pr > |t| 
Diet*Time C 48 8.3567 23.08 <.0001 
Diet*Time C 72 8.29 22.9 <.0001 
Diet*Time F 0.5 5.7 15.74 <.0001 
Diet*Time F 1 5.6367 15.57 <.0001 
Diet*Time F 2 5.95 16.43 <.0001 
Diet*Time F 4 7.1667 19.79 <.0001 
Diet*Time F 12 7.16 19.77 <.0001 
Diet*Time F 24 8.26 22.81 <.0001 
Diet*Time F 48 7.7233 21.33 <.0001 
Diet*Time F 72 8.19 22.62 <.0001 
Diet*Time L 0.5 5.65 15.6 <.0001 
Diet*Time L 1 5.41 14.94 <.0001 
Diet*Time L 2 5.96 16.46 <.0001 
Diet*Time L 4 7.22 19.94 <.0001 
Diet*Time L 12 7.5467 20.84 <.0001 
Diet*Time L 24 7.6233 21.05 <.0001 
Diet*Time L 48 7.97 22.01 <.0001 
 
Diet*Time R 0.5 6.1067 16.87 <.0001 
Diet*Time R 1 6.23 17.21 <.0001 
Diet*Time R 2 6.3333 17.49 <.0001 
Diet*Time R 4 7.8867 21.78 <.0001 
Diet*Time R 12 8.4967 23.47 <.0001 
Diet*Time R 24 8.0467 22.22 <.0001 
Diet*Time R 48 7.8933 21.8 <.0001 
Diet*Time R 72 8.0833 22.32 <.0001 
 
Table (d3) Results of p Values of Culturable E.coli Counts 
 
Effect Diet _Diet Estimate Standard 
Error 
DF t Value Pr > |t| 
Diet C F 0.015 0.181 64 0.08 0.9342 
Diet C L 0.09417 0.181 64 0.52 0.6048 
Diet C R -0.3962 0.181 64 -2.19 0.0323 
Diet F L 0.07917 0.181 64 0.44 0.6634 
Diet F R -0.4112 0.181 64 -2.27 0.0265 
Diet L R -0.4904 0.181 64 -2.71 0.0087 
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Table (e1) Results of Type 3 Tests of Fixed Effects of Bacterial Domain Analyzed by qRT-
PCR 
Effect Num DF Den DF F Value Pr > F 
Diet 3 48 1.54 0.2164 
Time 5 48 34.25 <.0001 
Diet*Time 15 48 1.01 0.4649 
 
Table (e2) Results of Least Squares Means of Bacterial Domain Analyzed by qRT-PCR 
Effect Diet Time Estimate Pr > |t| 
Diet C   10.5431 <.0001 
Diet F   10.6724 <.0001 
Diet L   10.5573 <.0001 
Diet R   10.6951 <.0001 
Time   0.5 10.2064 <.0001 
Time   1 10.291 <.0001 
Time   2 10.437 <.0001 
Time   4 10.4894 <.0001 
Time   12 10.8713 <.0001 
Time   24 11.4067 <.0001 
Diet*Time C 0.5 10.1075 <.0001 
Diet*Time C 1 10.0758 <.0001 
Diet*Time C 2 10.4756 <.0001 
Diet*Time C 4 10.6361 <.0001 
Diet*Time C 12 10.7209 <.0001 
Diet*Time C 24 11.2426 <.0001 
Diet*Time F 0.5 10.2772 <.0001 
Diet*Time F 1 10.21 <.0001 
Diet*Time F 2 10.4199 <.0001 
Diet*Time F 4 10.4101 <.0001 
Diet*Time F 12 11.185 <.0001 
Diet*Time F 24 11.5322 <.0001 
Diet*Time L 0.5 10.104 <.0001 
Diet*Time L 1 10.5281 <.0001 
Diet*Time L 2 10.362 <.0001 
Diet*Time L 4 10.2593 <.0001 
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Table (e2) Cont’d 
Effect Diet Time Estimate Pr > |t| 
Diet*Time L 12 10.7251 <.0001 
Diet*Time L 24 11.3652 <.0001 
Diet*Time R 0.5 10.337 <.0001 
Diet*Time R 1 10.3499 <.0001 
Diet*Time R 2 10.4905 <.0001 
Diet*Time R 4 10.652 <.0001 
Diet*Time R 12 10.8541 <.0001 
Diet*Time R 24 11.4868 <.0001 
 
Table (e3) Results of p Values of Bacterial Domain Analyzed by qRT-PCR 
Effect Diet _Diet t Value Pr > |t| 
Diet C F -1.46 0.1517 
Diet C L -0.16 0.8737 
Diet C R -1.71 0.0933 
Diet F L 1.3 0.2009 
Diet F R -0.26 0.7993 
Diet L R -1.55 0.1271 
 
Table (f1) Results of Type 3 Tests of Fixed Effects of Lactobacillus spp. Analyzed by qRT-
PCR 
Effect Num DF Den DF F Value Pr > F 
Diet 3 48 5.97 0.0015 
Time 5 48 33.11 <.0001 
Diet*Time 15 48 1.84 0.0567 
 
Table (f2) Results of Least Squares Means of Lactobacillus spp. Analyzed by qRT-PCR 
Effect Diet Time Estimate t Value Pr > |t| 
Diet C   7.4969 126.51 <.0001 
Diet F   7.5866 128.02 <.0001 
Diet L   7.3831 124.59 <.0001 
Diet R   7.7258 130.37 <.0001 
Time   0.5 7.0121 96.61 <.0001 
Time   1 7.2136 99.39 <.0001 
Time   2 7.4239 102.29 <.0001 
Time   4 7.679 105.8 <.0001 
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Table (f2) Cont’d 
Effect Diet Time Estimate t Value Pr > |t| 
Time   12 7.7968 107.43 <.0001 
Time   24 8.1633 112.48 <.0001 
Diet*Time C 0.5 6.8506 47.19 <.0001 
Diet*Time C 1 7.0892 48.84 <.0001 
Diet*Time C 2 7.497 51.65 <.0001 
Diet*Time C 4 7.7415 53.33 <.0001 
Diet*Time C 12 7.7154 53.15 <.0001 
Diet*Time C 24 8.0877 55.72 <.0001 
Diet*Time F 0.5 7.2324 49.82 <.0001 
 
Table (f3) Results of p Values of Lactobacillus spp. Analyzed by qRT-PCR 
Effect Diet _Diet t Value Pr > |t| 
Diet C F -1.07 0.2896 
Diet C L 1.36 0.1811 
Diet C R -2.73 0.0088 
Diet F L 2.43 0.019 
Diet F R -1.66 0.1032 
Diet L R -4.09 0.0002 
 
Table (g1) Results of Type 3 Tests of Fixed Effects of Bifidobacterium spp. Analyzed by 
qRT-PCR 
Effect Num DF Den DF F 
Value 
Pr > F 
Diet 3 48 5.97 0.0015 
Time 5 48 33.11 <.0001 
Diet*Time 15 48 1.84 0.0567 
 
Table (g2) Results of Least Squares Means of Bifidobacterium spp. Analyzed by qRT-PCR 
Effect Diet Time Estimate t Value Pr > |t| 
Diet C   7.4969 126.51 <.0001 
Diet F   7.5866 128.02 <.0001 
Diet L   7.3831 124.59 <.0001 
Diet R   7.7258 130.37 <.0001 
Time   0.5 7.0121 96.61 <.0001 
Time   1 7.2136 99.39 <.0001 
Time   2 7.4239 102.29 <.0001 
Time   4 7.679 105.8 <.0001 
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Table (g2) Cont’d      
Effect Diet Time Estimate t Value Pr > |t| 
Time   12 7.7968 107.43 <.0001 
Time   24 8.1633 112.48 <.0001 
Diet*Time C 0.5 6.8506 47.19 <.0001 
Diet*Time C 1 7.0892 48.84 <.0001 
Diet*Time C 2 7.497 51.65 <.0001 
Diet*Time C 4 7.7415 53.33 <.0001 
Diet*Time C 12 7.7154 53.15 <.0001 
Diet*Time C 24 8.0877 55.72 <.0001 
Diet*Time F 0.5 7.2324 49.82 <.0001 
Diet*Time F 1 7.0288 48.42 <.0001 
Diet*Time F 2 7.6019 52.37 <.0001 
Diet*Time F 4 7.4929 51.62 <.0001 
Diet*Time F 12 8.1362 56.05 <.0001 
Diet*Time F 24 8.0276 55.3 <.0001 
Diet*Time L 0.5 6.8172 46.96 <.0001 
Diet*Time L 1 7.3123 50.38 <.0001 
Diet*Time L 2 7.1289 49.11 <.0001 
Diet*Time L 4 7.6901 52.98 <.0001 
Diet*Time L 12 7.3718 50.79 <.0001 
Diet*Time L 24 7.9785 54.96 <.0001 
Diet*Time R 0.5 7.1482 49.24 <.0001 
Diet*Time R 1 7.4241 51.15 <.0001 
Diet*Time R 2 7.4678 51.45 <.0001 
Diet*Time R 4 7.7916 53.68 <.0001 
Diet*Time R 12 7.9637 54.86 <.0001 
Diet*Time R 24 8.5595 58.97 <.0001 
 
Table (g3) Results of p Values of Bifidobacterium spp. Analyzed by qRT-PCR 
Effect Diet _Diet Estimate t Value Pr > |t| 
Diet C F -0.08974 -1.07 0.2896 
Diet C L 0.1137 1.36 0.1811 
Diet C R -0.2289 -2.73 0.0088 
Diet F L 0.2035 2.43 0.019 
Diet F R -0.1392 -1.66 0.1032 
Diet L R -0.3427 -4.09 0.0002 
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Table (h1) Results of Type 3 Tests of Clostridium cluster IV Analyzed by qRT-PCR 
Effect Num DF Den DF F Value Pr > F 
Diet 3 48 2.92 0.0432 
Time 5 48 6.14 0.0002 
Diet*Time 15 48 1.17 0.323 
 
 
Table (h2) Results of Least Squares Means of Clostridium cluster IV Analyzed by qRT-
PCR 
Effect Diet Time Estimate t Value Pr > |t| 
Diet C   9.442 169.44 <.0001 
Diet F   9.5791 171.9 <.0001 
Diet L   9.3887 168.49 <.0001 
Diet R   9.5729 171.79 <.0001 
Time   0.5 9.615 140.89 <.0001 
Time   1 9.6021 140.7 <.0001 
Time   2 9.705 142.2 <.0001 
Time   4 9.3747 137.36 <.0001 
Time   12 9.2689 135.81 <.0001 
Time   24 9.4083 137.86 <.0001 
Diet*Time C 0.5 9.6346 70.59 <.0001 
Diet*Time C 1 9.3917 68.81 <.0001 
Diet*Time C 2 9.7726 71.6 <.0001 
Diet*Time C 4 9.3436 68.45 <.0001 
Diet*Time C 12 9.1663 67.16 <.0001 
Diet*Time C 24 9.3433 68.45 <.0001 
Diet*Time F 0.5 9.6296 70.55 <.0001 
Diet*Time F 1 9.5429 69.91 <.0001 
Diet*Time F 2 9.8147 71.91 <.0001 
Diet*Time F 4 9.4056 68.91 <.0001 
Diet*Time F 12 9.6465 70.67 <.0001 
Diet*Time F 24 9.4354 69.13 <.0001 
Diet*Time L 0.5 9.3901 68.79 <.0001 
Diet*Time L 1 9.7488 71.42 <.0001 
Diet*Time L 2 9.4624 69.32 <.0001 
Diet*Time L 4 9.2628 67.86 <.0001 
Diet*Time L 12 9.1311 66.9 <.0001 
Diet*Time L 24 9.3369 68.41 <.0001 
Diet*Time R 0.5 9.8058 71.84 <.0001 
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Table (h2) Cont’d  
Effect Diet Time Estimate t Value Pr > |t| 
Diet*Time R 2 9.7701 71.58 <.0001 
Diet*Time R 4 9.4869 69.5 <.0001 
Diet*Time R 12 9.1317 66.9 <.0001 
Diet*Time R 24 9.5175 69.73 <.0001 
 
Table (h3) Results of p Values of Clostridium cluster IV Analyzed by qRT-PCR 
Effect Diet _Diet t Value Pr > |t| 
Diet C F -1.74 0.0884 
Diet C L 0.68 0.5018 
Diet C R -1.66 0.1034 
Diet F L 2.42 0.0195 
Diet F R 0.08 0.9373 
Diet L R -2.34 0.0237 
 
Table (i1) Results of Type 3 Tests of Clostridium cluster XIVa-b Analyzed by qRT-PCR 
Effect Num DF Den DF F Value Pr > F 
Diet 3 48 2.21 0.0987 
Time 5 48 7.38 <.0001 
Diet*Time 15 48 0.97 0.5033 
 
Table (i2) Results of Least Squares Means of Clostridium cluster XIVa-b Analyzed by 
qRT-PCR 
Effect Diet Time Estimate t Value Pr > |t| 
Diet C   7.6775 93.76 <.0001 
Diet F   7.8472 95.84 <.0001 
Diet L   7.6463 93.38 <.0001 
Diet R   7.8915 96.38 <.0001 
Time   0.5 7.6092 75.88 <.0001 
Time   1 7.635 76.13 <.0001 
Time   2 7.6942 76.72 <.0001 
Time   4 7.5681 75.47 <.0001 
Time   12 7.7879 77.66 <.0001 
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Table (i2) Cont’d 
Effect Diet Time Estimate t Value Pr > |t| 
Time   24 8.2995 82.76 <.0001 
Diet*Time C 0.5 7.4547 37.17 <.0001 
Diet*Time C 1 7.3929 36.86 <.0001 
Diet*Time C 2 7.7104 38.44 <.0001 
Diet*Time C 4 7.5678 37.73 <.0001 
Diet*Time C 12 7.6679 38.23 <.0001 
Diet*Time C 24 8.2714 41.24 <.0001 
Diet*Time F 0.5 7.6966 38.37 <.0001 
Diet*Time F 1 7.5674 37.73 <.0001 
Diet*Time F 2 7.7583 38.68 <.0001 
Diet*Time F 4 7.5057 37.42 <.0001 
Diet*Time F 12 8.2656 41.21 <.0001 
Diet*Time F 24 8.2899 41.33 <.0001 
Diet*Time L 0.5 7.5267 37.53 <.0001 
Diet*Time L 1 7.8852 39.31 <.0001 
Diet*Time L 2 7.5436 37.61 <.0001 
Diet*Time L 4 7.2467 36.13 <.0001 
Diet*Time L 12 7.4617 37.2 <.0001 
Diet*Time L 24 8.2142 40.95 <.0001 
Diet*Time R 0.5 7.7588 38.68 <.0001 
Diet*Time R 1 7.6947 38.36 <.0001 
Diet*Time R 2 7.7644 38.71 <.0001 
Diet*Time R 4 7.9521 39.65 <.0001 
Diet*Time R 12 7.7565 38.67 <.0001 
Diet*Time R 24 8.4226 41.99 <.0001 
 
Table (i3) Results of p Values of Clostridium cluster XIVa-b Analyzed by qRT-PCR 
Effect Diet _Diet t Value Pr > |t| 
Diet C F -1.47 0.1492 
Diet C L 0.27 0.7891 
Diet C R -1.85 0.0707 
Diet F L 1.73 0.0892 
Diet F R -0.38 0.7039 
Diet L R -2.12 0.0394 
 
 
Table (j1) Results of Type 3 Tests of Bacteroidetes Group Analyzed by qRT-PCR 
Effect Num DF Den DF F Value Pr > F 
Diet 3 48 0.43 0.7348 
Time 5 48 60.46 <.0001 
Diet*Time 15 48 0.42 0.9642 
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Table (j2) Results of Least Squares Means of Bacteroidetes Group Analyzed by qRT-PCR 
 
Effect Diet Time Estimate t Value Pr > |t| 
Diet C   8.8407 68.65 <.0001 
Diet F   8.9442 69.69 <.0001 
Diet L   8.9126 69.38 <.0001 
Diet R   8.9963 70.22 <.0001 
Time   0.5 8.1627 50.5 <.0001 
Time   1 8.2294 51.05 <.0001 
Time   2 8.3247 51.83 <.0001 
Time   4 8.6191 54.24 <.0001 
Time   12 9.7778 63.74 <.0001 
Time   24 10.427 69.06 <.0001 
Diet*Time C 0.5 8.0908 24.96 <.0001 
Diet*Time C 1 7.9448 24.36 <.0001 
Diet*Time C 2 8.2836 25.75 <.0001 
Diet*Time C 4 8.6313 27.17 <.0001 
Diet*Time C 12 9.7462 31.74 <.0001 
Diet*Time C 24 10.3473 34.2 <.0001 
Diet*Time F 0.5 8.1377 25.15 <.0001 
Diet*Time F 1 8.0969 24.98 <.0001 
Diet*Time F 2 8.2942 25.79 <.0001 
Diet*Time F 4 8.5684 26.91 <.0001 
Diet*Time F 12 10.0218 32.87 <.0001 
Diet*Time F 24 10.5461 35.02 <.0001 
Diet*Time L 0.5 8.1432 25.17 <.0001 
Diet*Time L 1 8.5171 26.7 <.0001 
Diet*Time L 2 8.2138 25.46 <.0001 
Diet*Time L 4 8.5187 26.71 <.0001 
Diet*Time L 12 9.7881 31.91 <.0001 
Diet*Time L 24 10.2945 33.98 <.0001 
Diet*Time R 0.5 8.279 25.73 <.0001 
Diet*Time R 1 8.3587 26.05 <.0001 
Diet*Time R 2 8.5071 26.66 <.0001 
Diet*Time R 4 8.758 27.69 <.0001 
Diet*Time R 12 9.5549 30.95 <.0001 
Diet*Time R 24 10.5201 34.91 <.0001 
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Table (j3) Results of p Values of Bacteroidetes Group Analyzed by qRT-PCR 
Effect Diet  Diet t Value Pr > |t| 
Diet C F -0.73 0.4662 
Diet C L -0.51 0.6123 
Diet C R -1.1 0.2749 
Diet F L 0.22 0.8235 
Diet F R -0.37 0.7131 
Diet L R -0.59 0.5552 
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